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Abstract 
 
Oxidised bases in DNA are removed by a number of DNA glycosylases in the first 
step of base excision repair. These include 8-oxoguanine DNA glycosylase (OGG1), 
endonuclease III-like 1 (NTH1) and the Nei-like proteins, NEIL1, NEIL2 and NEIL3. 
While NEIL1 and NEIL2 are relatively well characterized, the function of NEIL3 is still 
not fully understood. Although all three proteins show homology to the Escherichia 
coli Fpg/Nei family, NEIL3 is the largest member with an extended C-terminal domain 
and contains a valine instead of the highly conserved proline residue at amino acid 
position two. While it has been reported that recombinant murine NEIL3 shows DNA 
glycosylase and AP lyase activities in vitro, its biological role remains unclear. 
Therefore, to gain an insight into the function of NEIL3 in vivo, the full-length human 
NEIL3 cDNA has been expressed in Saccharomyces cerevisae as a prelude to 
undertake a yeast 2-hybrid screen to determine specific protein-protein interactions. 
To date, cDNA library screenings for potential hNEIL3 interactors have been 
completed and clones expressing potential interactors have been isolated, 
sequenced and analysed. This data, along with the results of other confirmatory 
experiments are presented in this thesis. Furthermore, clones of Pichia pastoris 
harbouring an expression cassette with full-length human NEIL3 or mouse NEIL1 or 
truncated versions of hNEIL3 with amino acid length 1-394 and 1-502 cDNA have 
been generated in preparation for its overexpression in a eukaryotic system. It is 
envisaged that the expression of 6XHis tagged hNEIL3 in P. pastoris will enable the 
purification of hNEIL3 protein that can be used in enzyme assays and for further in 
vitro investigations of putative protein interactions discovered by yeast two-hybrid 
(Y2H) screen.  
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1 Abbreviations 
3′P    3′-phosphate 
3′PUA    3′-phospho α,β-unsaturated aldehyde 
5′dRP    5′-deoxyribonucleotide phosphate 
5′P    5′-phosphate 
5-OH-U   5-hydroxyuracil 
5-OH-C   5-hydroxycytosine 
6XHis    polyhistidine tag 
2-oxoA    2-oxo-1,2-dihydroadenine 
8-oxoA    8-oxo-7,8-dihydroadenine 
8-oxoG   8-oxo-7,8-dihydroguanine 
ADH    alcohol dehydrogenase 
AP    apurinic/apyrimidinic 
APE1    apurinic/apyrimidinic (abasic) endonuclease 
APE2    apurinic/apyrimidinic (abasic) endonuclease 2 
APNG    alkylpurine DNA-N-glycosylase 
APS    ammonium persulphate 
APTX    forkhead-associated domain histidine triad-like protein  
AmpR    ampicillin resistance sequence 
ATM    ataxia telangiectasia mutated 
ATR    ATM and Rad3-related 
BER    base excision repair 
BLAST    basic local alignment search tool 
bp    base pair(s) 
cDNA    complementary DNA 
cfu    colony forming unit(s) 
conc.    concentration 
DDR    DNA-damage response 
DSB(s)   DNA double strand break(s) 
DHT    dihydrothymine 
DHU     dihydrouracil 
DNA-BD   DNA binding domain 
DMSO    dimethylsulfoxide 
DR    direct reversal 
dRPase   deoxyribophosphodiesterase 
dsDNA    double-stranded DNA 
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FapyA    4,6-diamino-5-formamidopyrimidine 
FapyG    2,6-diamino-4-hydoxy-5-formamidopyrimidine 
FEN1    Flap endonuclease 1 
GAPDH   glyceraldehyde-3-phosphate dehydrogenase 
Gh    guanidinohydantoin 
H2TH motif   helix-two turn-helix motif 
HDAC1   histone deacetylase-1 
HhH motif   helix-hairpin-helix motif 
HR    homologous recombination 
HRP    horseradish peroxidase 
hN3-394   truncated version of human NEIL3, amino acids 1-394 
hN3-502   truncated version of human NEIL3, amino acids 1-502 
hNEIL3   human NEIL3 
IPTG    isopropyl-β-D-thiogalactopyranoside 
LacZ    LacZ gene 
LB-Carb   Lysogeny broth - agar plate with carbenicillin 
LB-Carb-broth   Lysogeny broth with carbenicillin 
Leu2    leucine coding gene (Leu2) 
LexA    LexA – repressor 
LigI    DNA ligase I 
LigIIIα    DNA ligase III alpha 
M1dG    pirymido-[1,2 α ]purine-10(3H)-one-2′-deoxyribose 
M2H    mammalian two-hybrid 
Me-FapyG   2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine 
MGMT    O6-methylguanine-DNA methyltransferase 
mNEIL3   mouse NEIL3 
mNTH1   mouse NTH1 
MMEJ    microhomology-mediated end joining 
MMR    mismatch repair 
MOLT4   human acute lymphoblastic leukaemia cells 
MutS, MutL, MutH  methyl-directed mismatch repair proteins 
NaOAc   sodium acetate 
NEIL/Neil   nei-like 
NER    nucleotide excision repair 
NHEJ    non-homologous end joining 
NLS    nuclear localization sequence 
NTH1    endonuclease III-like 1  
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OGG1    8-oxoguanine DNA glycosylase 
PARP-1   Poly (ADP-ribose) polymerase 1 
PCR    polymerase chain reaction 
pEG202   bait vector used in yeast two-hybrid 
pEG202-N3   pEG202 containing hNEIL3 cDNA 
pEG202(-NLS)  pEG202 and pEG202-NLS 
pEG202(-NLS)-N3  pEG202 and pEG202-NLS containing hNEIL3 cDNA 
PNK    polynucleotide kinase  
Pro2    proline at amino acid position two (N-terminal) 
Polβ    DNA polymerase β 
Polδ    DNA polymerase δ 
Polε    DNA polymerase ε 
ROS    reactive oxygen species 
SDS-PAGE   sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SMUG1   single-strand selective monofunctional uracil DNA glycosylase 
SNP    single nucleotide polymorphism 
SOD    superoxide dismutase 
Sp    spiroiminodihydantoin 
SSB(s)    DNA single-strand breaks 
ssDNA    single-stranded DNA 
TDG    thymine DNA glycosylase 
Tg    thymine glycol 
TEMED   tetramethylethylendiamine 
TopoIIIα   DNA topoisomerase IIIα 
UAS    upstream activation sequence 
UDG/UNG   uracil-DNA glycosylase 
UvrD    DNA helicase II 
Val2    valine at amino acid position two 
vDNA    viral DNA 
X-gal    bromo-chloro-indolyl-galactopyranoside 
Y2H    yeast two-hybrid 
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2 Introduction 
 
DNA damage in aerobic cells is mainly caused by reactive oxygen species (ROS). 
ROS are formed as by-products of electron transport in mitochondria or by exposure 
to environmental agents. At low concentrations ROS are mediators of specific 
physiological processes such as cell proliferation and inflammatory responses. 
However, if the concentrations become too high, the negative effects of these 
oxidants are increased including DNA damage which can cause various changes in 
the chemistry of bases, sugars and phosphates resulting in mutagenesis or cell death 
(Nakabeppu et al., 2004; Uchida, 2003; Winczura et al., 2012). One of several DNA 
repair mechanisms, base excision repair (BER) is a major pathway that can 
recognize and replace damaged DNA bases (David & Williams, 1998). BER is 
initiated by DNA glycosylases. The oxidative damage-specific DNA glycosylases in 
bacteria have been extensively studied and in Escherichia coli, formamidopyrimidine 
[fapy]-DNA glycosylase (Fpg), endonuclease VIII (Nei), and endonuclease III (Nth) 
act on overlapping sets of modified DNA bases (Wallace, 2002). Nth and the 
mammalian homologues 8-oxoguanine DNA glycosylase (OGG1) and nth 
endonuclease III-like 1 (NTH1) have an internal lysine (Lys) residue at the active site, 
while Fpg and Nei use an N-terminal proline (Pro) residue. Nth and Nei in E. coli act 
as DNA glycosylases that remove oxidized pyrimidines, including free radical - 
damaged thymines and cytosines. Fpg, also known as MutM, can recognize and 
repair oxidized purines such as 8-oxo-7,8-dihydroguanine (8-oxoG) and 2,6-diamino-
4-hydroxy-5-formamidopyrimidine (FapyG) (Tchou et al., 1994; Hazra et al., 2002a; 
Wallace, 2002). NEIL1, NEIL2 and NEIL3 are mammalian proteins of the Nei-like 
(NEIL) family. Nei-like is designated in this way, because Nei, encoded by the nei 
gene of E. coli, is homologous to NEIL1, NEIL2 and NEIL3. However, NEIL2 is the 
only protein of these three which recognizes oxidized pyrimidines exclusively while 
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NEIL1 is a functional hybrid of Fpg and Nei as it can repair oxidized purines and 
pyrimidines. NEIL3 has recently been shown to act on oxidized purines such as 
FapyG, 4,6-diamino-5-formamidopyrimidine (FapyA), and the hydantoin lesions 
guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp), preferentially on single-
stranded DNA (ssDNA) (Liu et al., 2013). 
 
2.1 DNA damage 
 
Under aerobic conditions, a cell of any origin has the potential to be under oxidative 
stress, the level of which can vary dramatically depending on different factors such 
as environmental stress levels (e.g. radiation or heat exposure). Oxidative stress is 
the imbalance between oxidants and antioxidants in favour of the oxidants that can 
lead to cell damage and death. Such oxidants can either enter a cell exogenously in 
the form of oxidising agents or are produced endogenously as by-products from 
mitochondria during oxidative phosphorylation (Devasagayam et al., 2004). Oxidants 
and radiation can lead to various types of DNA damage which include single- and 
double-strand DNA breaks, DNA inter-, intra-strand and protein cross-links, DNA 
adduction and oxidation, covalent dimer formation and spontaneous hydrolysis of a 
base leaving an abasic, an apurinic/apyrimidinic (AP) site (Bernstein et al., 2002; 
Drablos et al., 2004). 
 
One major reason for DNA damage caused by oxidants are ROS, chemically reactive 
molecules containing oxygen that are formed as a natural by-product during aerobic 
respiration (Devasagayam et al., 2004). ROS can attack and alter the chemical 
nature of cellular components. However, over time cells have developed an 
incredible diversity of defence mechanisms to either neutralize such threats before 
any damage has occurred or to recognize and repair or replace cellular 
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macromolecules (Pierce, 2012; Izumi et al., 2003). In particular the maintenance of 
genomic integrity plays a crucial role for the survival of any organism. A loss of 
genomic stability often leads to an increased risk of genetic diseases, premature 
aging and the formation of malignant diseases. The integrity of the genome is 
ensured by a strictly coordinated regulation of different cellular processes such as 
DNA replication, DNA repair, senescence and apoptosis. These processes are 
controlled and coordinated by DNA damage checkpoints (Shiotani & Zou, 2009). 
 
The activation of checkpoint signals can lead to an arrest of the cell cycle in G1 thus 
preventing DNA replication. This process allows the cell to remove lesions from its 
genomic DNA, and therefore hinders the rise of mutations or the collapse of the 
replication fork. The latter can lead to the formation of DNA double-strand breaks 
(DSBs) which can result in chromosomal damage and cell death. In many cases, 
checkpoint-signals stimulate the cellular DNA repair machinery and therefore greatly 
contribute to minimize the toxic effects of DNA damage (Li & Zou, 2005). 
 
Cell-cycle progression, DNA repair, DNA replication, transcription and apoptosis are 
coordinated by the DNA-damage response (DDR). Studies on genes involved in 
DDR have revealed that their deletion can lead to lethality, premature aging 
syndromes, cancer and neurodegenerative disorders (Nam & Cortez, 2011). 
Although to date the mechanism of DNA damage sensing within a cell remains 
unclear, it has been proposed that Rad1, Rad9 and Hus1, all fission yeast proteins, 
form a trimeric protein complex, a damage sensor clamp known to interact with DNA 
polymerase β (Polβ) and increasing its efficiency in DNA repair (Toueille et al., 2004). 
The structure of this complex is similar to the conformation of the eukaryotic DNA 
sliding clamp proliferating cell nuclear antigen (PCNA) a cofactor for DNA 
polymerase δ (Polδ). Therefore, PCNA is likely to have a similar function to that of 
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the Rad9/Rad1/Hus1 complex and thus increases the processivity of DNA replication 
in eukaryotes (Lowndes & Murguia, 2000; Venclovas & Thelen, 2000). 
 
If the integrity of the genome in mammalian cells is compromised, the activation of 
DDR is coordinated by three major protein kinases, ataxia telangiectasia mutated 
(ATM), DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia and 
Rad3-related (ATR) (Brown & Baltimore, 2003; Nam & Cortez, 2011). These 
serine/threonine-specific protein kinases belong to the phospho-inositol-3-kinase-like 
protein kinase family and share similar domain structures. However, while ATM and 
DNA-PK are activated primarily by DSBs, ATR can additionally be activated by a 
much wider spectrum of DNA lesions such as base adducts, stalled replication forks 
and DNA cross-links (Nam & Cortez, 2011). When activated, ATR phosphorylates 
the kinase Chk1 and this way initiates a signal transduction cascade that leads to G1 
cell cycle arrest that gives the cell time to repair the DNA damage before DNA 
replication is restarted (Brown & Baltimore, 2003). The tumour suppressor p53 is also 
regulated by the DDR and is one of the most important proteins involved in the 
maintenance of genomic integrity. In the cell, p53 plays an essential role in the 
regulation of cell cycle progression, apoptosis and DNA repair in response to various 
stress signals resulting from oxidative stress (Harris & Levine, 2005). 
 
2.1.1 Oxidation of DNA bases 
 
ROS are generated as by-products of the mitochondrial electron transport chain, 
such as superoxide (O2
●-), hydrogen peroxide (H2O2) and the highly reactive hydroxyl 
radical (●OH) (Figure 1). 
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Figure 1: Example for ROS formed during aerobic metabolism. 
The unpaired orbits of dioxygen can accept single electrons to 
form the superoxide radical (1) which then can accept more 
electrons to form hydrogen peroxide (2) and further reduction 
leads to the highly reactive hydroxyl radical (3). 
 
The most abundant oxidized DNA purine base, 8-oxoG, is generated by ROS and 
ionizing radiation where an additional oxygen is added to the C8 position of guanine  
(Figure 2). Furthermore, the frequency of 8-oxoG generation is increased in 
organisms with a higher metabolic rate and in mitochondrial DNA rather than in 
nuclear DNA (Beckman & Ames, 1998). Because of its abundant nature 8-oxoG is 
often used as an indicator for oxidative stress in a cell. 8-oxoG can lead to G  T 
transversions and is therefore highly mutagenic. Guanine can also be oxidized to 
FapyG (Figure 2) another abundant form of abnormal guanine that can lead to G  T 
base transversions and other base mutations (Jena & Mishra, 2012; Krwawicz et al., 
2007; Izumi et al., 2003; Morland et al., 2002). The levels of FapyG lesions in cells is 
significantly (6.5 fold) higher than the levels of 8-oxoG and FapyA and therefore new 
methods using FapyG to quantify the oxidative stress level have been developed  
(Hu et al., 2005). However, the best way to measure cellular oxidative stress might 
be to include several types of DNA lesions in such assays as the type of base 
oxidation varies depending on the type of oxidative stress the cell undergoes 
(Kanvah et al., 2010).  
 
Me-FapyG, the methylated analogue of FapyG, is the result of alkylation of guanine 
in DNA with subsequent oxidative attack or UV radiation (Figure 3) (Asagoshi et al., 
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2002). Furthermore, Me-FapyG is able to significantly block DNA synthesis in E. coli 
(Hu et al., 2005). Due to the fact that Me-FapyG is chemically distinct from FapyG, 
extrapolating results obtained with Me-FapyG to FapyG must be interpreted with 
care, although it is commonly done by several groups (e.g. Asagoshi et al., 2002; 
Graziewicz et al., 2000). 
 
Further oxidation of 8-oxoG caused by various oxidizing agents results in the 
hydantoin lesions Sp or Gh respectively while the pyrimidine ring of guanine is 
opened in Gh and closed in Sp (Figure 2) (Niles et al., 2004; Jena & Mishra, 2012). 
 
Figure 2: Examples of oxidations of guanine. O in grey is the oxidized site. N in grey is the  
β-N-glycosidic binding site. 
 
 
Figure 3: Oxidation of 7-methyl guanine (7mG) forms 
Me-FapyG. (Image taken from Asagoshi et al., 2002). 
Me-FapyG 7mG 
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Like 8-oxoG and FapyG, FapyA (Figure 4) is another very abundant oxidised base 
lesion generated by ionizing radiation or ROS. FapyA can be a toxic lesion due its 
ability to block DNA synthesis (Graziewicz et al., 2000). The oxidized adenine 
residue 8-oxo-7,8-dihydroadenine (8-oxoA) causes no mutagenic incorporation, does 
not block DNA synthesis by the E. coli DNA polymerase I and the DNA duplex 
conformation stays intact which implies that 8-oxoA has limited or no biological effect 
on DNA replication (Guschlbauer et al., 1991; Figure 4). However, a more recent 
study showed that 8-oxoA in mammalian cells can induce AC transversions and 
AG transitions at a rate comparable to that of 8-oxoG (Kamiya et al., 1995a). 
However, as other research showed that the AC transversion rate caused by  
8-oxoA is at least four times lower than for 8-oxoG, the real biological significance of 
8-oxoA remains to be determined (Tan et al., 1999). The C2 position in adenine is 
also prone for oxidation via ionizing radiation and various ROS resulting in 2-oxo-1,2-
dihydroadenine (2-oxoA; Figure 4). Although, 2-oxoA generally still pairs with thymine 
it can also pair with cytosine resulting in an AG transition (Hori et al., 2010; Kamiya 
& Kasai, 1995b). The 2-oxo-dATP nucleotide can be misincorporated opposite G 
during DNA synthesis resulting in a GT transversion (Inoue et al., 1998). 
 
 
Figure 4: Examples of oxidation of adenine. O in grey is the oxidized site. 
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Cytosine can be oxidized to 5-hydroxycytosine (5-OH-C; Figure 5) which has a weak 
C  T mutagenic activity. However, 5-OH-C can be deaminated to 5-hydroxyuracil 
(5-OH-U; Figure 6) which is a highly mutagenic lesion and responsible for C  T 
transition mutations (Kreutzer & Essigmann, 1998). 
 
 
Figure 5: Examples of oxidation and further deamination of cytosine. NH in grey is the 
deoxyribose binding site. OH in grey is the oxidized site. 
 
As a result of ionizing radiation and oxidative stress thymine can be transformed to 
thymine glycol (Tg; Figure 6) an abundant DNA lesion known to block DNA 
replication and also to form a Tg:G mismatch resulting in a TC transition (Krwawicz 
et al., 2007; Kusumoto et al., 2002; Yoon et al., 2003). 
 
 
Figure 6: An example of the oxidation of thymine. OH in 
grey is oxidized site. 
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2.1.2 Spontaneous DNA damage formation 
 
Two major forms of spontaneous DNA damage exist, deamination of bases and 
depurination. Depurination is the spontaneous DNA hydrolysis of the purines adenine 
and guanine at the β-N-glycosidic bond resulting in an AP site that can block DNA 
synthesis and is therefore cytotoxic (Breen & Murphy, 1995). It has been estimated 
that every day, between 2,000 – 10,000 DNA purine bases are lost due to 
depurination in a human cell (Lindahl, 1993). 
 
Base deamination, is the hydrolytic removal of an amine group from cytosine, 
adenine or guanine. Deamination of cytosine results in uracil that can lead to CT 
transition as uracil pairs with adenine during DNA replication (Figure 7).  
 
Figure 7: Deamination of cytosine (left) to uracil (right). 
 
2.1.3 UV damage 
 
The ultraviolet (UV) light spectrum includes the wavelengths in the range  
100-380 nm. This area is subdivided into UV-A (315-380 nm), UV-B (280-315 nm) 
and UV-C (100-280 nm). UV-B is the most mutagenic component of the UV spectrum 
that can lead to bipyrimidine photoproducts such as the toxic and mutagenic 
cyclobutane-pyrimidine dimers (Figure 8) and 6-4-photoproducts that are formed at 
5′-T-C-3′, 5′-C-C-3′, 5′-T-T-3′ DNA sequences (Figure 9) (Sinha & Häder, 2002; 
Cadet et al., 2005). 
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Figure 8: Formation of cyclobutane-pyrimidine dimers: thymine-thymine  
dimer (A) and thymine-cytosine dimer (B). (Image adapted from Sinha and Häder, 
2002). 
 
 
 
Figure 9: Formation of a 6-4 photoproduct, in this case 6-4 TT from 5′-T-T-3′.  
(Image adapted from Sinha and Häder, 2002). 
 
If these DNA lesions are not removed from DNA they can affect genomic integrity 
which subsequently can affect cell and tissue homeostasis and cause mutations in 
oncogenes and tumour-suppressor genes leading to carcinogenesis or apoptosis of 
the cell (Cadet et al., 2005). 
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2.1.4 Lipid peroxidation 
 
There is evidence that many damaging effects on cellular components under 
oxidative stress are caused by the products of lipid degradation. This process of 
peroxidative degradation of polyunsaturated fatty acids is called lipid peroxidation 
and is a result of a free radical chain reaction (Uchida, 2003). Lipid peroxidation 
includes three steps, the initiation, propagation and the termination step. The 
oxidative chain reaction is initiated by ROS such as ●OH attacking the double bonds 
of the polyunsaturated fatty acids which then leads to a lipid radical that reacts with 
O2 producing a lipid peroxyl radical (1 in Figure 10). This lipid peroxyl radical is highly 
reactive oxidizing further lipids and propagating a chain reaction (2 in Figure 10). This 
chain reaction carries on until a lipid radical reacts with another lipid radical or an 
antioxidant such as γ-tocopherol (vitamin E) terminates the process by transferring a 
hydrogen atom that renders the lipid peroxyl radical into a lipid peroxide that can be 
further processed either enzymatically or spontaneously into an inert hydroxy fatty 
acid or other stable products (4 in Figure 10) (Uchida, 2003; Sattler et al., 2006; 
Winczura et al., 2012). 
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Figure 10: The three steps of the lipid peroxidation chain reaction. Initiation step (1) renders a 
polyunsaturated fatty acid into a lipid peroxyl radical. This radical can react with further 
polyunsaturated fatty acids in the propagation step (2). Only if neutralized by an antioxidant 
such as γ-tocopherol or another lipid peroxyl radical is the chain reaction terminated (3). 
Further enzymatic or spontaneous conversion changes the lipid peroxide into a more stable 
product such as hydroxy fatty acid (4). (Image adapted from Sattler et al., 2006). 
 
The lipid peroxyl radical can cyclize and subsequently be further oxidized by O2 to 
form an isoprostane (Figure 11) (Winczura et al., 2012). The so formed isoprostane 
is highly unstable and either spontaneously rearranges to form other types of 
isoprostanes or it decays into fragments, releasing malondialdehyde (MDA;  
Figure 11) (Sattler et al., 2006; Winczura et al., 2012). 
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Figure 11: Formation of Isoprostane and MDA. (Image adapted from Sattler et al., 2006). 
 
In DNA, MDA reacts with guanine, adenine and cytosine to form several pre-
mutagenic adducts. The major adduct is the cyclic pirymido-[1,2 α ]purine-10(3H)-
one-2′-deoxyribose (M1dG; Figure 12) which can induce GT transversions or GA 
transitions at a similar frequency to 8-oxoG (Valko et al., 2006). 
 
 
Figure 12: Chemical structure of M1dG.  
(Image adapted from Winczura et al., 2012). 
 
Further DNA lesions caused by lipid peroxidation products, but also by exposure to 
carcinogens such as vinyl chloride, are etheno adducts where a five membered 
exocyclic ring is attached to DNA bases leading to 1,N2-ethenoguanine (1,N2-εG), 
N2,3-ethenoguanine (N2,3-εG), 3,N4-ethenocytosine (3,N4-εC) and  
1,N6-ethenoadenine (1,N6-εA). How the formation of etheno adducts exactly occur  
in vivo is not fully understood to date and remains to be determined (Winczura et al. 
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2012). However, exocyclic bases can be mutagenic. After DNA replication, 1,N2-εG 
can lead to GT and GC transversions (Langouet et al., 1997) and N2,3-εG is 
prone to base pair with cytosine and thymine leading to GA transitions if the latter 
(Cheng et al., 1991). 3,N4-εC can mismatch with thymine and adenine resulting in 
CA transversions and CT transitions (Moriya et al., 1994). If paired with adenine 
or cytosine, 1,N6-εA can lead to AT tranversions or AG transitions respectively 
(Pandya & Moriya, 1996). 
 
 
Figure 13: Structures of 1,N
2
-ethenoguanine (1,N
2
-εG), N
2
,3-ethenoguanine  
(N
2
,3-εG), 3,N
4
-ethenocytosine (3,N
4
-εC), 1,N
6
-ethenoadenine (1,N
6
-εA).  
(Image adapted from Winczura et al., 2012). 
 
 
 
 
 
 
 Thomas ROEDL – PhD Thesis – Salford 2013 15 
2.1.5 Alkylation DNA damage 
 
A very common form of alkylation is the methylation of DNA. Depending on the 
position of the methyl group, the nucleotide can be rendered pre-mutagenic or toxic. 
However, methylation of cytosine on C5 that forms 5-methylcytosine (5meC) is 
crucial for several functions within a cell such as regulation of gene expression and 
chromatin modification in eukaryotic cells (Jair et al., 2013). 
 
Figure 14 shows a summary of positions that are susceptible to methylation and 
alkylation in general whereas the different positions either cause toxicity, 
mutagenesis or spontaneous depurination. 
 
Figure 14: Summary of positions prone to methylation (Me) in 
thymine, adenine, cytosine and guanine. Me with a star 
represents toxic lesions, with a triangle pre-mutagenic lesions 
and with a circle lesions that are susceptible to spontaneous 
depurination. (Image adapted from Wyatt and Pittman, 2006). 
 
Commonly known agents that can cause DNA alkylation are cytotoxic anti-cancer 
drugs, N-nitroso compounds found in tobacco, methane gas released from industry 
and N-nitrosamines that are consumed with smoked meat (Hecht, 1999; Lijinsky, 
1999). 
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2.1.6 DNA strand breaks 
 
Double-strand breaks can be generated by blocking lesions that stop DNA replication 
and can lead to a collapse of the replication fork. Such blocking lesions are generally 
generated, either directly or indirectly by radiation, ROS or other chemical agents that 
cause oxidative damage to C1 or C4 of the deoxyribose in the phosphate backbone 
of DNA. Although, DSBs are essential for meiotic recombination they also can be 
indirectly lethal to cells by inducing mutations, deletions or translocations to the 
chromosomal DNA that can lead to apoptosis or cancer whereas apoptosis is 
controlled by the ATM-ATR signalling pathway that arrests cell cycle in G1 phase 
allowing DSBs repair mechanisms to resolve DNA damage (Kaina, 2003). Ionising 
radiation and ROS generate single-strand breaks (SSBs) and if these breaks lie in 
close proximity on opposite strand this will result in in double-stranded DNA (dsDNA) 
breaks (DSB). If unrepaired, DSBs can trigger apoptosis (Demple & DeMott, 2002). 
 
2.2 Antioxidants: the first instance of DNA protection 
 
Antioxidants are molecules and enzymes that can prevent other molecules from 
being oxidised and either are taken up from the environment (e.g. certain essential 
vitamins) or produced in the cell itself. One example is the enzyme superoxide 
dismutase (SOD) that can dismutate the radical superoxide (O2
−) to oxygen (O2)
 and 
hydrogen peroxide (H2O2) (Peter et al., 2006). Superoxide is a highly reactive ROS 
that is generated as a by-product of the mitochondrial respiration pathway. If not 
neutralized by antioxidants such as SOD it can lead to chain-reactions that oxidise 
cellular macromolecules such as DNA (Keyer & Imlay, 1996).  
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2.3 DNA repair pathways 
 
To maintain genomic integrity, living organisms have developed several DNA repair 
pathways that include, direct reversal (DR), mismatch repair (MMR), nucleotide 
excision repair (NER), BER, homologous recombination (HR), and non-homologous 
end joining (NHEJ) (Hakem, 2008; Figure 15). 
 
 
Figure 15: Overview of DNA-repair pathways for different DNA lesions. DR = Direct reversal; 
MMR = mismatch repair; NER = nucleotide excision repair; BER = base excision repair;  
HR = homologous recombination; NHEJ = non-homologous end joining (examples for DNA 
damage shown in this picture are O
6
-methylation of guanine (DR pathway), A/A mismatch 
(MMR pathway), UV light damage produced pyrimidine dimers (NER pathway), oxidation of 
guanine to 8-oxoG (BER pathway). 
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2.3.1 Direct reversal (DR) 
 
The DR pathway repairs DNA base alterations such as pyrimidine dimers induced by 
UV radiation (Section 2.1.1) or O6-methylguanine produced by alkylating agents that 
transfer methyl- or other alkyl-groups to DNA bases (Section 2.1.5). Pyrimidine 
dimers are a type of intrastrand crosslink whereby either two thymines or cytosines 
that are next to each other on the same DNA strand are linked by covalent bonds. In 
many species including bacteria, fungi and non-placental animals, these lesions can 
be repaired by the enzyme photolyase in a process known as photoreactivation 
(Sancar et al., 2006). The O6-alkyl adduct O6-methylguanine (Figure 16), on the other 
hand, is repaired in E. coli by the enzymes Ada and Ogt and in mammalian cells by 
O6-methylguanine-DNA methyltransferase (MGMT). 
 
 
Figure 16: The guanine derivative 
O
6
-methylguanine bears a methyl 
group on its oxygen (dotted box). 
 
Instead of replacing damaged bases DR changes them back into their original state. 
Therefore, unlike BER it is a one-step pathway which does not require the excision of 
the damaged base. However, because MGMT repairs O6-methylguanine-DNA by 
transferring the alkyl group from the oxygen in the DNA to its own amino acid residue 
cysteine in its active site, it can only be used once before it becomes inactivated and 
subsequently degraded by the proteasome (Pierce, 2012; Hakem, 2003).  
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2.3.2 Mismatch repair (MMR) 
 
If, after DNA replication an incorrect base was incorporated and not corrected by the 
proofreading activity of the replicating DNA polymerase, the base mismatch is 
repaired by the MMR complex. It is known that in bacteria the subsequent 
methylation of a GATC sequence in the newly replicated strand is delayed and 
therefore the methyl group on the parental strand can be recognised and identified by 
the MMR proteins. Then the complementary strand is nicked before the guanine in 
the GATC sequence. This allows the MMR complex to bend the DNA and to bring 
the mismatched bases close to the methylated CTAG sequence. Subsequently 
exonucleases remove nucleotides from the new strand just before the 5′ guanine of 
the GATC sequence and the 3′ end of the nucleotide just after the mismatched base 
pair. Finally DNA polymerase closes the gap with bases complementary to the 
parental strand and nicks in the deoxyribose-phosphate backbone are sealed by 
DNA ligase (Pierce, 2012). Several enzymes are known that are involved in the MMR 
complex. In E. coli it is the homodimer MutS that binds to a mismatched base, while 
MutL recognises the binding and identifies the new DNA strand by binding to the 
methyl group on the CTAG sequence in the old strand. Then MutH nicks the nascent 
strand, the helicase II (UvrD) separates the double-stranded DNA, exonucleases 
remove the oligonucleotide that contains the DNA lesion and finally polymerase III 
resynthesizes the excised DNA (Iyer et al., 2006). 
 
Although several proposals have been made about the function of MMR in eukaryotic 
cells, the mechanism of recognition of a mismatched base remains unclear (Hsieh & 
Yamane, 2008; Iyer et al., 2006; Jiricny, 2006). However, it is known that different 
types of base mismatch specific homologs of the methyl-directed mismatch repair 
proteins in E. coli exist in eukaryotes. MutS binds to single base-base mismatches 
and 1-2 base insertion/deletion. If more than two bases are inserted/deleted then 
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MutSβ will recognize it instead of MutS. The three eukaryotic heterodimers MutLα, 
MutLβ and MutLγ have a similar function to that of MutL in E. coli, but in addition, 
MutLα and MutLβ have an endonuclease activity and therefore can nick the dsDNA 
(the role performed by MutH in E. coli). Pluciennik et al., (2010) discovered that 
interaction of PCNA with MutLα orientates this endonuclease in the direction on the 
dsDNA that is needed for correct incision on the oligonucleotide that contains the 
DNA lesion. 
 
Beside its exonuclease activity, necessary for the final excision of this 
oligonucleotide, Exo1 can carry out the prior separation of the dsDNA and therefore 
no helicase such as the UvrD in E. coli is needed. The resulting gap is then closed by 
DNA Polδ (Larrea et al., 2010; Iyer et al., 2006). 
 
2.3.3 Nucleotide excision repair (NER) 
 
NER removes bulky DNA lesions such as UV radiation-induced thymine dimers and 
6-4-photoproducts, inter- and intra-strand crosslinks formed by DNA reactive 
substances, large-volume adducts and ring systems such as benzo[a]pyrene and 
aflatoxin residues (Friedberg, 2001; Hoeijmakers et al., 1990). Like in MMR, in NER 
an oligonucleotide containing the lesion is removed and replaced by DNA synthesis. 
Due to the change of conformation of the DNA structure (helix distortion) caused by 
the DNA lesion the NER enzyme complex is able to recognize the DNA damage. 
Subsequently, the double-stranded DNA is separated and the single strands are 
stabilized by single-strand binding proteins. Then, in eukaryotic NER, the strand that 
carries the lesion is cleaved and as oligonucleotide of 25-30 nucleotides removed, 
the gap filled by a DNA polymerase and the phosphodiester bond sealed by a DNA 
ligase (Pierce, 2012; Hakem, 2008). Two sub-pathways of NER exist, global genome 
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NER (GG-NER) and transcription-coupled NER (TC-NER). GG-NER guards the 
whole genome while TC-NER repairs actively transcribed genes. However, except 
from different proteins involved in the recognition of the damaged DNA the repair 
pathways are the same (Hakem, 2008). 
 
2.3.4 Homologous recombination (HR), Non-homologous end-joining (NHEJ) 
 
In order to repair DSBs, cells have two major pathways, homologous recombination 
(HR) and non-homologous end-joining (NHEJ). All proteins involved in this repair 
process are closely linked to the ATM-ATR signalling pathway described in Section 
2.1 (Shrivastav et al., 2008). NHEJ ligates the break ends directly and uses short 
homologous DNA sequences that are present in ss overhangs on the ends of DSBs. 
Only if the overhangs are compatible, will NHEJ repair the DSB without loss of DNA 
sequence (Moore, & Haber, 1996). Incorrect NHEJ can lead to carcinogenesis due to 
translocations and telomere fusion (Espejel et al., 2002). HR on the other hand 
needs a second, homologous DNA molecule that can act as a template for the repair 
process and is therefore much more precise than the NHEJ pathway. Furthermore, 
HR uses the homologous DNA from the sister chromatid and therefore incorporates 
new genetic information into a chromosome during mitosis (Moynahan & Jasin, 
2010). 
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2.3.5 Base excision repair (BER) 
 
The BER is a highly conserved pathway from bacteria to mammals that combats 
oxidative and alkylation damage occurring in the DNA molecule. Substrates include 
chemically modified bases, AP sites generated by spontaneous depurination and 
SSBs. Two types of BER exist, short patch (SP-) and long patch (LP-) BER. In  
SP-BER a DNA glycosylase, specific for the type of base lesion, flips the base 
outside the DNA helix and releases the damaged base from the β-N-glycosidic bond 
resulting in an AP site (Figure 17, Figure 18 and Figure 19). The DNA glycosylases 
involved in BER fall into two main groups, monofunctional and bifunctional, regarding 
their mechanisms of action.  
 
Bifunctional DNA glycosylases such as NTH1 and OGG1 have an AP-lyase (DNA-
(apurinic or apyrimidinic site) lyase) activity and can perform β-elemination which 
cuts at the C-O-P bond 3′ to the AP-site resulting in a 3′-phosphate unsaturated 
aldehyde (3′PUA; Figure 17, 2 in Figure 18). The 3′PUA will then be removed by 
apurinic endonuclease 1 (APE1; Figure 17, 2 in Figure 18) which results in a 3′OH 
and a 5′P site. The NEIL proteins on the other hand are bifunctional DNA 
glycosylases that can perform β,δ-elimination and therefore cut the AP-site also on 
its 5′ site leaving a 3′-phosphate (3′P). This phosphate group will then be further 
processed by the polynucleotide kinase (PNK) forming a 3′OH site (Figure 17, 3 in 
Figure 18). The resulting gap with 5′P and 3′OH overhangs is ready to be filled with 
the correct base by Polβ that uses the opposite DNA strand as template (Date et al., 
1992; Sandigursky & Franklin, 1992). The final step in SP-BER is ligation by DNA 
ligase III α (LigIIIα) which joins the 3′OH end to the 5′P (Figure 17) (Brown, 2002). 
 
Monofunctional DNA glycosylases on the other hand are not able to process the 
resulting AP site after release of the damaged base. Therefore, APE1 is needed 
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which can due to its endonuclease activity cut the AP site resulting in a 3′OH and a 
deoxyribose phosphate (5′dRP) overhang (Figure 17, 1 in Figure 18). Because of the 
high affinity of poly(ADP-ribose)polymerase-1 (PARP-1) for DNA SSBs it binds to this 
SSB intermediate generated by APE1 before any other downstream protein can bind. 
This way PARP-1 regulates DNA repair activity by binding to DNA strand breaks 
allowing other repair enzymes such as Polβ and LigIIIα to act on the lesion while 
XRCC1 acts as a scaffold for these proteins (Parsons et al., 2005; Woodhouse et al., 
2008). The 5′dRP is released by Polβ resulting in a 3′OH and 5′P gap that can be 
filled by the DNA polymerase activity of Polβ and sealed by LigIIIα (Figure 17). 
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Figure 17: Scheme for the mammalian short patch (SP) BER. 
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Figure 18: A comparison of reactions catalysed by monofunctional and bifunctional 
DNA glycosylases. In the first step, DNA glycosylases recognise, bind to and then flip 
the damaged base lesion out of the DNA helix. Monofunctional DNA glycosylases such 
as uracil DNA glycosylase (UDG; 1) catalyse an one-step removal of the damaged base 
leaving an AP site which is then further processed by APE1 and Polβ. Bifunctional DNA 
glycosylases, such as OGG1 (2) and NEIL1 (3) are able to attach to the AP site by their 
nucleophilic active site residue and cleave either at 3′ via their β-lyase activity (OGG1; 
2), or at 3′ and 5′ via their β,δ-lyase activity (NEIL1; 3) which results in a DNA single-
strand break for OGG1 and a gap for NEIL1. The unsaturated aldehyde produced by 
OGG1 is further processed by APE1 and the 3′-phosphate produced by NEIL1 is 
excised by PNK. 
 
The LP-BER pathway on the other hand shares enzymes that are involved in DNA 
replication such as Polδ, DNA polymerase ε (Polε), Flap endonuclease 1 (FEN1), 
PCNA and DNA ligase I (LigI) (Izumi et al., 2003). LP-BER removes and 
resynthesizes a patch of 2 – 15 nucleotides. Interestingly there are overlapping 
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substrates within the SP- and LP-BER which might increases the overall protection of 
the genome against oxidative damage (Figure 19) (Hegde et al., 2008b). 
 
Figure 19: Scheme for the mammalian long patch (LP) BER. 
Due to the fact that in each step of BER a potential toxic lesion is generated such as 
an AP site, it is suggested that proteins work tightly together in big complexes during 
the BER process where they “hand over” each product until the resynthesized DNA 
strand is ligated (Campalans et al., 2005). 
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2.3.5.1 DNA glycosylases in E. coli 
 
Due to their overlapping substrate specificity it is difficult to identify new DNA 
glycosylases on the basis of their activity in cell extracts. Hence, most of the human 
DNA glycosylases where cloned on the basis of functional complementation or 
sequence homology with E. coli or yeast homologs already discovered (Hazra et al., 
2003). 
 
In E. coli the enzyme Fpg is essential for the repair of oxidized purines, such as  
8-oxoG, FapyA (Wiederholt et al., 2002) and FapyG (Wiederholt et al., 2003). Fpg is 
a bifunctional DNA-glycosylase with a β/δ AP lyase activity leading to a 3′P blocking 
residue and a 5′P site at the DNA strand break (Zharkov et al., 2003). The activity of 
Fpg is accomplished by the amino acid residue proline at amino acid position two 
(Pro2). This N-terminal residue of the Fpg/Nei family acts as a nucleophile in the 
DNA-glycosylase/AP lyase reaction (Saparbaev et al., 2002). 
 
Nei encoded by the nei gene in E. coli excises various oxidized pyrimidines such as 
5-OH-C and 5-OH-U and the oxidized purine FapyA (Wallace et al., 2003). Like Fpg, 
the active residue Pro2 plays a major role as a nucleophile in its activity as a DNA 
glycosylase (Saparbaev et al., 2002). However, although its sequence is similar to 
that of Fpg its function is homologous to that of Nth (described underneath). 
Furthermore, it has been shown by site directed mutagenesis studies that the 
removal of the Glu3 and Glu174 residues in Nei resulted in a loss of activity on 5-OH-
U substrates indicating that these residues are essential for the function of the DNA 
glycosylase domain in Nei (Burgess et al., 2002). 
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Nth encoded by the nth gene in E. coli is a DNA glycosylase essential for the removal 
of Tg (Alanazi et al., 1997). This bifunctional DNA glycosylase contains an internal 
Lys residue crucial for its β-lyase activity. 
 
The monofunctional adenine glycosylase MutY is expressed in E. coli and excises 
adenine that is mispaired with 8-oxoG, guanine or cytosine. If MutY excises A 
mispaired with 8-oxoG the following DNA replication cycle may result in an 8-oxoG:C 
DNA base pair that can then be repaired by Fpg/MutM (Krokan et al., 1997, Williams 
& David, 1998), or it may result in another 8-oxoG:A mispair. 
 
2.3.5.2 DNA glycosylases in mammalian cells 
 
Like the E. coli Fpg, OGG1 releases oxidized purines such as 8-oxoG and FapyG 
from dsDNA (Hazra et al., 2002a; Takao et al., 2002; Hitomi, Iwai, & Tainer, 2007). 
OGG1 is a bifunctional DNA glycosylase belonging to the E. coli Nth type that 
contains, like NTH1, an internal Lys residue at its active site (amino acid position 
249; Hazra et al., 2002b). Its expression is cell cycle independent (Dhenaut et al., 
2000). 
 
The localization of OGG1 depends on the isoform and the level of oxidative stress 
present in the cell. Isoform 1a is known to be located to the nucleus because of its 
NLS at the C-terminus and isoform 2a which has a unique C-terminus and a 
mitochondrial targeting signal is located in the mitochondria (Nishioka et al., 1999; 
Campalans et al., 2007). OGG1 belongs to the E. coli Nth family that features a 
conserved helix-hairpin-helix (HhH) motif. This protein structure is required for 
interaction with phosphate and oxygen atoms of the DNA backbone and is essential 
for DNA binding in these enzymes (Huffman et al., 2005). 
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After OGG1 removes 8-oxoG it remains bound to the resulting AP site until APE1 
releases it from the 5′P (Hill et al., 2001). Recent studies have also revealed that 
NEIL1 can stimulate OGG1 activity similar to APE1 (Mokkapati et al., 2004). 
 
NTH1, the human ortholog to E. coli endonuclease III, is like OGG1 a bifunctional 
DNA glycosylase that contains a Lys residue at its active site (amino acid position 
220) and a HhH motif for DNA interaction. Its β AP lyase activity results in a 3′PUA 
residue that has to be further processed by APE1. However, unlike OGG1, instead of 
oxidized purines, it can release pyrimidine lesions such as dihydrouracil (DHU),  
5-OH-U and Tg from dsDNA (Hazra et al., 2002a; Takao et al., 2002). Mouse NTH1 
(mNTH1) was shown to be active in the nucleus and mitochondria and contains 
transport signals for both organelles in its N-terminal region (Takao et al., 1998). 
 
MUTYH, also known as hMYH, is the human ortholog of the E. coli MutY DNA-
glycosylase and is localised in the nucleus and mitochondria (Takao et al., 1998). 
hMYH removes misincorporated adenine or 2-oxoA from 8-oxoG or G prior to DNA 
replication (Ohtsubo et al., 2000; Ushijima et al., 2005). There is evidence that the 
resulting AP site is then processed by proteins involved in LP-BER as hMYH 
interacts with APE1, PCNA and RPA (Parker et al., 2001). 
 
To investigate their biological significance, NTH1 and OGG1 genes have been 
knocked out in mice. However, because no obvious phenotype such as cancer 
caused by unrepaired DNA lesions has been observed in these mice the assumption 
arose that there must be a backup pathway or enzyme(s) that is/are able to 
recognize and neutralize DNA lesions that are usually substrates for NTH1 and 
OGG1. This was confirmed when the Nei-like proteins NEIL1, NEIL2 and NEIL3 were 
discovered. Like Fpg, Nei contains a helix-two turns-helix (H2TH) DNA binding motif 
that is also found in all three NEIL proteins. Similarly, the substrate specificities of 
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NEIL1, NEIL2 and NEIL3 overlap with that of Fpg and Nei (Hazra et al., 2003). 
Furthermore, although the NEIL proteins are different to NTH1 and OGG1 in both 
domain structure and reaction mechanism, they act on many of the same substrates 
which confirmed the assumption that at least NEIL1 and NEIL2 act as backup 
proteins in NTH1/OGG1 knockout mice (Das et al., 2007a). 
 
2.3.5.2.1 NEIL1 
 
Extracts from NTH1 knockout mice were still able to repair Tg lesions after exposure 
to 8 Gy X-Ray radiation. As mNTH1 is known to be a major DNA glycosylase in the 
repair of Tg lesions it was suggested that another protein, NEIL1, acts as backup 
DNA glycosylase thus having a complementary function to that of NTH1 (Takao et 
al., 2002). 
 
NEIL1 is mainly expressed during the S-phase of the cell cycle and is a bifunctional 
DNA glycosylase with a β/δ AP lyase activity and is a functional hybrid of Fpg and 
Nei. It excises oxidized purines as well as pyrimidines from single-stranded (ss) DNA 
and dsDNA such as 8-oxoG, FapyA, FapyG, Tg and 5-OH-U (Dou et al., 2003). 
Unlike Fpg, NEIL1 shows nearly no activity against 8-oxoG in dsDNA when paired to 
cytosine. However, it can stimulate the enzyme activity of OGG1 and catalyses the 
incision of resulting AP site with its β/δ AP lyase activity (Mokkapati et al., 2004). 
 
Furthermore, although NEIL1 is not as efficient as OGG1 in the removal of the  
8-oxoG, the excision of the 8-oxoG derivatives Gh and Sp is more than 100-fold 
faster than that of Tg and 5-OHC, especially if paired with T, G or C. Hence, these 
hydantoin lesions are the most preferred substrates for NEIL1 in vitro (Krishnamurthy 
et al., 2008). 
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Structural comparison of NEIL1 with Fpg and Nei reveals that in total, the amino acid 
sequence is more homologous to Nei than Fpg, but the conserved H2TH domain 
shows a higher correlation to Fpg than to Nei. In addition, a “zinc-less finger” also 
known to be a DNA binding motif is found uniquely in NEIL1 in place of the highly 
conserved zinc finger motif found in Fpg (Doublié et al., 2004). However, while Fpg 
and Nei feature a C-terminal zinc ﬁnger motif needed to stabilize DNA binding, NEIL1 
does not. Therefore, the extended C-terminal of NEIL1 features its own unique DNA 
binding motif (Doublié et al., 2004). Unlike NEIL2 and NEIL3, NEIL1 has a lysine 
residue at amino acid position 54 that is highly conserved in Fpg and Nei and 
essential for their function together with Pro2 (Rosenquist et al., 2003; Takao et al., 
2002). 
 
Furthermore, NEIL1 has been shown to interact through its C-terminal residue 
(amino acid position 288-349) with the Werner syndrome protein (WRN) a DNA 
helicase (Das et al., 2007a). This interaction is enhanced when intracellular oxidative 
stress is increased. NEIL1 is active in a BER protein complex that involves several 
proteins such as Polβ, LigIIIα, PNK and x-ray repair cross-complementing 1 protein 
(XRCC1) (Dou et al., 2003). 
 
Interestingly, NEIL1-/- mice cells show a significant accumulation of (5′R) – and (5′S)-
8,5′-cyclo-2′-deoxyadenosine DNA lesions, which was not observed in OGG1-/- mice 
cells used as control. As this kind of DNA damage is normally removed by NER 
rather than by BER it might be an indicator that NEIL1 is also involved in NER 
(Jaruga et al., 2010). 
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2.3.5.2.2 NEIL2 
 
Like NEIL1, NEIL2 has a Pro2 as the active site to fulfil its function as a DNA 
glycosylase. Interestingly, except for a few conserved domains such as the DNA 
glycosylase and H2TH domains, NEIL1 and NEIL2 show no other significant 
homology and whereas NEIL1 is cell cycle dependent NEIL2 is not. However, both 
act as bifunctional DNA glycosylases with βδ AP lyase activity and excise various 
oxidized pyrimidines such as 5-OH-U and 5-OH-C with preference for a DNA bubble 
structure (Dou et al., 2003). NEIL2 in its function as a DNA glycosylase excises  
5-OH-U and other oxidized derivatives of cytosine that are similar to substrates for 
NTH1. Compared to NEIL1, only weak excision activity of NEIL2 on dsDNA was 
observed. The preferred substrate of NEIL2 is ssDNA (Bandaru et al., 2007). 
However, in complex with the Y box-binding (YB-1) protein its activity on dsDNA was 
increased by 7-fold (Das et al., 2007b).  
 
2.3.5.2.3 NEIL3 
 
The nucleophile Pro2 residue present in E. coli Fpg and Nei is only preserved in 
NEIL1 and NEIL2 (Section 2.3.5.2.1 and 2.3.5.2.2). Instead, NEIL3 has a valine 
residue at amino acid position 2 (Val2) which, nevertheless, acts in the same way as 
Pro2 in the DNA glycosylase reaction by forming a Schiff base intermediate with the 
C1 atom of the damaged DNA (Liu et al. 2010). Site-directed mutagenesis studies on 
Pro2 in NEIL1 and NEIL2 showed the functional importance of this residue for the 
activity of these proteins (Bandaru et al., 2002). Because of problems to recover 
active full-length NEIL3, the possible biological functions of NEIL3 remain unclear 
and thus are the focus of this project. 
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Conserved domains of hNEIL3 
 
Several parts of the NEIL3 protein have been characterized as they are highly 
conserved in other proteins such as in E. coli Fpg/Nei and NEIL1/NEIL2. This 
structural information can be seen in Figure 20, Figure 27 and Figure 105 and have 
been assembled via the use of the basic local alignment search tool (BLAST), 
InterPro and publications from Morland et al. (2002), Torisu et al. (2005), Liu et al. 
(2010) and Krokeide et al. (2009) as described in detail below. 
 
 
Figure 20: Summary of conserved domains in human NEIL3 and their positions within the 
protein. 
 
As mentioned above, NEIL3 has a Val2 residue at the active side in place of the Pro2 
residue more commonly found in homologs. However, Liu et al. (2010) recently 
showed that the N-terminal Val2 residue in mNEIL3, like Pro2, also forms an imine 
intermediate (Schiff base) by using a borohydride-dependent “trapping assay” which 
can reduce the transient Schiff base intermediate to a covalent protein-DNA complex 
(Figure 21). 
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Figure 21: An example of a Schiff base intermediate and the 
chemical reaction of borohydride-dependent “trapping assay” that 
Liu et al. (2010) used to produce a covalent bond between the 
DNA backbone and the protein. OGG1 forms a Schiff base 
intermediate during processing an 8-oxoG lesion (1). If 
borohydride is added once the Schiff base intermediate is formed 
(2) then an irreversible cross-linking (trapping) of the enzyme to 
the DNA will result (3). (Image adapted from Bruner et al., 1998). 
 
Torisu et al. (2005; Figure 105) and BLAST studies carried out in this project with the 
hNEIL3 protein sequence compared with the human proteome (Figure 22) show, that 
the C-terminus of NEIL3 has homology with the C-terminus of AP-endonuclease 2 
(APE2) and the C-terminus of DNA topoisomerase IIIα (TopoIIIα). The N-terminal 
region (amino acids 1-313) of APE2 is homologous to the Xth-like AP endonuclease 
family that includes APE1 (Tsuchimoto et al., 2001). Like APE1, APE2 has the ability 
to recognize and bind specifically to AP DNA (Hadi & Wilson, 2000). Furthermore, 
the C-terminal domain of APE2 is homologous to a region in human TopoIIIα 
(Zumstein et al., 1986). This C-terminal sequence (amino acids 314-518) is 
conserved in many proteins which are involved in nucleic acid metabolism. This gives 
an indication that NEIL3 is also acting in nucleic acid metabolism. Recent studies 
have shown that NEIL3 excises DNA lesions preferentially from ssDNA (Liu et al., 
2012; Liu et al., 2013). However, because only truncated versions of NEIL3 were 
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used in these studies, it might be the case that the additional GRF zinc fingers at the 
C-terminal end also found in other DNA binding proteins, might affect the affinity of 
NEIL3 for different DNA structures including ssDNA and dsDNA. 
 
 
Figure 22: BLAST result of the amino acid sequence of hNEIL3 
compared with the human proteome. Correlations of hNEIL3 
sequence to other proteins are shown as followed:  = ATP binding 
cassette (unknown domain);  = RanBP binding protein (or RanBP 
binding domain);  = TopoIIIα (GRF zinc finger domain);  = APE2 
(GRF zinc finger domain). 
 
In addition to the BLAST results an InterProScan revealed an FPG zinc finger at 
amino acid position 247-281 (highlighted in Figure 23) in addition to the already 
known domains. 
 
  
 
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Figure 23: InterPro signature analysis for human NEIL3 protein sequence. 
 
NLS motif 
 
The location and existence of a putative NLS in hNEIL3 has been a matter of debate. 
For example, Morland et al. (2002), Torisu et al. (2005), Takao et al. (2009) and Liu 
et al. (2010 and 2012) stated that human NEIL3 has a putative nuclear localization 
signal (NLS) motif. However, Liu et al. (2010 and 2012) and Takao et al. (2009) did 
not mention any exact amino acid position while Torisu et al. (2005) only mention the 
position between amino acids 463 and 470 (Figure 27) but without stating a 
reference. Furthermore, the existence of an NLS could not be confirmed; neither via 
BLAST (NCBI; Figure 22) nor by further bioinformatical research via the European 
Bioinformatics Institute webpage (http://www.ebi.ac.uk; Figure 23) nor GeneCards 
(http://www.genecards.org) nor UniPort (http://www.uniprot.org/). However, the NLS 
in hNEIL3 was initially shown on NCBI – Conserved domains in 2008 (personal 
observation). Furthermore, Morland et al. (2002) did show via fluorescence 
experiments in living HeLa S3 cells that NEIL3 is located to nuclei after translation 
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and that NEIL3 contains a putative NLS at amino acid position 462-469 predicted by 
the PSORTII algorithm. 
 
GRF-zinc finger motifs in NEIL3 
 
Zinc finger (Znf) domains are relatively small protein motifs that allow the protein to 
bind DNA, RNA, other proteins or lipid substrates (Hall 2005; Matthews & Sunde 
2002). How the protein binds to a particular sequence of DNA depends on the amino 
acid sequence of the Znf motif. The Znf domains can be present in clusters, where 
the Znf can have different binding specificities. Because of the many different types 
of Znf motifs with different sequences resulting in different structures, the functions 
also vary. For example, they can function in zinc sensing, chromatin remodelling, 
gene transcription and protein folding (Laity et al., 2001). Although there is no recent 
study which characterizes the zinc finger domains in NEIL3, another study by Das et 
al. (2004) confirmed that NEIL2 has a zinc finger domain crucial for its structure and 
enzyme activity. This information about zinc finger domains, leads to the conclusion, 
that it is necessary to express NEIL3 in full-length to obtain its correct structural 
integrity and enzyme activity. This is confirmed by the recent study of Liu et al. (2010) 
who showed that full-length mouse NEIL3 has a DNA glycosylase activity in vitro 
while other groups expressed NEIL3 to a maximum amino acid length of 300 and 
were not able to detect DNA glycosylase activity (Krokeide et al., 2009; Takao et al., 
2009). NEIL3 contains two additional zinc finger motifs at the C-terminal end which 
were not expressed in the truncated versions of Krokeide et al. (2009) and Takao et 
al. (2009) and are not present in other Nei/Fpg homologs, but could be essential for 
NEIL3 to interact with the correct DNA substrates or with other proteins (Figure 27; 
Figure 105). 
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A BLAST analysis to search for conserved domains in hNEIL3 revealed conservation 
of these domains in the C-terminus of hNEIL3 between amino acid position 813 and 
943 (Figure 22). The duplicated GRF-zinc finger motif in NEIL3 (Figure 27 and Figure 
105) is also conserved in the human APE2 and TopoIIIα. 
 
TopoIIIα contains two GRF zinc finger domains, one at amino acid position 811-852 
and one at amino acid position 895-939 (Figure 24). Further BLAST results showed a 
correlation between the hNEIL3 C-terminus and APE2 at amino acid position 242-
291, which includes a putative AP binding site, and amino acid position 466-515 
which includes a GRF zinc finger domain (Figure 25). 
 
 
Figure 24: Conserved domains in human TopoIIIα. 
 
 
Figure 25: Conserved domains in human APE2. 
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RanBP zinc finger motif 
 
Between amino acid position 317 and 345 is a conserved, putative Ras-related 
nuclear protein binding protein (RanBP) zinc finger motif, in this case from RanBP2 
(also known as Nup-358). RanBP1 can diffuse into the nucleus due to its small size  
(23 kDa) and as it also carries an N-terminal nuclear export sequence it is actively 
transported back to the cytoplasm (Seewald et al., 2003). RanBP2 on the other hand, 
is a large protein (358 kDa) that is located in the nuclear pore complex and is known 
to interact with various protein partners. However, its zinc fingers are known to bind 
to RanGDP, another protein that is needed for an active transport of cargo into the 
nucleus where it is transformed to RanGTP that acts as a nuclear export protein. 
Thus, as already suggested by Morland et al. (2002) this conserved RanBP zinc 
finger motif in NEIL3 might play a role in its nuclear transport. 
 
Fpg-like zinc finger motif 
 
There is a highly conserved Fpg-like zinc finger domain at amino acid position  
247 – 281 (KVYKRPNCGQCHCRITVCRFGDNNRMTYFCPHCQK; Figure 23). This 
zinc finger motif acts in Fpg as a DNA binding motif and might also play an important 
role in the ability of NEIL3 to interact correctly with DNA structures to fulfil its specific 
biological functions (Tchou et al., 1993). 
 
Unique domain in hNEIL3 
 
All NEIL3 proteins identified so far contain a highly conserved domain at amino acid 
position 362 - 403 (LMKYPCNTFGKPHTEVKINRKTAFGTTTLVLTDFSNKSSTL) 
(Figure 26). However, to date no biological role has been linked to this domain and it 
is not found in any other of the Nei homologs (Krokeide et al., 2009). 
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Figure 26: Unique motif on NEIL3 found to be highly conserved amongst several 
species. (Image taken from Krokeide et al., 2009). 
 
Conserved moieties in NEIL proteins 
 
The Glu3 moiety, essential for the DNA glycosylase activity of the E. coli Nei and Fpg 
(Burgess et al., 2002, Lavrukhin et al., 2000), is conserved in all three NEIL proteins. 
Furthermore, site directed mutagenesis studies have shown that the Glu3 residue 
plays an important role in the activity of NEIL1 and NEIL2 (Bandaru et al., 2002). All 
three NEIL proteins also contain a lysine residue (Lys55 in NEIL1, Lys51 in NEIL2, 
Lys82 in NEIL3) that corresponds to the Lys52 and Lys56 residues in Nei and Fpg, 
respectively. These motifs in Nei and Fpg are necessary to coordinate the 5′P group 
of the damaged deoxynucleotide (Zharkov et al., 2003). Gly4 is preserved in all NEIL 
proteins and in E. coli Nei but not in Fpg where leucine is substituted. The Gly4 
residues in the NEIL proteins and Nei and the Leu4 residue in Fpg are thought to be 
part of the active site (Pro2 and Glu3) of these proteins (Zharkov & Grollman, 2002). 
 
Predicted structure of NEIL3 
 
NEIL3 contains a H2TH domain which is a typical motif for all proteins from the 
Fpg/Nei superfamily including all NEIL proteins. Liu et al. (2013) was the first group 
to solve the crystal structure of a truncated version of mouse NEIL3 (N-terminus with 
324 amino acids). They discovered that unlike the bacterial Fpg, NEIL3 has no  
αF-β9/10 loop that can hold 8-oxoG. This would explain why, to date, no excision 
activity on 8oxo-G for NEIL3 has been observed. Furthermore, NEIL3 not only lacks 
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two of three motifs essential for the stabilisation of the DNA strand opposite the base 
damage, but even contains negatively charged residues that do not allow proper 
binding of the phosphate backbone of the undamaged, template strand. This fact 
correlates well with the discovery that NEIL3 prefers ssDNA substrates (Liu et al. 
2010, 2012 and 2013). 
 
 
Figure 27: Neil3: full-length mNEIL3; ∆324Neil3: truncated version of 
mNEIL3 containing the conserved DNA glycosylase domain; NEIL1: 
human NEIL1; NEIL2: human NEIL2; Nei: E. coli Nei (endonuclease 
VIII); Fpg: E. coli Fpg (MutM). The schematic representation of mouse 
NEIL3 in this diagram is the same as for human NEIL3 including the 
first amino acids shown above the N-terminal end (Figure 105). 
(Image adapted from Liu et al., 2010). 
 
Expression patterns of NEIL3 
 
NEIL3 is mainly expressed in haematopoietic tissues, thymus and testes (Morland et 
al., 2002; Torisu et al., 2005; Takao et al., 2009; Figure 28). Although Takao et al. 
(2009) did not find expression of NEIL3 in adult mouse brain cells, Hildestrand et al. 
(2009) found expression during embryonic mouse brain development where 
expression levels were highest during the E12.5 stage (Figure 29).  
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Figure 28: Tissue expression patterns of human 
NEIL3 relative to GAPDH. He, heart; Br, brain; 
Sp, spleen; Lu, lung; Li, liver; SM, skeletal 
muscle; Ki, kidney; Te, testis. (Image taken from 
Takao et al., 2009). 
 
 
Figure 29: Quantified mRNA levels of NEIL3 
normalized to GAPDH. The mRNA was obtained 
from mouse brain extracts at four different 
developmental stages. (Image taken from 
Hildestrand et al., 2009). 
 
Further expression patterns have been published in several tumour and healthy 
tissues and in macrophages and activated T-lymphocytes where the highest 
expression levels were found in activated CD4-positive T-lymphocytes (Zhou et al., 
2008, Figure 30). 
 
 
Figure 30: Cell and tissue expression patterns of human NEIL3. (Image taken from Zhou et 
al., 2008). 
 
Furthermore, it has been shown that the expression levels of NEIL3 are cell cycle 
dependent. The expression of NEIL3 is upregulated in cells that leave the G0 phase 
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and start dividing. This, and the fact that the expression pattern of NEIL3 is related to 
that of FEN1, a protein active on replication forks during S phase, which might be an 
indicator for the activity of NEIL3 in replication associated DNA repair (Neurauter et 
al., 2012). Metastatic cancer cells also show a high level of NEIL3 expression, 
although this is not the only protein involved in BER to be upregulated (Figure 31) 
(Kauffmann et al., 2008). 
 
 
Figure 31: Standardized mean differences 
of log(ratio) between tumours that will 
metastzie within 4 years and tumours that 
will not for genes involved in DNA repair. 
(Image taken from Kauffmann et al., 2008). 
 
In general it can be said that expression levels of NEIL3 are elevated in tumour cells 
compared to normal cells except for testes (Figure 32) (Hildestrand et al., 2009). 
NEIL3 
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Figure 32: This image of a transcript profile of mNEIL3 was taken from Hildestrand et al. 
(2009). Amounts were normalized to β-actin and mNEIL3 mRNA levels are shown relative to 
the stomach cancer sample which showed the lowest expression level of mNEIL3 
Abbreviations: Adr G, adrenal gland; Bre, breast; Cer, cervix; Col, colon; End, endometrium; 
Eso, esophagus, Kid, kidney; Liv, liver; Lun, lung; Lym N, lymph node; Ova, ovary; Pan, 
pancreas; Pro, prostate; Sto, stomach; Tes, testis; Thy G, thyroid gland; Uri B, urinary 
bladder; Ute, uterus. 
 
DNA glycosylase activity of NEIL3 
 
The ability of NEIL3 to act as a DNA glycosylase has now been confirmed by several 
groups. The first indication came from Morland et al. (2002) who observed the 
removal of Me-FapyG lesions from [3H]-methyl-faPy-poly(dG:dC) by full-length 
mouse NEIL3 expressed in a baculovirus Sf9 insect cell system. However, no active 
NEIL3 was recovered from expression in E. coli or in a cell-free system. Hence, the 
group assumed that posttranslational modifications might be necessary for the DNA 
glycosylase activity of NEIL3 and this could be one explanation for activity only being 
observed in mammalian and insect cells Morland et al. (2002). Further evidence in 
support of this is indicated from the work of Takao et al. (2009) who could not confirm 
a DNA glycosylase activity of NEIL3 expressed in E. coli. On the other hand Krokeide 
et al. (2009) had no problem expressing full-length NEIL3 in a cell-free system in the 
presence of [35S] methionine. However, although the translated protein was 
confirmed via western blotting no activity on 8-oxoG or Me-Fapy lesions could be 
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detected. Furthermore, they tried to express full-length NEIL3 in and a truncated 
version in E. coli and although expression was successful no activity on dsDNA and 
ssDNA containing 8-oxoG, 5-ohU, Me-Fapy or abasic sites was observed. However, 
more recently both full length mNEIL3 and a truncated version of hNEIL3 have been 
found to act as DNA glycosylases on oxidized purines such as Sp, Gh, FapyA, 
FapyG and the oxidized pyrimidine Tg on ssDNA and dsDNA (Liu et al., 2010, 2012). 
Subsequently it was shown that overall DNA glycosylase activity in NEIL3-/- mouse 
tissue extracts from brain, heart, thymus and spleen tissues was nearly 2 fold lower 
on Sp or Gh ssDNA substrates compared to dsDNA substrates and to extracts from 
NEIL3+/+. This suggests that NEIL3 is the main DNA glycosylase in mammalian cells 
for the excision of Sp and Gh from ssDNA (Rolseth et al., 2013). Thus, in general the 
activity of mNEIL3 might be more similar to that of NEIL1 as it repairs oxidized 
purines and pyrimidines, preferentially from ssDNA.  
 
Liu et al. (2010) expressed the DNA glycosylase domain of a truncated version of 
mNEIL3 in an E. coli mutant. This mutant lacked Fpg, Nei, and MutY glycosylase 
activities and interestingly, the truncated version of mNEIL3 decreased the level of 
FapyG lesions about two fold more than a control expressing NEIL1. The fact that Liu 
et al. (2010) found that mNEIL3 prefers lesions in single-stranded DNA, fork and 
bubble substrates, might be an indicator that mNEIL3 is active during DNA replication 
similar to NEIL1. 
 
AP lyase activity of NEIL3 
 
Takao et al. (2009) reported that mNEIL3 has an AP lyase activity which is specific 
for ssDNA. This group used a truncated version of mNEIL3 (amino acids 1-290) that 
only contained the conserved DNA glycosylase domain and expressed it in E. coli. 
Therefore, they concluded that the C-terminal domain could be responsible for the 
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regulation of enzyme activity or function to direct the appropriate repair in vivo via 
interactions with other proteins (Takao et al., 2009). Subsequently, Liu et al. (2010) 
determined that mNEIL3 acts as bifunctional DNA glycosylase under in vitro 
conditions.  
 
NEIL3 and its role in human immunodeficiency virus integration 
 
Recent siRNA studies have revealed that BER proteins play an important role in 
retroviral integration into the host genome (Espeseth et al., 2011a; Yoder et al., 2011; 
Zhou et al., 2008). Zhou et al. (2008) used a siRNA screen to identify six genes 
coding for essential host factors for HIV DNA integration: AKT, PRKAA1, CD97, 
BMP2K, SERPINB6 and NEIL3. The protein kinases AKT1 and PRKAA1 are 
important proteins involved in many cellular processes including glucose transport, 
glycolysis, fatty acid and protein synthesis. They might support HIV replication and 
integration by their capability of inhibiting cell apoptosis. Like SERPINB6 and NEIL3 
the protein kinase BMP2K, involved in the regulation of bone mineralization, is also 
able to aid HIV replication and integration although their functional role remains 
unclear and is under investigation. CD97 on the other hand seems to play a role after 
HIV was integrated which needs to be determined (Zhou et al., 2008). 
 
Espeseth et al. (2011a) made additional screens using siRNA targeting other 
essential BER proteins and discovered that knockdown of NEIL3 decreased HIV 
infection efficiency by 70%. After reverse transcription, the viral DNA is located to the 
nucleus and integrated into the chromosomal DNA. While HIV reverse transcription 
and the localization into the nucleus seem to be unaffected in cells lacking BER 
proteins, the integration into the host chromosome is significantly decreased (Yoder 
et al., 2011). Furthermore, Espeseth et al. (2011a) showed that HeLa P4/P5 cells 
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transfected with siRNAs targeting MUTYH, NTH1 or Polβ also decreased HIV 
integration up to 70% compared to control cells transfected with luciferase siRNA. 
 
Before Zhou et al. (2008) published their results instead of BER it was NHEJ that 
was frequently linked to HIV replication (Daniel et al., 2004, Kilzer et al., 2003, Li et 
al., 2001). However, only one of the proteins found in the siRNA screening carried 
out by Espeseth et al. (2011a) was related to NHEJ while 23% of the hits were linked 
to BER. Furthermore, other groups have already shown, that the HIV-1 transactivator 
of transcription (Tat) protein which is responsible for efficient viral transcription 
(Debaisieux et al., 2012), induces expression of BER proteins such as Polβ 
(Srivastava et al., 2001) and OGG1 (Imai et al., 2005). As large protein complexes 
are very important for the efficiency of BER, it is likely that the knockdown of 
essential proteins involved in BER such as the scaffold protein XRCC1, decreases 
the integration efficiency of HIV due the loss of functionality of other proteins that rely 
on XRCC1. 
 
NEIL3 and the brain 
 
While NEIL1, NEIL2, OGG1 and NTH1 have been found to show similar expression 
levels regardless of the age of the brain, NEIL3 protein was only observed during 
embryonal brain development and then only in regions that contain stem cells such 
the subventricular zone, the rostral migratory stream, and the hilar region of the 
hippocampal formation (Rolseth et al., 2008). Sejersted et al. (2011) confirmed these 
findings from another perspective. They investigated the expression levels of NEIL3 
in damaged mouse brains and examined an increase in NEIL3 during regeneration of 
damaged brain regions leading to the conclusion that expression of NEIL3 is 
triggered in rapidly proliferating cells. 
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Regnell et al. (2012) demonstrated that in neural/progenitor stem cells lacking NEIL3, 
the proliferation rate was reduced resulting in learning and memory deficits of the 
tested mice as well as decreased anxiety-like behaviour. Although there was no 
obvious difference between brain phenotypes of Neil3+/+ and Neil3-/- mice, Rolseth et 
al. (2013) confirmed the results by Regnell et al. 2012. They found a reduced self-
renewal capacity of neural/progenitor stem cells in Neil3-/- mice while the 
differentiation capacity was not affected. 
 
Other proteins involved in BER 
 
APE1 is the mammalian ortholog of E. coli Xth (exonuclease III) and plays a role as a 
transcriptional co-factor, as a suppressor of ROS via a redox site and in DNA repair 
where it incises AP sites (Tell et al., 2005). More recently it was found that APE1 also 
plays a major role in neuroprotection when its expression is induced by PACAP and 
its downstream mediators CREB and ATF2 (Stetler et al., 2010). The AP site 
substrates for APE1 are generated spontaneously or by monofunctional DNA 
glycosylases. APE1 cuts the deoxyribose backbone which results in a 3′OH and a 
5′dRP moiety. Due to their β AP-lyase activity, OGG1 and NTH1 leave a 3′ PUA 
group after they cut an AP site. This blocking residue is removed by the  
3′ phosodiesterase activity of APE1 in preparation for the next step in BER, the gap 
filling by Polβ. In addition, APE1 acts as a stimulator for OGG1 by releasing it from 
the AP site and therefore increasing its turnover (Hill et al., 2001). 
 
It is known that XRCC1 is an important protein involved in the repair of indirect SSBs 
(caused by BER) and direct SSBs (caused by DNA damaging agents). Although it 
has no enzymatic activity itself, it is an important scaffold protein for other DNA repair 
proteins. It stabilizes protein complexes involved in BER and is usually found in 
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complex with DNA ligase III (Vidal et al., 2001b). Which proteins these are and how 
XRCC1 interacts will be discussed in Section 2.3.6 in more detail. 
 
PNK is a downstream protein for bifunctional DNA glycosylases with β/δ AP lyase 
activity such as NEIL1 and NEIL2. After excising an oxidized base from DNA 
bifunctional DNA glycosylases cut the resulting AP site which leaves a 3′P blocking 
residue. This phosphate is then removed by PNK generating a 3′OH group that 
enables Polβ to fill the resulting gap. 
 
FEN1 is active during DNA replication where it processes the 5′ ends of the Okazaki 
fragments via its ribonuclease activity on displaced RNA-DNA primers generated 
during discontinuous DNA replication on the lagging DNA strand (Neurauter et al., 
2012; Turchi et al., 1994; Bambara et al., 1997). FEN1 is also essential for the repair 
of reduced AP sites that cannot be processed by β-elemination or occurred during 
long-patch BER (Klungland et al., 1997). 
 
PCNA plays an important role as a sliding clamp in DNA replication and repair. In 
long patch BER, PCNA acts as a DNA polymerase processivity factor for Polδ which 
thereby stays attached to DNA (McConnell et al., 1993). Interestingly, its structure 
resembles that of the 9-1-1 complex, containing Rad9, Rad1 and Hus1 which is 
involved in the ATR-mediated detection of DNA damage in yeast (Section 2.1) (Li & 
Zou, 2005; Dou, et al., 2008).  
 
Poly(ADP-ribose)polymerase 1 (PARP-1) is involved in SSB repair and catalyses the 
attachment of poly(ADP-ribose) polymers to itself as well as to histones, nuclear 
proteins, DNA repair proteins, transcription factors and chromatin modulators using 
NAD+ as a donor of ADP-ribose units (Hooten et al., 2011).  
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Polβ is an essential protein in SP BER where it can process the 3′dRP overhangs 
produced by APE1 and then resynthesizes the missing nucleoside. Polδ/ε on the 
other hand are involved in DNA synthesis of the repair products of NER but also of 
the LP BER pathway.  
 
RPA stimulates LP BER. It can enhance functionality of FEN1 and unwinds dsDNA in 
preparation for BER (DeMott et al., 1998). LigIIIα seals the phosphate backbone by 
synthesising the phosphodiester bonds between the 3′OH and 5′P groups of the 
repaired DNA in the last step of SP and LigI in LP BER (Section 2.3.5) (Lehman, 
1974; Chen et al., 1995). 
 
2.3.6 Reported protein interactions with mammalian BER proteins 
 
Table 1 and Figure 33 summarize proteins related to BER known to interact with 
each other during different stages of the pathway. It has been shown that PARP-1 
binds directly to BER proteins such as OGG1 (Hooten et al., 2011) and NEIL1 
(Hooten et al., 2012) through its BRCA1 C-terminal domain. This domain is 
comprised of around 100 amino acids and is conserved in several proteins that play 
a role in DNA repair, recombination and cell cycle control. The BRCA1 C-terminal 
domain is known to be essential for various protein-protein interactions and as a 
phospho-protein binding domain (Zhang et al., 1998, Yu et al., 2003). 
 
XRCC1 interacts with the DNA glycosylases OGG1 (Marsin et al., 2003), NEIL1 
(Wiederhold et al., 2004) and NEIL2 (Das et al., 2006) but also with other BER 
proteins including APE1 (Vidal et al., 2001b), LigIIIα and Polβ (Caldecott et al., 1995; 
Whitehouse et al., 2001), PARP-1 (Leppard et al., 2003; Caldecott, Aoufouchi, 
Johnson, & Shall, 1996), PNK (Whitehouse et al., 2001, Wiederhold et al., 2004) and 
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PCNA (Fan et al., 2004). The interaction with PARP-1 and DNA glycosylases 
indicates the involvement of XRCC1 in the SSB repair process and BER pathway. 
However, PARP-1 might also play a role in BER in searching for indirect SSBs 
caused by DNA glycosylases. Once PARP-1 recognized a SSB it binds to XRCC1. 
XRCC1 on the other hand acts as a stabilizing protein for LigIIIα necessary to seal 
the SSB. In addition XRCC1 can recruit further proteins such as PNK, Polβ and 
APE1 in order to prepare the gap for ligation (Leppard et al., 2003).  
 
Table 1: Summary of known protein interactions of important BER proteins. 
 
APE1= apurinic/apyrimidinic (abasic) endonuclease; YB1= Y box binding protein 1; PKC= 
protein kinase C; XRCC1= X-ray repair complementing defective repair in Chinese hamster 
cells 1; APTX= aprataxin, forkhead-associated domain histidine triad-like protein; PNK= 
polynucleotide kinase 3′-phosphatase; Polβ= human DNA polymerase β; LIG3α= human 
ligase 3 alpha; FEN-1= flap structure-specific endonuclease; PCNA= proliferating cell 
nuclear antigen; WRN= Werner syndrome ATP-dependent helicase; CSB= Cockayne 
syndrome B protein; RPA= replication protein A; NTH1= endonuclease III-like 1 (E. coli); 
OGG1= 8-oxoguanine DNA glycosylase; NEIL1= nei endonuclease VIII-like 1 (E. coli); 
NEIL2= nei endonuclease VIII-like 2 (E. coli); MUTYH= mutY homolog (E. coli); UNG= uracil-
DNA glycosylase; PARP-1= poly(ADP-ribose) polymerase 1. 
1 
Vidal et al. (2001a); 
2 
Yang et al.(2001); 
3 
Marenstein et al. (2003); 
4 
Xia et al. (2005); 
5 
Kavli 
et al.(2002); 
7 
Caldecott et al. (1995); 
8 
Vidal et al. (2001b); 
9 
Whitehouse et al. (2001);  
10 
Clements et al. (2004); 
11 
Leppard et al. (2003); 
12 
Klungland & Lindahl, (1997); 
13 
Parker et 
al. (2001); 
14 
Otterlei et al. (1999); 
15 
Fan et al. (2004); 
16 
Caldecott et al. (1996); 
17 
Hegde et al. 
(2008a); 
18 
Mokkapati et al. (2004); 
19 Sidorenkoa et al. (2008); 20 Wiederhold et al. (2004);  
21 
Das et al. (2006); 
22 
Dou et al. (2008); 
23 
Das et al. (2007a); 
24 
Marenstein et al. (2001);  
25 
Muftuoglu et al. (2009); 
26 
Das et al. (2007b); 
27 
Marsin et al. (2003); 
28 
Dantzer et al. (2002); 
29 
Hazra et al. (2002a); 
30
Hooten et al. (2012); 
31
Hooten et al. (2011). 
 
 
NTH1 APE
(3) YB1(24)
OGG1 XRCC1
(27) APE(1, 19) PARP-1(31) PKC(28)
NEIL1 LIG3α
(20) Polβ(20) PNK(20) XRCC1(20) CSB(25) PCNA(22) FEN-1(17) PARP-1(30) OGG1(18) WRN(26)
NEIL2 LIG3α
(21) Polβ(21) PNK(21) XRCC1(21) YB1(23)
MUTYH APE
(2,4,13) PCNA(13) RPA(13)
UNG PCNA
(14) RPA(14)
XRCC1 LIG3α
(7,9,16) NEIL1 (20) NEIL2(21) PNK(9, 20) APE(8) PCNA(15) FEN-1(12) PARP-1(11,16) OGG1(27) Polβ(9) APTX(10)
LIG3α NEIL1
(22) NEIL2(21) XRCC1(7,9) PARP-1(11)
Polβ NEIL1
(22) NEIL2(21) XRCC1(9)
PARP-1 LIG3α
(11) NEIL1(30) XRCC1(11, 16) OGG1(31)
PCNA NEIL1
(22) XRCC1(15)
PNK NEIL1
(22) NEIL2(21) XRCC1(9, 20)
Other BER proteins
DNA-Glycosylases
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Figure 33: Known interactions between several BER proteins (references see Table 1). 
 
2.4 Theoretical background to methods used in this thesis 
2.4.1 Yeast Two-Hybrid assay 
 
To investigate the biological role of hNEIL3 a yeast two-hybrid (Y2H) assay, a system 
that allows the examination of protein-protein interactions was carried out. In Y2H, 
the chosen ‘bait’ protein (hNEIL3) is expressed in the Saccharomyces cerevisae 
strain EGY48 fused to the DNA-binding domain of a bipartite transcription factor 
(LexA; Figure 34), while the second protein (the prey) is expressed from a cDNA 
library, bound to the activation domain (B42; Figure 34) which, in combination with 
LexA activates transcription. Neither LexA nor B42 alone are able to activate the 
transcription; only if they are in close proximity due to interaction of the bait protein 
with a prey protein, will transcription of a downstream reporter gene occur. In this 
project the LexA-operator is responsible for the expression of two genes; Leu2, which 
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is involved in leucine biosynthesis and LacZ (Figure 34). The use of two reporter 
systems allows a double selection, which decreases the number of false negatives 
(Muelhardt, 2009).  
 
 
Figure 34: Theory of the yeast two-hybrid assay used in this project. Here LacZ is shown as 
an example for a reporter gene. 
 
Molecular cloning of hNEIL3 cDNA into two bait vectors, pEG202 and pEG202-NLS 
(Appendix, Figure 98 and Figure 99) was necessary to carry out the Y2H assay. The 
vectors contain an ampicillin resistance gene (AmpR) and there is a LexA region 
before the multiple cloning site. This region allows expression of a fusion protein 
featuring LexA as the DNA-binding domain and hNEIL3 as the bait protein (Bait in 
Figure 34; Lewis et al., 1994). The expression of this fusion protein is controlled by 
the alcohol dehydrogenase (ADH) promoter and ADH terminator region (Appendix 
Figure 98 and Figure 99) which starts and stops the transcription in yeast. 
Furthermore, Figure 99 shows that pEG202-NLS contains a NLS in the multiple 
cloning site that ensures the expressed bait fusion protein will be located into the 
nucleus. 
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As recent protein interaction studies with NEIL1 and NEIL2 carried out by Wiederhold 
et al. (2004) and Das et al., (2006) showed that there are genuine interactions with 
both human Polβ and LigIIIα the Y2H assay was also used to estimate if LigIIIα and 
Polβ is also interacting with NEIL3. The fact that nothing was published regarding 
interaction studies with NEIL3 might be due to problems in expressing NEIL3 in full 
length. However, as it was possible in this project to express full length NEIL3 fused 
to LexA in the Y2H system it was also tested for interaction with these two proteins 
using Y2H. 
 
2.4.2 Protein overexpression in Pichia pastoris 
 
Although E. coli is a commonly used expression system, overexpression of 
recombinant full length hNEIL3 in E. coli has not been successful (Section 2.3.5.2.3). 
Therefore, it was decided to use methylotrophic yeast, P. pastoris, which are 
commonly used for the expression of recombinant proteins (Daly & Hearn, 2005) and 
thus is more likely to process the nascent polypeptide chain of hNEIL3 correctly 
following translation. Posttranslational modifications may be essential to study the 
role of NEIL3 in vivo. Furthermore, higher yields of protein can be obtained than with 
other yeast strains such as S. cerevisae and P. pastoris is amenable for use in large 
scale fermentation. In this project pGAPZαA (Invitrogen) was the overexpression 
vector of choice. This vector is designed for high-level protein expression in  
P. Pastoris and employs a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
promoter for constitutive expression of the protein of interest and therefore no 
manual induction of gene expression is needed by adding methanol. Furthermore, 
this vector contains an α-factor secretion signal sequence that is fused to the  
N-terminal of the expressed protein. A myc epitope and a polyhistidine tag (6XHis) 
are fused to the C-terminal end of the expressed protein, which simplifies protein 
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purification and identification with tag-specific antibodies. Following site-specific 
linearization with AvrII and electroporation into P. pastoris, the plasmid DNA 
integrates into the yeast genome via homologous recombination at the GAPDH 
promoter locus. In this project cloning of the hNEIL3 cDNA sequence and truncated 
versions into the pGAPZαA vector and subsequent integration it into the yeast 
genome was successfully performed. 
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3 Materials 
3.1 Media preparation for bacterial methods 
 
Lysogeny broth (LB)-broth was prepared at a concentration of 8 g LB-broth powder 
(Sigma-Aldrich) in 400 ml dH2O and used for liquid cultures. LB-agar was prepared 
by adding 14 g of LB-agar powder (Sigma-Aldrich) to 400 ml dH2O. The mixtures 
were autoclaved at 121°C for 20 min to dissolve the powder and sterilise the 
medium. After the LB-agar had cooled to ~50°C, carbenicillin or kanamycin sulphate 
was added to obtain an antibiotic concentration of 50 µg/ml and plates were poured 
and allowed solidify before use, or stored at 4°C. For liquid cultures, carbenicillin or 
kanamycin sulphate was added to LB-broth to a final conc. 50 µg/ml just before 
inoculation.  
 
3.2 X-Gal and IPTG Preparation 
 
X-Gal stock solution: 
50 mg/ml X-Gal: 25 mg X-Gal powder was dissolved in 500 µl of  
N,N′-dimethylformamide and stored at -20°C. 
 
IPTG stock solution: 
100 mM IPTG: 12 mg of IPTG powder was dissolved in 500 µl dH2O, filter sterilized 
and stored at -20°C.  
Treatment of LB-Agar plates (Carb.) with X-Gal/IPTG: 
100 µl (100 mM) IPTG and 20 µl X-Gal (50 mg/ml) were spread evenly on each LB-
agar plate. 
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3.3 Ethylenediaminetetraacetic acid (EDTA) stock solution 
To obtain a 0.5 M ethylenediaminetetraacetic acid (EDTA) stock solution, 18.61 g 
EDTA-disodium-salt was dissolved in 70 ml of dH2O and the pH adjusted to pH 8.0 
by adding NaOH and adjusted with dH2O to a total volume of 100 ml. 
 
3.4 TE-Buffer (Tris-EDTA-Buffer) 
To prepare Tris/EDTA (TE) buffer, 10 ml of 1 M Tris-HCl pH 7.5 and 2 ml of 500 mM 
EDTA were mixed and pH was adjusted to 8.0 with NaOH. 
 
3.5 5X TBE 
5X Tris/Borate/EDTA (TBE) stock solution: 54 g of Tris base (Trizma base, Sigma-
Aldrich) and 27.5 g of boric acid was dissolved in 900 ml of dH2O. 20 ml of 0.5 M 
(4.65 g) EDTA was added and the solution was adjusted with dH2O to a final volume 
of 1 L. 
 
3.6 Loading buffer for agarose gel electrophoresis (Loading dye) 
Twenty-five milligrams of bromophenol blue, 4 g sucrose and 2.4 ml of 0.5 M EDTA 
were mixed and made up to 10 ml with dH2O. 
 
3.7 Buffers for SDS-PAGE 
3.7.1 Acrylamide stock solution  
The premade acrylamide stock solution (Protogel, National Diagnostics) contained 
30% acrylamide and 0.8% bis-acrylamide. 
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3.7.2 “Lower Tris” (4x stock solution) 
To prepare 4x stock solution of lower Tris buffer, 1.5 M Tris-HCl pH 8.8, 0.4% (w/v) 
SDS, 18.17 g Tris base and 2 ml of 20% (w/v) SDS were added to 80 ml of dH2O. 
Then, the pH was adjusted with HCl until pH 8.8 and dH2O added to bring the 
solution up to 100 ml. 
 
3.7.3 “Upper Tris” (4x stock solution) 
To prepare 4x stock solution of upper Tris buffer, 0.5 M Tris-HCl pH 6.8, 0.4% (w/v) 
SDS, 6.06 g Tris base, 2 ml of 20% (w/v) SDS were added to 80 ml of dH2O. Then, 
the pH was adjusted with HCl until pH 6.8 and dH2O added to bring the solution up to 
100 ml. 
 
3.7.4 Separating gel (10 %) 
For 12 ml of separating gel mix (enough for two mini gels, Labnet), 4 ml of Protogel 
(30% acryl, 0.8% bis), 3 ml of 4x Lower Tris (Section 3.7.2) and 5 ml of dH2O were 
mixed. Just before pouring, 80 µl of 10% (w/v) APS (ammonium persulphate) and 8 
µl TEMED (tetramethylethylendiamine, 0.10%) were added to catalyse 
polymerisation. 
 
3.7.5 Stacking gel (5 %) 
For 6 ml of stacking gel mix (enough for two mini gels, Labnet), 1 ml of Protogel (30% 
acryl, 0.8% bis), 1.5 ml of 4x Upper Tris (Section 3.7.3) and 3.5 ml of dH2O were 
mixed. Just before pouring, 80 µl of 10% (w/v) APS and 8 µl TEMED (0.13%) were 
added to catalyse polymerisation. 
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3.7.6 SDS-running buffer (10x stock solution) 
To prepare a 10x stock solution of SDS-running buffer, 15 g Tris base (final conc. 
250 mM), 72 g glycine (final conc. 1.92 M), 5 g SDS (or 50 ml of 10% (w/v) SDS) 
were dissolved in a final volume of 500 ml of dH2O.  
 
3.7.7 SDS-running buffer (1x) – Bio-Rad 
To prepare a 1x stock solution of SDS-running buffer, 50 ml of 10x Tris/glycine stock 
solution (Bio-Rad), 5 ml of 10% (w/v) SDS (0.1% (w/v) final conc.) and 445 ml dH2O 
were mixed (enough to fill the Labnet tank) to give a final conc. of 25 mM Tris and 
192 mM glycine. 
 
3.7.8 SDS-PAGE sample buffer (5x stock solution) 
Two millilitres of 100% glycerol (20% final conc.), 3ml of 1 M Tris-HCl pH 6.8 (300 
mM final conc.), 5 ml of 20% (w/v) SDS (10% (w/v) final conc.), 0.386 g of DTT (0.25 
M final conc.) and 5 mg bromophenol blue (0.05% (w/v) final conc.) were mixed 
together to obtain a 5x stock solution of SDS-PAGE Sample Buffer. 
 
3.7.9 Coomassie blue staining solution 
The stain was prepared by mixing 1.25 g Coomassie blue R250 (0.25% (w/v) final 
conc.), 200 ml methanol (40% (v/v) final conc.), 50 ml acetic acid (glacial, 10% (v/v) 
final conc.) and 250 ml dH2O to obtain a final volume of 500 ml. The Coomassie stain 
was reused several times. 
 
3.7.10 Destain solution 
The destain solution was prepared by mixing 100 ml of methanol (20% (v/v) final 
conc.), 25 ml of acetic acid (glacial, 5% (v/v) final conc.) and 375 ml of dH2O to 
obtain a final volume of 500 ml.  
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3.8 Buffers for Western Blotting 
 
3.8.1 Western blot transfer buffer 
The transfer buffer contained 6.05 g Tris base (25 mM final conc.), 28.8 g glycine 
(final conc. 192 mM), 400 ml methanol (20% (v/v) final conc.) and 1600 ml dH2O and 
was stored at 4°C. 
 
3.8.2 10x TBS 
To prepare 500 ml of 10X TBS buffer, 30.25 g of Tris base and 43.8 g of NaCl was 
added to 450 ml of dH2O. The pH adjusted to pH 7.5 with conc. HCl (~15 ml), made 
up to 500 ml with dH2O and stored at 4°C. 
 
3.8.3 TBS(T) 
To prepare 500 ml of TBS(T), 50 ml of 10x TBS (50 mM Tris-HCl final conc.; 150 mM 
NaCl, Section 3.8.2) and 0.5 ml Tween-20 (0.1% (v/v) final conc.) was mixed, the 
volume made up to 500 ml with dH2O and stored at room temperature. 
 
3.8.4 5% blocking buffer 
To prepare blocking buffer, 5% (w/v) non-fat milk (Marvel) was mixed with TBS(T) 
(Section 3.8.3). 
 
3.8.5 Antibody dilution buffer 
To prepare 0.5% blocking buffer, used as dilution buffer for antibodies, the  
5% Blocking Buffer (Section 3.8.4) was diluted 1:10 with TBS(T) (Section 3.8.3). 
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3.9 Buffers and solutions for Y2H 
 
3.9.1 10X TE 
To prepare 10X TE, 50 ml of 1 M Tris-HCl pH 7.5 and 10 ml of 0.5 M EDTA pH 8.0 
were added to 440 ml dH2O, mixed and autoclaved.  
 
3.9.2 10X LiOAc (Lithium acetate) 
Fifty-one grams of lithium acetate (1 M final conc.) was made up to a total volume of 
500 ml with dH2O, mixed until dissolved and autoclaved. 
 
3.9.3 50% PEG-3350 
Two-hundred and fifty grams of polyethylene glycol-3350 were made up to a total 
volume of 500 ml with dH2O, mixed until dissolved and autoclaved. 
 
3.9.4 1x TE/LiOAc/H2O 
Just before use, 1 part 10x TE (Section 3.9.1), 1 part 10x LiOAc (Section 3.9.2) and 8 
parts dH2O were mixed together. 
 
3.9.5 1x TE/LiOAc/PEG-3350 
Just before use, 1 part 10x TE (Section 3.9.1), 1 part 10x LiOAc (Section 3.9.2) and 8 
parts 50% PEG-3350 (Section 3.9.3) were mixed together. 
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3.9.6 Glucose/galactose/raffinose 
 
To obtain 20% (w/v) glucose, 10 g of glucose was dissolved in 50 ml dH2O. 
To obtain 20% (w/v) galactose, 10 g of galactose was dissolved in 50 ml dH2O. 
To obtain 10% (w/v) raffinose, 5 g of raffinose was dissolved in 50 ml dH2O. 
All solutions were mixed in 50 ml Falcon tubes by warming (not boiling) in a 
microwave at medium power, followed by shaking at 260 rpm for few minutes. Once 
all ingredients were dissolved, the solution was filter sterilized and stored at 4°C. 
 
3.9.7 Amino acid (and pyrimidine) solutions 
Fifty-millilitre (4 mg/ml) stock solutions of tryptophan, uracil, leucine and histidine 
were prepared by filter sterilizing and stored at 4°C. If a precipitate formed (especially 
uracil), the tubes were heated briefly in a microwave oven to aid dissolution before 
use. 
 
3.9.8 YPD broth/agar plates 
Twenty-five grams of YPD powder (Sigma-Aldrich) were weighed into 500 ml dH2O 
and autoclaved. For YPD agar plates, 10 g agar powder (Invitrogen) was added prior 
autoclaving. 
 
3.9.9 YNB broth/agar plates 
To prepare YNB broth, 3.35 g yeast nitrogen base without amino acids but including 
ammonium sulphate (MP/Anachem) and 0.3 g his-/ura-/trp-/leu- dropout mix 
(MP/Anachem) were weighed into 500 ml dH2O and autoclaved. For YNB agar plates 
10 g agar powder (Invitrogen) was added prior autoclaving. 20% (w/v) glucose 
(Sigma-Aldrich) or 20% (w/v) galactose (Fisher) and 10% (w/v) raffinose (Alfa Aesar), 
respectively were added when autoclaved media reached ~50°C to avoid 
caramelisation. 
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3.9.10 YNB selective liquid cultures 
To prepare 10 ml selective liquid YNB-Broth, the following ingredients were pipetted 
per universal tube: 
 
1 ml, 20% (w/v) glucose stock or  
1 ml, 20% (w/v) galactose + 1 ml, 10% (w/v) raffinose 
 
50 µl, 4 mg/ml histidine solution (0.02 mg/ml final conc.) 
50 µl, 4 mg/ml uracil solution (0.02 mg/ml final conc.) 
150 µl, 4 mg/ml leucine solution (0.06 mg/ml final conc.) 
100 µl, 4 mg/ml tryptophan solution (0.04 mg/ml final conc.) 
 
Appropriate amino acids were left out for selection and the volume made up to 10 ml 
with YNB-Broth. Subsequently, the prepared liquid media were inoculated with one 
colony from a plate or with 100 µl from another liquid culture. Usually, the liquid 
cultures were incubated at 30°C in a table top shaker at 220 rpm overnight. 
Sixty millilitres (required for small scale transformation) and 300 ml (required for large 
scale transformation) liquid cultures were prepared with the same ratio of ingredients 
as described above. 
 
3.9.11 YNB selective plate preparation 
To prepare selective YNB-Agar plates, the following amounts of ingredients (as 
required) were pipetted into 50 ml Falcon tubes (25 ml per plate) and YNB-Agar  
(~ 50°C) added to a volume of 50 ml: 
 
5 ml, 20% (w/v) glucose stock or 5 ml, 20% (w/v) galactose + 5 ml, 10% (w/v) 
raffinose 
 
The medium was mixed by inversion and ~25 ml poured into each petri dish. 
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3.9.12 LB-medium  
Ten grams of LB-Broth (Sigma-Aldrich) were dissolved in 500 ml of dH2O by 
autoclaving. In order to prepare plates, 7.5 g of agar (Invitrogen) was added before 
autoclaving. 
 
3.9.13 LB-(ampicillin)-medium (LBA) 
The LB-medium (500 ml) prepared in Section 3.9.12 was allowed to cool to around 
50°C and 1 ml of 50 mg/ml carbenicillin (prepared in dH2O and filter sterilised) was 
added prior to pouring the plates or inoculation of liquid cultures. 
 
3.9.14 LB-(kanamycin)-medium (LBK) 
The LB-medium (500 ml) prepared in Section 3.9.12 was allowed to cool to 50°C and 
500 µl of 50 mg/ml kanamycin sulphate (prepared in dH2O and filter sterilised) was 
added prior to pouring the plates or inoculation of liquid cultures. 
 
3.9.15 Trp- bacterial minimum medium for electroporation  
In order to prepare a trp- bacterial minimum medium, 5.25 g K2HPO4 (potassium 
phosphate, dibasic), 2.25 g KH2PO4 (potassium phosphate, monobasic),  
0.5 g ammonium sulphate and 0.25 g sodium citrate were dissolved in 80 ml dH2O 
and autoclaved along with 7.5 g agar in 400 ml dH2O. After autoclaving, the two 
solutions were mixed together and when the solution cooled to ~50°C, 0.5 ml of 20% 
(w/v) MgSO4, 5 ml of 4 mg/ml uracil, 5 ml of 4 mg/ml histidine, 5 ml of 4 mg/ml 
leucine, 5 ml of 20% glucose, 0.5 ml of 50 mg/ml kanamycin sulphate and 0.5 ml of 
1% thiamine HCl (all filter sterilized) were added. 
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3.9.16 X-Gal plates for blue/white screening 
For blue white selection, X-Gal plates were prepared by adding 50 ml phosphate 
buffer (4.40 g sodium phosphate (2xH2O; dibasic) and 1.95 g sodium phosphate 
(2xH2O; monobasic) in 50 ml dH2O, mixed and autoclaved just before use, no pH 
adjustment was necessary) and 0.4 ml of 100 mg/ml X-gal to autoclaved 450 ml 
YNB-Agar at ~50°C. 
 
3.10 Buffers and solutions for overexpression in P. pastoris 
 
3.10.1 YPD(S) broth/agar plates (Zeocin selection) 
Twenty-five grams of YPD powder (Sigma-Aldrich) were weighed into 500 ml dH2O 
and autoclaved. For YPD agar plates, 10 g agar powder (Invitrogen) was added prior 
autoclaving. For Zeocin selection 0.5 ml of 100 mg/ml Zeocin was added and stored 
at 4°C. For YPDS broth/agar plates containing 1 M sorbitol, 91.1 g sorbitol was 
added prior to autoclaving. 
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4 Methods  
4.1 Transformation into NovaBlue cells 
 
Transformation of the two plasmid vectors, pEG202-NLS and pEG202 (OriGene; a 
generous gift of Dr. Ian Hampson, University of Manchester) as well as the other 
vectors pGEM-T (Promega) and pJET1.2/blunt (Fermentas), was carried out as 
described in the NovaBlue manual (Novagen). All these plasmids contain an 
ampicillin-resistance gene. For the transformation of pEG202(-NLS), 1µl (~10 ng) of 
the DNA was added to 20 µl NovaBlue-cells and incubated on ice for 5 min followed 
by a heat-shock at 42°C for 30 s and incubation on ice for 2 min. The bacteria were 
then plated out onto LB-Agar plates with 50 µg/ml carbenicillin (LB-Carb). Two plates 
were prepared for each transformed plasmid, one with 10 µl and the other with 40 µl 
of the transformation mixture. To make sure the plates were sterile, a control with no 
bacteria was also incubated overnight at 37°C. This confirmed the competent E. coli 
must have been transformed correctly.  
 
4.2 -80°C stock preparation of yeast and bacterial cultures 
4.2.1 Yeast -80°C stocks 
 
All yeast culture stocks were prepared by adding 400 µl glycerol to 600 µl of a fresh 
overnight liquid culture and stored at -80°C. 
 
4.2.2 Bacterial -80°C stocks 
 
All bacterial culture stocks were prepared by adding 80 µl DMSO to 920 µl of a fresh 
overnight liquid culture and stored at -80°C. 
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4.2.3 KC8 -80°C stock preparation 
 
The bacterial E. coli strain KC8 was used in the Y2H method to recover library 
plasmid DNA. The library plasmid (pJG4-5) contains a tryptophan gene that allows 
cells to produce tryptophan and to survive on media lacking this amino acid. To 
prepare electroporation-ready KC8 cells, some of the purchased cells were streaked 
onto an LB agar plate (Section 3.1) containing 50 µg/ml kanamycin sulphate and 
incubated at 37°C overnight. The next day a single colony was picked to inoculate 5 
mL of LB-Broth (Section 3.1) containing 50 µg/ml kanamycin sulphate. This liquid 
culture was incubated at 37°C overnight with shaking at 260 rpm. All of the 5 mL 
were used to inoculate 500 ml LB-Broth containing 50 µg/ml kanamycin sulphate. 
This liquid culture was grown at 37°C, 260 rpm until the OD600 reached 0.5. The 
culture was put on ice for 30 min followed by a centrifugation at 5,000 rpm (3,500 x g) 
for 10 min at 4°C. The supernatant was poured off and the pellet resuspended in 300 
ml of ice-cold 10% (v/v) glycerol. Then the culture was centrifuged again as above, 
the supernatant poured off and the pellet resuspended in 150 ml of ice-cold 10% (v/v) 
glycerol. Centrifugation was repeated as above, the supernatant poured off, the pellet 
resuspended in 10 ml of ice-cold 10% (v/v) glycerol, centrifuged again and the 
supernatant aspirated carefully. The pellet was resuspended in 2 ml of ice-cold 10% 
(v/v) glycerol. Working aliquots of 75 μl per tube were prepared and stored at -80°C. 
 
4.3 Plasmid DNA extraction 
 
The plasmid DNA extraction (miniprep) was carried out as described in the QIAprep 
Miniprep (Qiagen) or the Pureyield Plasmid Miniprep Kit Handbook (Promega At 
least two colonies were picked to inoculate 5 ml of LB-broth containing 50 µg/ml 
carbenicillin or kanamycin sulphate. After overnight incubation in a shaker at 37°C 
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(220 rpm), 1.5 ml (3 ml for Pureyield Plasmid Miniprep Kit) of the liquid cultures was 
used for plasmid DNA extraction. After analysing the quantity and purity of the DNA 
obtained, it was stored at -20°C. To obtain large quantities of plasmid DNA the 
Qiagen Plasmid Maxi Kit was used according to the manufacturer’s instructions. 
 
4.4 Quantification of DNA  
 
The DNA life science analyser (Jenway-Genova) in combination with a TrayCell 
cuvette (Hellma) and subsequently the Nanodrop 2000 system (Thermo scientific) 
were used to quantify the conc. and determine the quality of plasmid DNA obtained.  
 
4.5 Digestion with restriction endonucleases 
 
All digestions were carried out by incubating the DNA with experiment dependent 
restriction endonucleases under the conditions recommended by the supplier (New 
England Biolabs Ltd, UK).  
 
4.6 Agarose gel electrophoresis  
 
One per cent and 0.8% agarose (Bioline) gels were prepared in 0.5x TBE 
electrophoresis buffer (Section 3.5) by heating the mixture in a microwave 
oven. After the agarose had dissolved and the solution cooled to around 
50°C, GelRed was added (2 µl per 100 ml). Two microlitres of loading 
buffer were added to the DNA samples before loading the gel. The DNA 
was subjected to electrophoresis at 80 - 100 V for 45 to 90 min. The DNA 
bands were imaged and recorded using the G:BOX gel documentation 
system and GeneSnap software (Syngene). The molecular size marker, 
HyperLadder I (Bioline) was included to gauge the size of bands obtained. 
Figure 35: 
HyperLadder I  
(Bioline). 
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4.7 Polymerase chain reaction 
 
Several different DNA polymerases (Taq, Dream Taq (Fermentas), Phusion (NEB), 
BioXAct-short and MyTaq (Bioline)) were used for the polymerase chain reaction 
(PCR) throughout the project and the manufacturer’s instructions were followed 
where appropriate. Individual reaction conditions were determined empirically as 
required.  
 
4.8 DNA Ligation 
4.8.1 Insert:Vector molar ratio calculation  
 
In most cases a 3:1 (insert:vector) ratio was used. The amount of insert DNA 
required was calculated using the following formula: 
 
 
4.8.2 Ligation of hNEIL3 into pGEM-T vector (Promega) 
 
After hNEIL3 was obtained by PCR with BioXAct-short, it was ligated into the pGEM-
T vector following the manufacturer’s instructions. 
 
4.8.3 Ligation of hNEIL3 into pJET1.2/blunt vector (Fermentas) 
 
Phusion DNA polymerase generates blunt end products. Therefore, the CloneJET 
PCR Cloning Kit (Fermentas) was used and carried out as according to the 
manufacturer’s instructions.  
 Thomas ROEDL – PhD Thesis – Salford 2013 70 
4.9 DNA sequencing 
 
For DNA sequencing, BigDye v1.1 (Applied Biosystems) together with the provided 
5x buffer (obtained from the DNA sequencing Facility at the University of 
Manchester) was used in the reaction mix. Table 2 and  
Table 3 show the amounts of each constituent and the conditions used for DNA 
sequencing reactions of plasmid DNA. 
Table 2: Reaction mix used for the DNA sequencing reaction. 
Primer 1.0 µl (4-10 pmol/µl) 
Template DNA 1.0 µl (300 – 500 ng DNA) 
BigDye v1.1 1.0 µl 
5 X Buffer 3.5 µl 
H2O 13.5 µl 
Total 20.0 µl 
 
Temp. Time 
96°C 5 min 
96°C 10 s 
35 Cycles 50°C 5 s 
60°C 4 min 
4°C hold 
 
Table 3: Reaction mix used for the DNA sequencing reaction. 
Primer 1.0 µl (4-10 pmol/µl) 
Template DNA 1.0 µl (300 – 500 ng DNA) 
BigDye v1.1 1.0 µl 
5 X Buffer 3.5 µl 
H2O 13.5 µl 
Total 20.0 µl 
 
Temp. Time 
96°C 5 min 
96°C 10 s 
35 Cycles 50°C 5 s 
60°C 4 min 
4°C hold 
 
After the DNA sequencing reaction was finished an ethanol precipitation was carried 
out (protocol provided by sequencing facility, Manchester University). 
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Ethanol Precipitation Protocol: 
Twenty microlitres of the sequencing reaction were transferred to a 1.5 ml 
microcentrifuge tube. Then, 2 µl of 3 M sodium acetate pH 4.5, 44 µl 100% ethanol 
and 1 µl of BlueDye (GlycoBlue) were added followed by incubation at room 
temperature for 10-30 min. After centrifugation at 17,000 x g for 10 min the 
supernatant was aspirated and 100 µl of 80% (v/v) ethanol was added and the 
mixture incubated at room temperature for 2 min. Subsequently, the tubes were 
centrifuged briefly, the supernatant aspirated and the lid left open for evaporation of 
the ethanol (>20 min). A little blue point was visible at the bottom of the tube which 
indicated the position of the DNA pellet. After ethanol precipitation the tubes were 
taken for sequencing at the DNA sequencing Facility at the University of Manchester. 
 
4.10 Bradford assay 
4.10.1 Protein extraction for Bradford assay 
 
Yeast colonies (one per extraction) were used to inoculate 10 ml YNB (Glu) ura-/his- 
medium and the culture placed in a shaking incubator at 30°C and 250 rpm 
overnight. Subsequently, 1.5 ml of each liquid culture was transferred to sterile 1.5 ml 
centrifuge tubes and centrifuged at maximum speed (17,000 x g) for 2 min. The 
supernatant was discarded, each pellet resuspended in 1.5 ml dH2O and spun at 
maximum speed for a further 2 min. The supernatant was again discarded and each 
pellet resuspended in 100 µl TBS(T) buffer (Section 3.8.3) followed by sonication on 
ice at full power (highest amplitude and frequency possible) for 15-30 s to break open 
the yeast cell walls. After sonication the suspension was centrifuged at maximum 
speed for 2 min, the supernatant transferred to fresh 1.5 ml centrifuge tube and 
stored at -20°C. 
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4.10.2 BSA standard dilutions 
 
Five milligrams per millilitre of BSA stock solution (5 mg BSA in 1 ml TBS(T)-buffer) 
was prepared and stored at -20°C until needed. To obtain a standard curve for the 
Bradford reagent, the stock solution was diluted 1:2 with TBS(T) (250 µl stock 
solution + 250 µl TBS(T) buffer) to obtain 2.5 mg/ml BSA solution (considered 
Dilution 1). Dilution 1 was diluted five more times (Dilution 2-6, Table 4). Dilution 7 
contained 500 µl of TBS(T) buffer only without BSA added and was used to blank the 
spectrophotometer. 
 
Table 4: Final concentrations of BSA protein standards. 
BSA 
(Final conc.) 
Dilution number 
5 mg/ml Undiluted 
2.5 mg/ml Dilution 1 
1.25 mg/ml Dilution 2 
0.625 mg/ml Dilution 3 
0.3125 mg/ml Dilution 4 
0.15625 mg/ml Dilution 5 
0.078125 mg/ml Dilution 6 
0 mg/ml Dilution 7 (blank) 
 
4.10.3 Bradford reagent assay method 
 
The Bradford reagent was mixed in the bottle prior to use and brought to room 
temperature. The BSA standards were prepared as described in Section 4.10.2 and 
50 µl of each standard dilution was pipetted into a disposable plastic cuvette and  
1.5 ml of Bradford reagent added. Each sample was incubated at room temperature 
for approximately 5 min (max. 45 min) prior to measuring. The absorbance of each 
sample was measured at 595 nm within 10 min of each other. From the data 
obtained a standard curve was plotted. Then, 10 µl of unknown protein solution was 
combined with 1.5 ml of Bradford reagent and the OD595 measured. Two more 
different dilutions of unknown protein were measured to decrease failure and the 
mean, considering the dilution factor, was calculated.  
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4.11 SDS-PAGE 
4.11.1 Protein extraction from yeast for direct SDS gel loading  
 
To extract proteins from yeast a modified method described by Kushnirov (2000) was 
performed. Therefore, 1.5 ml of a fresh overnight liquid culture was transferred to a 
sterile 1.5 ml centrifuge tube and spun at maximum speed (17,000 x g) for 1 min. The 
supernatant was discarded and the pellet resuspended in 100 µl of dH2O and 100 µl 
0.2 M NaOH. The mixture was incubated at room temperature for 5 min and then 
centrifuged at maximum speed for 1 min. The supernatant was discarded, the pellet 
resuspended in 50 µl (1x) SDS-PAGE sample buffer (Section 3.7.8) and heated at 
95°C in a heating block for 3 min. The tube was centrifuged at maximum speed for 1 
min and supernatant transferred to a sterile 1.5 ml centrifuge tube. 20 µl of the 
soluble protein mixture was loaded directly into a well of an SDS-PAGE gel (Section 
4.11.3). 
 
4.11.2 Casting of SDS-PAGE gels 
 
The gel plates were assembled, a comb placed in position and a mark made 
approximately 1 cm below the bottom of the comb after which the comb was 
removed. The separating gel mixture (Section 3.7.4) was poured and carefully 
overlaid with 200 µl of water saturated 2-propanol. After the gel had polymerised (10 
to 30 min) the 2-propanol was rinsed off and the plates dried by passing Whatman 
filter paper between them. The stacking gel mixture (Section 3.7.5) was then poured 
directly onto the separating gel. After polymerisation (5 to 10 minutes) the gel was 
transferred to the electrophoresis tank (Labnet). The inner chamber was filled with 1x 
SDS-running buffer (Section 3.7.7) to the top and the outer chamber only until 1 cm 
over lower edge of the gel glass plate. Then the combs were removed and the wells 
loaded with the denatured protein samples. 
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4.11.3 SDS gel loading 
 
Protein samples were prepared as described in Table 5. After mixing the samples 
were heated at 95°C for 5 min and 20 µl (~15-30 µg) loaded in each well. If the wells 
were blocked by gel fragments a syringe needle was used to empty the wells. SDS-
PAGE was carried out at 200 V for 45 min or until the tracking dye reached the 
bottom of the gel. The protein ladder used was a Full-range Rainbow Marker (GE 
Healthcare, Figure 36). 
Table 5: Sample preparation scheme for SDS gel loading. 
Cell-Lysate/ 
Protein mixture 
x µl (30-60 µg) 
 Calculated by Bradford assay  
    (Section 4.10) 
TE-buffer x µl (up to 40 µl) 
Sample buffer (4x) 10 µl 
Total 40 µl 
 
 
Figure 36: Full-range Rainbow 
Marker (GE Healthcare, Image 
taken from: http://bit.ly/wVQsay). 
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4.11.4 Coomassie blue staining dye 
 
Because SDS-PAGE was performed in duplicate it was possible to stain one gel with 
Coomassie blue while the other was used for western blotting. The gel was stained in 
Coomassie blue dye (Section 3.7.9) with gentle agitation for  
20 - 60 min. Then the gel was destained in destain solution (Section 3.7.10) for 3 x 
15 min followed by incubation overnight.  
 
4.12 Western blot 
 
Proteins separated by SDS-PAGE were transferred to a nitrocellulose membrane 
(Hybond ECL, GE Healthcare) using a Mini Trans-Blot Electrophoretic Transfer Cell 
(Bio-Rad).  
 
4.12.1 Blotting 
 
The transfer buffer was prepared as described in Section 3.8.1 and stored at 4°C. 
Two hours before use the bottles were chilled at -20°C to ensure as cold conditions 
during blotting are provided as possible. The fibre pad, filter paper (two per gel), SDS 
gel and membrane were pre-wetted in western blot transfer buffer and the gel 
sandwich assembled as shown in Figure 37. 
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Figure 37: Gel sandwich assembling (Image taken from: 
Mini Trans-Blot Electrophoretic Transfer Cell instruction 
manual, Bio-Rad). 
 
The cassette was closed and slotted into a module. The module then was placed in a 
tank (black side to negative cathode) along with a frozen cooling unit and filled with 
Western Blot transfer buffer (Section 3.8.1). A magnetic stirring bar was added and 
the tank put onto a magnetic stirrer. Electrophoretic transfer was carried out for one 
hour at 100 V. 
 
4.12.2 Western blotting 
 
After transfer, the membrane was transferred to a plastic container and blocking 
buffer (Section 3.8.2) was added until the membrane was fully covered. Blocking was 
performed at room temperature for one hour or overnight. Afterwards, the blocking 
buffer was discarded, the membrane transferred into a polythene bag made from a 
piece of autoclave bag heat sealed on three sites. Five millilitres of primary antibody 
(1/10000 to 1/25000 rabbit monoclonal anti LexA ,Abcam) diluted in 0.5% blocking 
buffer, was added and the bag heat sealed. The membrane was incubated at room 
temperature on a rocking table for about 1.5 hours. The membrane was then 
transferred to a plastic container, washed 3 x 10 min in TBS(T), transferred to a fresh 
polythene bag and incubated with 5 ml of 1/3000 horseradish peroxidase (HRP) 
conjugated secondary antibody (diluted with TBS(T)) on a rocking table at room 
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temperature for about 45 minutes. Following this, the membrane was again washed  
3 x 10 min with TBS(T). After the last wash the TBS(T) was drained off by dipping 
one side of the membrane onto a paper tissue. Subsequently, the membrane was 
transferred to cling film (protein side up) and 5 ml of enhanced chemiluminescence 
(ECL) reagent, prepared according to the manufacturer’s instructions, poured on the 
membrane and incubated at room temperature for 1 min. Excess ECL reagent was 
drained off and the membrane wrapped in cling film. The wrapped membrane was 
placed in the G:BOX and continuous pictures with 30 s, 1 min and 2 min exposure 
times were taken. Depending on the results of the initial pictures taken, the exposure 
time was increased or decreased, as appropriate. 
 
4.13 Yeast two-hybrid 
 
4.13.1 Small scale transformation 
 
Prior to transformation, a 60 ml liquid culture was inoculated with the appropriate 
amount of an overnight 10 ml liquid culture to obtain an OD600 of 0.15 (calculation 
used: OD600 wanted / OD600 got x final volume = volume to inoculate). The 60 ml 
liquid culture was incubated at 30°C and 220 rpm until the OD600 reached 0.7-1.0 
(after 5-7 h). Then the culture was transferred into two 50 ml Falcon tubes (30 ml 
each). The tubes were centrifuged at 3000 rpm (1500 x g) for 5 min, the supernatant 
was discarded and the pellet resuspended in 30 ml (15 ml each tube) of sdH2O. The 
suspensions were brought together into one tube, centrifuged at 3000 rpm (1500 x g) 
for 5 min and as much supernatant as possible was aspirated and the pellets stored 
on ice (for up to 2 hours). 1 ml of 1xTE/LiOAc/dH2O and 2 ml of 1xTE/LiOAc/PEG-
3350 were freshly prepared (Sections 3.9.4 and 3.9.5) and 50 µg of carrier DNA 
(from salmon sperm) was added to sterile 1.5 ml centrifuge tubes. Afterwards, the 
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pellets were resuspended in 0.3 ml 1xTE/LiOAc/dH2O and 100 µl of this mixture, 100 
ng of the appropriate plasmid and 300 µl of 1xTE/LiOAc/PEG-3350 were added to 
the 1.5 ml tube containing the carrier DNA. The tubes were mixed by inversion and 
placed in a petri dish at 30°C in a table top shaker at 63 rpm for 30 min. After 
incubation, 70 µl of DMSO was added to each tube and mixed by inversion followed 
by a heat shock. For this, the tubes were placed in a preheated water bath at 42°C 
for 5 min, then immediately centrifuged at 1,000 rpm (65 x g) for 1 min. The 
supernatant was discarded and each pellet resuspended in 500 µl sdH2O. One 
hundred microliters of each transformation mixture was carefully spread onto 
appropriate plates and transferred to an incubator at 30°C for a 30 min incubation 
with the plates not inverted. Finally, the plates were inverted and left in the incubator 
at 30°C overnight. 
 
4.13.2 Large scale transformation of library cDNA 
 
The large scale transformations were carried out with cDNA libraries obtained from 
placental tissue (generous gift from Dr. Ian Hampson, University of Manchester) and 
Jurkat T-Cells (OriGene) as followed. 
 
Day1 
For the large scale transformation of a cDNA library, 10 ml YNB (Glu) ura-/his- 
medium was inoculated with one colony of EGY48 yeast carrying pEG202-N3 and 
pRB1840 plasmids and incubated at 30°C and 250 rpm for 7 hours. Next, this culture 
was transferred into 50 ml YNB (Glu) ura-/his- medium and incubated at 30°C and 
250 rpm overnight.  
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Day2 
The next day, the OD600 of the 60 ml culture was measured and, depending on the 
results, 300 ml of YNB (Glu) ura-/his- medium was inoculated with a volume of culture 
to obtain an OD600 of 0.2. The culture was incubated at 30°C and 250 rpm until an 
OD600 of 1 was reached (approx. 4 hours). Meanwhile, 31 x 1.5 ml sterile centrifuge 
tubes were put into a bag and stored at -20°C (one tube was labelled as control). 
Once the 300 ml culture reached OD600 of 1, it was transferred into 6 x 50 ml Falcon 
tubes and the cells were harvested by centrifugation at 3,000 rpm (1,500 x g) for  
5 min. The supernatant was poured off and the pellet resuspended in 5 ml sterile 
dH2O. All six solutions were poured together into one 50 ml Falcon tube and the cells 
harvested again by centrifugation at 3,000 rpm (1,500 x g) for 5 min. The supernatant 
was poured off and the pellets put on ice (up to 2 h). The 31 x 1.5 ml centrifuge tubes 
were taken out of the freezer and 50 µg of (pre-boiled) salmon sperm carrier DNA 
was pipetted into each tube and fresh 5 ml and 10 ml aliquots of 1xTE/LiOAc/H2O 
and 1xTE/LiOAc/PEG-3350 respectively were prepared (Sections 3.9.4 and 3.9.5). 
 
The cell pellet was resuspended in 1.5 ml of 1xTE/LiOAc/H2O and 50 µl aliquots 
were pipetted into the 30 pre-chilled sterile 1.5 ml microcentrifuge tubes. To ensure 
each yeast cell obtained just one copy of the plasmid a maximum of 1 g of pJG4-5-
based library plasmid DNA was aliquotted into each of the thirty microcentrifuge 
tubes, followed by 300 µl of 1 x TE/LiOAc/PEG-3350, mixed by inversion and 
incubated at 30°C and 63 rpm for 30 min. Subsequently, 40 µl of DMSO was pipetted 
into each tube and mixed by inversion followed by a heat shock at 42-45°C for 5 min. 
To estimate the transformation efficiency a control plate was prepared: 10 µl of one 
transformant was diluted 1:10 with 990 µl of sdH2O into a fresh 1.5 ml centrifuge tube 
and 100 µl of the dilution was spread onto a YNB (Glu) ura-/his-/trp- plate followed by 
incubation at 30°C overnight (this plate was for estimation of total transformants 
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described in Section 4.13.3). In addition, 100 µl of the same transformant was used 
to inoculate 10 ml of YNB (Glu) ura-/his-/trp- liquid medium and incubated at 30°C and 
220 rpm overnight. A plate and liquid culture was also prepared for the control tube 
that lacked the library vector. Finally, the remaining transformants were poured into  
3 x 300 ml YNB (Glu) ura-/his-/trp- medium (10 transformants per 300 ml culture) and 
incubated at 30°C and 280 rpm overnight. 
Day3 
After it was confirmed that the controls did not show any growth, neither on plates nor 
in liquid cultures, and that the 300 ml cultures only contained yeast (checked via 
microscope for bacterial contamination) the 3 x 300 ml YNB (Glu) ura-/his-/trp- 
cultures were poured in equal amounts into 50 ml Falcon tubes, centrifuged at 2500 
rpm (1000 x g) for 10 min and the supernatant decanted. Next, all pellets were 
resuspended in a total volume of 200 ml sdH2O. Then the suspensions were split 
among four Falcon tubes followed by centrifugation at 2,500 rpm (1000 x g) for 5 min. 
The supernatant was decanted, the pellets resuspended in equal volumes of sdH2O 
(~2.5 ml) and brought together into one 50 ml Falcon tube. The total volume was 
estimated and an amount of sterile 50% (v/v) glycerol equalling half that volume was 
added. The suspension was split into 1 ml aliquots and stored at -80°C. 
 
4.13.3 Library cDNA screening (placental cDNA library) 
 
The number of colony forming units (cfu) in the frozen 1 ml aliquots prepared on Day 
3 in Section 4.13.2 was estimated (2.8 x 10
8 cfu/ml) by incubating 100 µl of this 
aliquot on YNB (Gal,Raf) ura-/his-/trp- plates at 30°C for three days and the number of 
total transformants (1.47 x 107) was estimated (therefore the plate for examination of 
total transformants prepared in Section 4.13.2 (Day 2) was used).  
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A YNB (Gal,Raf) ura-/his-/trp-/leu- liquid culture containing 1x107 cfu/ml of viable 
transformants was incubated at 30°C and 150 rpm for 4 hours to induce prey protein 
production. Next, 100 µl of culture was spread onto YNB (Gal,Raf) ura-/his-/trp-/leu- 
plates (~1x106 cfu/plate). After colonies appeared they were transferred onto 
separate YNB (Gal,Raf) ura-/his-/trp-/leu- master plates and incubated at 30°C 
overnight. Each colony from these master plates was resuspended in 100 µl sdH2O 
and then (2 µl) spotted onto each plate as shown in Table 6. 
Table 6: Media used for testing colonies during Y2-H screening. 
Plate Selection Positives 
YNB (Glu) ura-/his-/trp-/leu- No growth 
YNB (Gal,Raf) ura-/his-/trp-/leu- Growth 
YNB (Glu) ura-/his-/trp- + X-gal No blue colonies 
YNB (Gal,Raf) ura-/his-/trp- + X-gal Blue colonies 
 
After incubation at 30°C for 1-2 days all positives estimated were picked from the 
YNB (Gal,Raf) ura-/his-/trp-/leu- plate to inoculate 5 ml YNB-(Glu) trp- liquid cultures 
followed by incubation at 30°C at 250 rpm overnight. Finally, 600 µl of each overnight 
culture was transferred into 2 ml tubes containing 400 µl of 80% glycerol and stored 
at -80°C until needed for subsequent plasmid extraction. 
 
4.13.4 Library plasmid DNA extraction of potential positives 
 
Initially, the standard method described in the DupLEX-A application guide (OriGene) 
was used to extract pJG4-5 plasmids, carrying a library cDNA insert, from the EGY48 
yeast strain. However, after low efficiency was experienced a new PCR method was 
developed that allowed a highly specific and much faster analysis of inserts in 
potential positive pJG4-5 plasmids. 
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4.13.4.1 “Modified” standard method 
 
Plasmid extraction from yeast 
In this method, potential positive clones were grown in 3 ml YNB (Glu) trp- liquid 
medium at 30°C and 250 rpm overnight. If growth was observed the next day, 10 ml 
of fresh YNB (Glu) trp- liquid medium was inoculated with 100 µl of the 3 ml overnight 
culture and incubated at 30°C and 250 rpm overnight. On day three, 2 ml of each 
culture was transferred into 2 ml centrifuge tubes and spun at 17,000 x g for 30 s. 
The supernatant was discarded and a further 2 ml of the 10 ml overnight culture 
added, spun again at 17,000 x g for 30 s and the supernatant discarded. This was 
repeated until all of the 10 ml overnight culture was used. Each pellet was then 
resuspended in 600 µl TE-buffer and sonicated on ice at maximum amplitude and 
frequency for 30 s. Plasmid DNAs were extracted using a miniprep kit (Pureyield 
Plasmid Miniprep System, Promega) and the concentration and purity of the DNA 
was measured in the Nanodrop. 
 
Electroporation of extracted plasmid DNA into KC8 E. coli 
Following the testing of different electroporation conditions, the parameters listed in 
Table 7 resulted in the highest transformation efficiency of E. coli KC8 cells using a 
Micro Pulser (Bio-Rad) instrument. 
 
Table 7: Electroporation conditions used to transform E. coli KC8 cells. 
Volume competent cells (KC8) 40 µl 
Yeast plasmid DNA 10 µl (>20 ng) 
Voltage 2.5 kV 
Time constant ~5 ms 
SOC medium for recovery 1 ml 
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After electroporation and recovery in super optimal broth with added glucose (SOC) 
the cultures were spread onto trp- bacterial minimum plates (Section 3.9.15) and 
incubated at 37°C overnight. The next day, at least one colony from each plate was 
transferred into 5 ml LB-Broth containing 50 µg/ml kanamycin and incubated in a 
shaking incubator at 37°C and 250 rpm overnight. Following incubation, plasmid DNA 
was extracted and the concentration/purity of the DNA was measured. 
 
4.13.4.2 “PCR Method” 
 
Because the use of the “modified” as well as the unmodified standard method 
described in the DupLEX-A application guide (OriGene) had given unsatisfactory 
results (Section 5), a new method was developed to allow a much faster and more 
specific analysis of library cDNA carried by potential yeast clones. The initial 
extraction of the plasmid DNA from yeast was performed as described in Section 
4.13.4.1. However, instead of transforming the obtained plasmid DNA into KC8 cells 
by electroporation a PCR with Taq DNA polymerase was performed followed by 
direct sequencing. Therefore, PCR conditions as shown in Table 8 and the following 
primers were used: 
 
pJG4-5 forward primer: 5′-CTG AGT GGA GAT GCC TCC-3′  
pJG4-5 reverse primer: 5′-GCC GAC AAC CTT GAT TG-3′  
 
Table 8: PCR conditions for library cDNA inserts with Taq DNA polymerase. 
 Temperature Time 
Pre-Denaturation 94°C 1 min 
Denaturation 94°C 30 s 
Annealing 55°C 30 s 
Extension 72°C 2 min 
Final-Extension 72°C 5 min 
30 Cycles   
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4.13.5 Mating assay to confirm potential interaction partners for hNEIL3 
 
The mating assay was used to confirm the potential positive findings of the placental 
cDNA library screen by transforming pEG202-N3 and the reporter pRB1840 (or 
pSH18-34) into yeast strain RFY206 and the isolated potential positive library vector 
pJG4-5 back into EGY48. These two clones were then cross streaked onto YPD 
plates for mating (Figure 38). 
 
Figure 38: Cross streak method for transformed 
mating strains RFY206 (horizontal arrow) and 
EGY48 (vertical arrow) 
 
The plate was incubated at 30°C overnight and three parts (start of horizontal arrow, 
start of vertical arrow and the crossed part in Figure 38) were transferred onto 
selective media (YNB (Glu,X-Gal), ura-, his-, trp- and YNB (Gal,X-Gal), ura-, his-, trp-) 
for LacZ selection. 
 
4.13.6 Interaction studies with LigIIIα and Polβ 
 
To estimate if the interacting protein partners LigIIIα and Polβ found for NEIL1 and 
NEIL2 (Das et al., 2006; Wiederhold et al, 2004) are also interacting with NEIL3 the 
CDS cDNA of both proteins where cloned into the library vector pJG4-5 to make Y2H 
studies. The only restriction sites available in the multiple cloning site of pJG4-5 were 
EcoRI and XhoI. However, as both restriction sites were also present in LigIIIα and 
Polβ it was not possible to use the pGEM-T method as described in Section 4.8.2. 
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Therefore, a workaround was established that made it possible to clone the cDNA 
directly into the pJG4-5 vector. Firstly, the pJG4-5 vector was linearized with EcoRI 
and XhoI and then the sticky overhangs were blunted by the blunting enzyme mung 
bean nuclease (NEB). After blunting the linearized vector it was possible to ligate the 
PCR product of either LigIIIα or Polβ into pJG4-5. At this point it was important, that 
the primers used for amplification were designed in a way that the 3′ G on the EcoRI 
and the 5′ G on the XhoI site of the vector were excluded. This way, only if the insert 
is ligated the right way around the final restriction sites for EcoRI and XhoI in the 
insert stay intact and can be targeted and digested by EcoRI and XhoI. If the insert 
was ligated the wrong way around the restriction sites were destroyed and therefore 
restriction digest with EcoRI and XhoI failed (Figure 39). 
 
 
Figure 39: Cloning method used for insertion of either LigIIIα or Polβ 
into the library vector pJG4-5. For more details see text. 
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4.14 Overexpression in Pichia pastoris 
 
The P. pastoris strain X-33 used in this project was a generous gift of Dr Natalie 
Ferry. The pGAPZαA vectors containing either full length mNEIL1 or hNEIL3 cDNA, 
or truncated versions of hNEIL3 with amino acid length 1-394 or 1-502 (hN3-394 or 
hN3-502) were generated by Mengxin Yin and Constantina Stylianou (2010). Primers 
used to construct the hNEIL3 clones are shown in Table 9 (Yin, 2010). 
 
Table 9: Primers used for hNEIL3, hN3-394 and hN3-502 generation (Yin, 2010). 
hNEIL3 Forward 5′-CTC GAG AAA AGA ATG GTG GAA GGA CCA GGC TG-3′ 
hNEIL3 Reverse 5′-GC GGC CGC GCA TCC AGG AAT AAT TTT TAT TCC TGG C-3′ 
hN3-394 Reverse 5′-GC GGC CGC ATC AGT CAA GAC AAG AGT TGT AGT TCC-3′ 
hN3-502 Reverse 5′-GC GGC CGC AGG ATT TAA GGT ACG AGG GCC ATC-3′ 
 
4.14.1 Electroporation of pGAPZαA constructs into P. pastoris 
 
Electroporation was used to transfect P. pastoris with linearized pGAPZαA 
constructs. Therefore, 5 ml of YPD was inoculated with P. pastoris and incubated at 
30°C at 250 rpm overnight in a 50 ml conical flask. Next day, 500 ml YPD broth was 
inoculated with 0.1 ml of the overnight culture and incubated at 30°C and 250 rpm 
until the OD600 reached 0.8 - 1.1. Then the culture was centrifuged in a cooled 
centrifuge at 3,000 rpm (1,500 x g) for 5 min and the pellet resuspended in 500 ml of 
ice-cold sdH2O. The suspension was centrifuged again at 3,000 rpm (1,500 x g) for 5 
min, the supernatant discarded and the pellet resuspended in 250 ml of ice-cold 
(<4°C) sdH2O. Centrifugation was repeated as before and the pellet was 
resuspended in 20 ml of ice-cold (<4°C) 1 M sorbitol solution. Then, following another 
centrifugation step, the pellet was resuspended in 1 ml of ice-cold (<4°C) 1 M sorbitol 
solution to obtain a final volume of approximately 1.5 ml (if the pellet was large more 
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1 M sorbitol was used). About 10 µg (dissolved in nuclease free sdH2O) of linearized 
pGAPZαA DNA construct was pipetted into 80 µl of the cell solution prepared before 
and transferred to an ice-cold (<4°C) 2 mm electroporation cuvette. The mixture was 
incubated on ice for 5 min and then pulsed in accordance with the manufacturer’s 
instructions (Micro Pulser, Bio-Rad). For P. pastoris, the programme chosen was pic 
and the resulting conditions observed after pulsing were always around 1.98 kV for 
5.1 ms. Directly after pulsing 1 ml of 1 M ice-cold (<4°C) sorbitol was added and the 
sample transferred to a 15 ml sterile tube and incubated at 30°C without shaking for 
1 h. After incubation, 10, 20, 50, 100, 200 and 500 µl were spread onto YPDS plates 
containing 100 µg/ml Zeocin and incubated at 30°C for three days. Once colonies 
appeared, two clones were picked and restreaked onto fresh YPD plates containing 
100 µg/ml Zeocin. 
 
4.14.2 Extraction of chromosomal DNA from P. pastoris using LiOAc-SDS 
 
In preparation for PCR analysis of homologous recombined constructs in P. pastoris 
clones, the chromosomal DNA was first extracted. Therefore, 4 ml of a 10 ml YPD 
culture that had been incubated at 30°C and 250 rpm for two days was centrifuged at 
maximum speed (~13,000 x g) for 30 s. Then the supernatant was discarded and the 
pellet resuspended in 300 µl of LiOAc-SDS solution (200 mM LiOAc and 1% SDS). 
This mixture was incubated for 10 min at 70°C with mixing every 2.5 min, after which 
900 µl of 96-100% ethanol was added, the sample mixed vigorously and centrifuged 
at 13,000 x g for 3 min. The supernatant was discarded and 70% ethanol was added 
to wash the pellet (twice) followed by centrifugation at 13,000 x g for 15 s. After the 
supernatant was discarded, the pellet containing precipitated proteins, cell debris and 
chromosomal DNA was dissolved in 100 µl dH2O. Insoluble cell components and 
debris were spun down by centrifugation at 13,000 x g for 15 s. Finally, the 
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supernatant which contained dissolved chromosomal DNA was transferred to a fresh 
1.5 ml centrifuge tube and the DNA concentration was measured prior to use as 
template DNA in the subsequent PCR. 
 
4.14.3 PCR of incorporated pGAPZαA inserts extracted from P. pastoris 
 
To confirm correct integration of the linearized pGAPZαA plasmid DNA into the 
chromosomal DNA of P. pastoris, PCR was carried out with primers shown in Table 
10. Reaction components shown in Table 11 and PCR conditions in  
 
Table 12. For this method, MyTaq Red Mix (Bioline) was used. This mix contains a 
Taq DNA polymerase, dNTPs and buffer and only the DNA template, primers and 
water had to be added in order to perform the PCR. 1000, 500, 250 and 125 ng of 
template DNA were used for PCR and although all worked, 500 ng seemed to give 
the best visual result in terms of band thickness. 
 
Table 10: Primer sequences for PCR of pGAPZαA insert. 
pGAP-Forward 5´-GCAAATGGCATTCTGACATCC-3´ 
3′ AOX1 5´-GTCCCTATTTCAATCAATTGAA-3´ 
 
Table 11: Components for the PCR of pGAPZαA inserts from extracted chromosomal DNA. 
DNA template x µl ~500 ng 
3′ AOX1 primer 2 µl 
pGAP Forward primer 2 µl 
dH2O x µl 
MyTaq Red Mix (Bioline) 25 µl 
Total 50 µl 
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Table 12: Conditions for PCR of pGAPZαA inserts from extracted chromosomal DNA. 
 Temperature Time 
Initial denaturation 95°C 3 min 
Denaturation 95°C 15 s 
30 cycles Annealing 55°C 15 s 
Extension 72°C 1 min 
Final Extension 72°C 5 min 
Soak while end 4°C -- 
 
4.14.4 Overexpression conditions 
 
For the overexpression of mNEIL1, full length hNEIL3 and its truncated versions 394 
and 502 different conditions were used for incubation to estimate the best 
parameters for optimal expression: 
 
Table 13: Overexpression conditions in P. pastoris 
Condition No. Temp. Time Volume 
Condition 1 28°C Up to 120 h 10 ml, 50 ml, 250 ml 
Condition 2 29°C Up to 120 h 10 ml, 50 ml, 250 ml 
Condition 3 30°C Up to 120 h 10 ml, 50 ml, 250 ml 
 
In addition all three conditions were repeated with baffled flasks for the 250 ml 
volume which showed a slightly faster growth confirmed via OD. The shaker speed 
used for incubation was 180 rpm. Every 24 h of incubation 1 ml samples were 
transferred from each flask to sterile 1.5 ml centrifuge tubes and centrifuged at 
17,000 x g. The supernatant was then transferred to a fresh sterile 1.5 ml centrifuge 
tube. Subsequently, the pellet and the supernatants were shock frozen in liquid 
nitrogen and stored at -80°C. This way it was possible to load all different stages of 
incubation times onto the same SDS-PAGE gel at once. 
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5 Results 
5.1 Y2H Summary 
 
The bait vectors, pEG202 and pEG202-NLS, containing hNEIL3-cDNA were 
generated and autoactivation tests to check if hNEIL3 autoactivates the reporter 
gene transcription on its own were carried out. Once the results of these preliminary 
tests were confirmed to be negative, the pEG202-hNEIL3 bait vector was used in 
Y2H studies to screen cDNA libraries obtained from placental tissue and Jurkat  
T-Cells. Subsequently, 60 potential positive clones obtained from the placental and 
27 potential positive clones from the Jurkat T-cell cDNA library screen were 
sequenced and subjected to bioinformatic analysis. 
 
5.2 Y2H bait vector preparation  
5.2.1 Preparation of hNEIL3 cDNA insert 
5.2.1.1 Designing primers for PCR of hNEIL3-cDNA 
 
For the PCR of the hNEIL3-cDNA (full length) it was necessary to design specific 
oligonucleotide primers. This was achieved by comparing the hNEIL3 cDNA 
sequence with the restriction-sites in the multiple cloning sites of pEG202 and 
pEG202-NLS (Appendix 8.2, Figure 98 and Figure 99). To make it possible to use 
one sort of primers for both vectors, the restriction-sequences for EcoRI and BamHI 
were chosen and added to the 5′ end of each primer. This is necessary to clone the 
hNEIL3 cDNA after amplification into the plasmids pEG202 (Figure 98) and pEG202-
NLS (Figure 99). Both vectors have restriction-sites for EcoRI and BamHI in their 
multiple-cloning-region. As the full length hNEIL3 cDNA contains a stop codon, it was 
not necessary to add one to the hNEIL3_stop_BamHI primer. However, if primers for 
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amplification of truncated versions of hNEIL3 are needed a stop codon must be 
included. 
 
Partial reverse Primer: hNEIL3_1538_Reverse (Tm= 63.33ºC) 
 
5′ - CAC AAC TCG GAG AAT GCA GA – 3′ 
 
Full Primer1:  hNEIL3_stop_BamHI (Tm= 69.79ºC) 
 
5′ - GGA TCC TTA GCA TCC AGG AAT AAT TTT TAT TCC TGG C – 3′ 
 
Full Primer2:  hNEIL3_start_EcoRI (Tm= 68.41°C) 
 
5′ - GAA TTC ATG GTG GAA GGA CCA GGC TGT AC – 3′ 
 
Tm-calculator provided by Finnzyme was used to calculate the annealing 
temperatures (can be found at http://www.finnzymes.com/tm_determination.html). 
 
5.2.1.2 PCR of pCMV6-AC/hNEIL3 with BioXAct-short 
 
Initially, the BioXAct-short DNA polymerase from Bioline was used for the 
amplification of the full length coding sequence (CDS) of hNEIL3. However, no bands 
were obtained (not shown). Taq polymerase was then used as a control and a band 
of the correct size was obtained (Figure 40). Therefore, it was assumed that the long 
(31 bases) full length reverse primer (hNEIL3_stop_BamHI, Section 5.2.1.1) could 
have caused problems and to test this, the PCR was repeated with a shorter reverse 
primer that annealed to bp 1538 – 1557 in hNEIL3 CDS (hNEIL3_1538_Reverse, 
Section 5.2.1.1) giving rise to a truncated version of NEIL3. Interestingly BioXAct-
short was able to amplify this truncated version of the hNEIL3 cDNA with the full 
forward (hNEIL3_start_EcoRI, Section 5.2.1.1) and the hNEIL3_1538_Reverse 
primer (Figure 41).  
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Figure 40: Agarose gel electrophoresis of hNEIL3 PCR products. The PCR of full length 
hNEIL3 with Taq polymerase did work, but with BioXAct-Short it did not. The lanes were 
loaded in duplicate. 
 
 
Figure 41: Agarose gel electrophoresis of truncated hNEIL3 (1538 bp) PCR products. The 
PCR worked for all conditions (68°C and 72°C extension temperature) as well as for both 
enzymes BioXAct-short and Taq polymerase. The lanes were loaded in duplicate. 
 
The PCR was repeated with the full length primers until the right conditions for the 
DNA polymerase BioXAct-Short were found to amplify the full length hNEIL3 cDNA 
(Table 14 and Table 15). This made it possible to obtain PCR products of hNEIL3 
shown in Figure 42 and A-NEIL3 and C-NEIL3 were used for further cloning. 
 
Table 14: PCR-Mix and conditions for the first PCR (ANEIL3). 
DNA 0.5 µl 
10x Buffer 5 µl 
50 mM MgCl2 2.5 µl  
100 mM dNTPs 1 µl Temp. Time 
10 µM Full Primer1 0.5 µl 95ºC 5 min 
10 µM Full Primer2 0.5 µl 95ºC 30 s 
30 Cycles BioXAct (short) 1 µl 54ºC 30 s 
H2O 39 µl 68ºC 5 min 
Total 50 µl 68ºC 10 min 
Obtained ANEIL3 (40 ng/µl) 
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Table 15: PCR-Mix and conditions for the second PCR (BNEIL3 and CNEIL3). 
DNA 1 µl 
10x Buffer 5 µl 
50 mM MgCl2 2 µl  
100 mM dNTPs 0.5 µl Temp. Time 
10 µM Full Primer1 0.5 µl 94ºC 1 min 
10 µM Full Primer2 0.5 µl 94ºC 30 s 
30 Cycles BioXAct (short) 0.5 µl 54ºC 45 s 
H2O 39 µl 68ºC 2 min 
Total 50 µl 68ºC 5 min 
 Obtained BNEIL3 (10 ng/µl) and CNEIL3 (30 ng/µl). 
 
 
Figure 42: Agarose gel electrophoresis of amplified NEIL3 PCR products. For A-NEIL3 
the PCR conditions in Table 14 were used, while for B-NEIL3 and C-NEIL3 those in 
Table 15 were used but with different amounts of template DNA (10 ng for B-NEIL3 and 
30 ng for C-NEIL3) 
 
5.2.1.3 Cloning of hNEIL3 (A-NEIL3 and C-NEIL3) into pGEM-T 
 
After A-NEIL3 and C-NEIL3 were ligated into pGEM-T (Table 16), a transformation 
with blue/white selection into NovaBlue E. coli cells was performed.  
 
Table 16: Scheme for the ligation of hNEIL3 into pGEM-T vector. 
2x Rapid Buffer 5 µl 
pGEM-T vector 1 µl 50 ng 
PCR product 1 µl ~35 ng 
T4 DNA Ligase 1 µl 
Deionized H2O 2.25 µl 
Total 10 µl 
The ligation was carried out at an incubation temperature of 4°C overnight.  
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White colonies from plates of ANEIL3 and CNEIL3 were picked and liquid cultures (LB-
Carb) were set up at 37ºC overnight. Plasmid purification and digestion with EcoRI 
and BamHI was performed and Figure 43 shows the sizes obtained for pGEM-T and 
the hNEIL3 insert. In some lanes a third band is visible which is likely to be 
incompletely digested plasmid DNA. However, the bands are all the expected size 
and samples A2 and C1 were then gel purified to obtain the hNEIL3 insert with EcoRI 
and BamHI overhangs. 
 
 
Figure 43: Agarose gel electrophoresis of pGEM-T/NEIL3 digested with EcoRI and BamHI. 
C1 - C4 and A1 - A4 are plasmids obtained from four different liquid cultures each. C1 - C4 
indicates that the PCR product C-NEIL3 is contained and A1 - A4 indicates that the PCR 
product A-NEIL3 is contained in the pGEM-T vector. 
 
5.2.2 Preparation of pEG202 and pEG202-NLS vectors 
 
A large scale double-digestion with EcoRI and BamHI and 4 X ~5 μg template DNA 
in a total volume of 50 μl was performed for pEG202 and pEG202-NLS. The 
linearized plasmids were purified from an agarose gel and a DNA concentration of 
~30 ng/µl was obtained for pEG202 and ~50 ng/µl for pEG202-NLS in a total volume 
of 300 μl for each vector. Figure 44 shows bands for the linearized plasmids 
pEG202-NLS and pEG202 at the predicted size (~10.2 kb). 
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Figure 44: Agarose gel electrophoresis of linearized pEG202 and pEG202-NLS after 
digestion with EcoRI and BamHI and gel purification. 
 
The linearised vectors were stored at -20ºC until they were used for the ligation with 
hNEIL3 cDNA. 
 
5.2.3 Cloning of hNEIL3 (A2) into pEG202 and pEG202-NLS 
 
The gel purified hNEIL3 DNA (A2, Figure 43) with EcoRI and BamHI overhangs was 
used to perform the ligation into both the pEG202 and pEG202-NLS vectors followed 
by a transformation into NovaBlue competent cells. Six colonies from each of the two 
plates were picked to inoculate 12 liquid cultures. All the liquid cultures grew and 
miniprep plasmid purification was performed. 
To confirm the insert was cloned into the yeast vectors successfully a digest with 
EcoRI and BamHI was carried out and an agarose gel ran to visualize the results. In 
Figure 45 it can be seen, that all clones have the correct size and thus were used for 
DNA sequencing. 
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Figure 45: Agarose gel electrophoresis of pEG202-N3 and pEG202-NLS-N3 double-digested 
with EcoRI and BamHI. 
 
5.2.4 DNA sequencing 
 
Because the DNA sequence of hNEIL3 in the pCMV6-AC vector from OriGene is 
different to the hNEIL3 cDNA sequence found on NCBI (http://www.ncbi.nlm.nih.gov/ 
nuccore/NM_018248.2), the DNA sequences were analysed for known single 
nucleotide polymorphisms (SNPs) using the SNP search tool available at 
http://www.ncbi.nlm.nih.gov/projects/SNP/. Several SNPs were found and are shown 
in Appendix 8.4. 
 
5.2.4.1 Primers used for DNA sequencing reactions: 
 
N3_641 (Tm=60.6°C): 5′ - CAG ATG AAC AGA TCC ATC ACC TC - 3′ 
N3_793r (Tm=62.4°C): 5′ - GGC ACA CAG TTA TTC TGC AGT GG - 3′ 
N3_1249 (Tm=60.3°C): 5′ - CAA AAC TCT CCT CCT GCT AGT G - 3′ 
hNEIL3_1538 Reverse (Tm= 57.3ºC): 5′- CAC AAC TCG GAG AAT GCA GA - 3′ 
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- To sequence the hNEIL3 insert in the pGEM-T vector the standard primers T7 
and Sp6 were used as well as N3_641. 
 
- To sequence the hNEIL3 insert in the pJET1.2/blunt vector standard primer 
T7, a reverse primer supported in the CloneJET kit, the N3_641 and the 
N3_1249 primers were used. 
 
5.2.4.2 DNA sequencing of pEG202(-NLS)-N3-(A2) (BioXAct-short) 
 
pEG202-N3 (A2) and pEG202-NLS-N3 (A2) shown in Figure 45 were used for 
sequencing. Unfortunately, as it is shown in Table 17, point-mutations developed 
during the cloning process. All of these point-mutations were confirmed by comparing 
the amplified hNEIL3 DNA with the DNA sequence provided by OriGene (see 
Appendix 8.2). To check if the observed mutations had arisen during the amplification 
and cloning process, the hNEIL3 DNA in pCMV6-AC was sequenced and showed no 
variation to the DNA sequence provided by the supplier (Appendix 8.2). Therefore, 
these mutations must have occurred during amplification of the hNEIL3 cDNA from 
pCMV6-AC by the BioXAct-short DNA polymerase. The same mutations were found 
in both vectors used (pEG202 and pEG202-NLS). 
 
Table 17: Point-mutations (not SNPs in hNEIL3) in the pEG202/N3 (A2) and pEG202-NLS/N3 
(A2) DNA sequence. 
 
Codon-Position (bp) 426 1014 1219 1639 1787 
OriGenSequence GAA (Glu) GAT (Asp) AAG (Lys) GCA (Ala) GGG (Gly) 
DNA sequencingResult GAG (Glu) GGC (Asp) GAG (Glu) GTA (Val) GAG (Glu) 
(grey: no change in resulting amino acid; black: change in resulting amino acid) 
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5.2.4.3 DNA sequencing of pEG202(-NLS)-N3(-C1) (BioXAct-short) 
 
Because, the hNEIL3 cDNA C1 shown in Figure 43 (obtained from another PCR) was 
also ligated into pEG202 and pEG202-NLS, DNA sequencing was performed to 
check if point mutations were also present in this sequence. However, like A2, many 
point mutations appeared (data not shown) and the constructs could not be used for 
further studies. 
 
5.2.4.4 DNA sequencing of pGEM-T-hNEIL3 ( BioXAct-short) 
 
From the DNA sequencing results of pEG202(-NLS)-N3 (A2 and C1) it was likely the 
base pair changes occurred during the initial PCR. Therefore, the PCR was repeated 
with BioXAct-short and the PCR products have been cloned into pGEM-T. To avoid 
loss of time, this construct was directly DNA sequenced. However, the hNEIL3 cDNA 
sequence again showed various point mutations, despite the presence of a 
proofreading activity on the DNA polymerase (data not shown). 
 
5.2.4.5 DNA sequencing of pGEM-T-partial-hNEIL3 ( BioXAct-short) 
 
The three DNA sequencing results showed that the BioXAct-short from Bioline, 
designated as a proofreading polymerase mixture, was not able to amplify hNEIL3 
cDNA without causing base changes. However, given the initial inability of this 
enzyme mixture to amplify full length NEIL3, (Section 5.2.1.2) it was decided to check 
if a truncated version of hNEIL3 (1000-1818bp) amplified with BioXAct-short and 
cloned into pGEM-T, also contained a significant number of base changes. However, 
analysis of this truncated NEIL3 clone again showed point mutations (data not 
shown). Interestingly, when all the DNA sequencing results were compared, apart 
from the random point mutations in the sequence, there was always one point 
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mutation which appeared in all four constructs, where guanine was changed to 
adenine at base pair position 1787 in the hNEIL3 sequence resulting in an altered 
amino acid (Figure 48). The significance of this is not known. 
 
5.2.5 PCR of pCMV6-AC/hNEIL3 (Phusion) 
 
To carry on with Y2H it was essential to obtain the hNEIL3 sequence without any 
base changes. Therefore, a new proofreading DNA polymerase called Phusion from 
Finnzymes was purchased (NEB). However, this DNA polymerase produces DNA 
fragments with blunt ends. Therefore, in place of pGEM-T, which has single  
T-overhangs to aid the ligation of Taq-generated amplicons, the CloneJET PCR 
Cloning Kit (Fermentas) was chosen for Phusion – generated ligation products. The 
conditions for the recommended two step PCR used for amplification of full length 
hNEIL3 are shown in Table 18. 
 
Table 18: Conditions for PCR of full length hNEIL3 with Phusion DNA polymerase. 
DNA   1.0 µl (10 ng) 
5x Buffer 10.0 µl 
100 mM dNTPs   0.4 µl (200 µM) Temp. Time 
10 µM Full Primer1   1.0 µl (0.2 µM) 98ºC 30 s 
10 µM Full Primer2   1.0 µl (0.2 µM) 98ºC 10 s 
30 Cycles 
Phusion   0.5 µl 72ºC 1 min 
H2O 36.1 µl 72ºC 10 min 
Total 50.0 µl 4ºC Hold 
 
The PCR product was then ligated into the pJET1.2/blunt vector (for vector map, see 
Appendix 8.1, Figure 97) using the conditions shown in Table 19 at a 3:1 insert to 
vector ratio. 
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Table 19: Scheme for the ligation of NEIL3 into pJET1.2/blunt vector. 
2x Reaction mix 10 µl 
pJET1.2/blunt vector 1 µl 50 ng 
PCR product 5 µl ~100 ng 
T4 DNA Ligase 1 µl 
Deionized H2O 3 µl 
Total 20 µl 
The ligation was carried out at an incubation 
temperature of 22.5 °C for 30 min.  
 
The pJET1.2/blunt vector has a size of 2974 bp and hNEIL3, including EcoRI and 
BamHI overhangs, 1830 bp. Figure 46 shows a digestion with EcoRI and BamHI of 
the miniprep of pJET1.2/blunt containing the hNEIL3 insert and the bands are of the 
expected sizes. 
 
 
Figure 46: Agarose gel electrophoresis of single- and double-digests with BamHI and EcoRI 
of pJET1.2/blunt vector containing NEIL3. 
 
A large scale digestion was performed and gel purified to obtain the pure hNEIL3 
fragment (data not shown) followed by ligation into pEG202 and pEG202-NLS. 
Figure 47 shows that hNEIL3 was cloned correctly into pEG202 and pEG202-NLS 
and the hNEIL3 insert was then subjected to DNA sequencing. 
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Figure 47: Agarose gel electrophoresis of a double-digest of  
pEG202(-NLS)-NEIL3 with EcoRI and BamHI. 
 
5.2.6 DNA sequencing of pEG202(-NLS)-N3 (Phusion) 
 
The DNA sequencing results showed no point mutations in the hNEIL3 DNA (data 
not shown). Now it was possible to perform a large scale plasmid extraction 
(Maxiprep) of pEG202-N3 and pEG202-NLS-N3 and to prepare for the Y2H 
screening. 
 
To sequence the whole of the hNEIL3 cDNA insert in pEG202 and pEG202-NLS and 
to ensure no mutation is present, the primers N3_641, N3_1538r, N3_793r and 
N3_1249 were used to perform the four sequencing reactions required. No base 
changes were obtained and as indicated in Figure 48 the point mutation that was 
induced when BioXAct Short was used (Section 5.2.4.5) was not obtained with 
Phusion DNA polymerase. 
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Figure 48: Summary of sequencing results. (Only the part is shown which represents the 
significant point mutation at bp 1787.) 
 
5.3 Small scale transformation of pEG202(-NLS)-N3 into EGY48 
 
The bait vectors pEG202-N3 and pEG202-NLS-N3 along with the other reporter 
plasmids (pRHFM1, pJK101, pSH17-4, and pEG202-Max) needed for the 
autoactivation tests and the repression assays were used to transform the yeast 
strain EGY48 (Figure 49). For more details on the vectors see Section 5.4 and  
Table 20. 
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Table 20: Summary of vectors used in Y2H. 
 
 
 
Figure 49: YNB (Glu) ura
-
 (pJK101) and YNB (Glu) his
-
 plates (all other vectors) with high 
colony number, showing high transformation efficiency of all necessary plasmids. pEG202-N3 
and pEG202-NLS-N3 = Bait vectors; pRHFM1 and pSH17-4 were used for the LacZ 
autoactivation test; pJK101 and pEG202-Max were used for the LexA repression assay. 
 
Vector name Genotype Description
pEG202-NLS-N3 HIS3, Ampr Bait vector containing hNEIL3 CDS fused to LexA and an additional NLS
pEG202-N3 HIS3, Ampr Bait vector containing hNEIL3 CDS fused to LexA only
pEG202-Max HIS3, Ampr
Bait vector containing Lex A fusion protein sequence. Used as positive control in the 
repression assay and western blot.
pJG4-5 TRP1, Ampr Prey vector containing a random protein cDNA
pRHFM1 HIS3, Ampr Bait protein used as a negative control in LacZ autoactivation test along with pJK101
pSH17-4 HIS3, Ampr Bait protein used as a positive control in LacZ autoactivation test along with pJK101
pJK101 URA3, Ampr, GAL1-2 ops.-LacZ LacZ reporter plasmid used in repression assay
pRB1840 URA3, Ampr, 1 op.-LacZ Low sensitivity LacZ reporter plasmid used in cDNA library screen
pSH18-34 URA3, Ampr, 8 ops.-LacZ High sensitivity LacZ reporter plasmid used in cDNA library screen
pBait HIS3, Ampr Used as positive control in mating assay in combination with pTarget.
pTarget TRP1, Ampr Used as positive control in mating assay in combination with pBait.
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5.4 Autoactivation tests and repression assay 
 
To test that the full length hNEIL3 fused with LexA (hNEIL3-LexA) protein is not 
autoactivating the leucine coding gene (Leu2) and LacZ expression on its own, 
autoactivation assays were carried out. If hNEIL3-LexA is able to interact with the 
activation domain of the transcription factor on its own and in absence of the prey 
fusion protein that contains the actual activating domain B42, it would cause false 
positive results. In addition, a repression assay was performed to show that, after 
translation, the hNEIL3-LexA fusion protein is able to enter the nucleus and bind to 
LexA operators in the genomic DNA of EGY48 or the reporter vectors used in this 
project, respectively.  
 
The following combinations of plasmids were transformed into yeast strain EGY48 as 
described in Section 4.13.1: 
 
For the Leu2 expression autoactivation test: 
- pEG202-N3  
- pEG202-NLS-N3 
 
For the LacZ expression autoactivation test: 
- pEG202-N3 or pEG202-NLS-N3 and pRB1840 (test) 
- pSH17-4 and pRB1840 (positive control) 
- pRFHM1 and pRB1840 (negative control) 
 
For the repression assay: 
- pEG202-N3 or pEG202-NLS-N3 and pJK101 (test) 
- pEG202-Max and pJK101 (positive control) 
- pJK101 only (negative control) 
 
The results of each of these tests and details about the function of each vector will be 
described in the following sections. 
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5.4.1 Autoactivation test of Leu2 expression by hNEIL3-LexA 
 
Before carrying out a large scale transformation with the cDNA library plasmids, the 
plasmid vectors pEG202-N3 and pEG202-NLS-N3 were tested for autoactivation of 
the leucine coding gene (Leu2). Therefore, clones containing either pEG202-N3 or 
pEG202-NLS-N3 where plated onto YNB (Glu) his-/leu-, or YNB (Glu) his- agar 
plates, respectively. No growth on YNB (Glu) his-/leu-, but on YNB (Glu) his- was 
observed which indicates full length hNEIL3-LexA did not activate Leu2 expression 
on its own (Figure 50).  
 
 
Figure 50: Plating EGY48 containing either pEG202-NLS/hNEIL3 or pEG202/hNEIL3 onto 
YNB (Glu) his
-
/leu
-
 or YNB (Glu) his
-
 agar respectively showed that full length hNEIL3 does 
not activate leucine expression on its own. 
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5.4.2 Autoactivation test of LacZ expression by hNEIL3-LexA 
 
In addition to Leu2, the potential of the hNEIL3-LexA fusion protein to autoactivate 
LacZ gene expression had also to be tested, in order for a correct interpretation of 
the results obtained by the subsequent cDNA library screening. The ADH promoter in 
pRFHM1 expresses a LexA-Bicoid homeodomain fusion that is not able to activate 
LacZ gene expression on its own, whereas the ADH promoter in pSH17-4 expresses 
a LexA-GAL4 activation domain fusion that activates LacZ gene expression. Hence, 
pRFHM1 clones were used as a negative and pSH17-4 clones as a positive control 
in the LacZ autoactivation test (Section 5.4.2). 
 
Figure 51 shows that neither pEG202-N3 (Figure 51, 2) nor pEG202-NLS-N3 (Figure 
51, 1) results in autoactivation of LacZ gene expression, indicated by the yellowish 
colour of the colonies that is the same as for the negative control (Figure 51, 3). The 
negative controls are EGY48 yeast cells that contain the pRFHM1 plasmid, and the 
positive controls are EGY48 cells containing the pSH17-4 plasmid (Figure 51, 4). 
 
 
Figure 51: Testing the LacZ gene autoactivation 
potential of pEG202-NLS-N3 (1) and pEG202-N3 
(2). No autoactivation of the LacZ gene occurred. (3) 
pRFHM1 as negative control and (4) pSH17-4 as 
positive control. 
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5.4.3 Repression assay 
 
To test if the bait vectors pEG202-N3 (Figure 52, 2) and pEG202-NLS-NEIL3 (Figure 
52, 3) were able to enter the nucleus and bind LexA operators, repression assays 
using the pJK101 reporter plasmid were performed (Figure 101). pJK101 contains a 
LexA operator between its upstream activation sequence (UAS) and the TATA box of 
the GAL1-10 promoter. pEG202-Max is a vector that expresses a LexA fusion protein 
known to tightly bind to LexA operators in pJK101 and therefore was used as a 
positive control in this repression assay that results in white colonies, while clones 
that contain pJK101 alone will not be repressed in the production of β-galactosidase 
and thus colonies turn blue on X-Gal containing plates. Hence, if hNEIL3-LexA fusion 
protein binds to the LexA operators it will reduce or abolish LacZ gene expression by 
disrupting the UAS-TATA box signalling in pJK101. 
 
 
Figure 52: Result of the repression assay. pEG202-N3 (2);  
pEG202-NLS-N3 (3); negative (1) and positive (4) control. 
 
Compared with the negative (Figure 52, 1) and positive (Figure 52, 4) controls, same 
levels of repression of LacZ expression was observed for both pEG202-N3 and 
pEG202-NLS-N3. This result indicated that NEIL3-LexA was able to enter the 
nucleus and therefore an additional NLS was not needed in this Y2H assay. 
 
1 
2 
3 
4 
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5.5 Western blot of hNEIL3-LexA expression 
 
To further check that the autoactivation tests were genuine, a western blot was 
performed to confirm hNEIL3-LexA expression in EGY48. Therefore, actual 
screening conditions where prepared, i.e. the clones were transformed with the bait 
vectors along with the LacZ reporter plasmid pRB1840 that was needed for 
subsequent blue/white screening once potential positive clones were identified via 
leucine selection (Section 5.6.3). Therefore, three 10 ml cultures were prepared, the 
first, (YNB (Glu) his-/ura-) was inoculated with an EGY48 colony containing pEG202-
N3 and pRB1840 reporter plasmid, the second (YNB (Glu) his-/ura-) with an EGY48 
colony containing pEG202-Max and pRB1840 plasmids (positive control) and finally 
(YNB (Glu) ura-) with EGY48 containing pRB1840 only (negative control) and 
incubated at 30°C and 250 rpm overnight or until OD600= ~3.0. The proteins were 
extracted as described in Section 4.11.1 and then separated by SDS-PAGE. The 
subsequent western blot was probed with a polyclonal anti-LexA antibody and the 
results showed a band at 91 kDa (61 kDa hNEIL3 + 30 kDa LexA, Figure 53, 1) as 
predicted for pEG202-N3. Lower molecular mass bands were also visible, probably 
representing different degradation states of the hNEIL3-LexA fusion protein. The 
negative control (Figure 53, 2) showed no band at 91 kDa and pEG202-Max, used as 
a positive control (Figure 53, 3), showed expression of a LexA fusion protein at  
~45 kDa. 
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Figure 53: Western blot of hNEIL3-LexA fusion protein expressed  
from pEG202-N3 (1), a negative (2) and a positive control (3). 
 
5.6 Y2H screening with a human placental cDNA library 
5.6.1 Large scale transformation of library cDNA 
 
As the autoactivation tests, the repression assay and the western blot showed 
encouraging results, it was likely that full length hNEIL3 could be used to screen a 
cDNA library by Y2H. Therefore, a large scale transformation of a placental cDNA 
library into EGY48 containing pEG202-N3 was performed as described in Section 
4.13.2. To estimate the transformation efficiency the control plate (made out of one of 
the 30 transformations and used in a 1:1000 dilution, Section 4.13.2) was examined 
after two days of incubation and 70 colonies were counted. Using the formula 
“colonies counted (70) x dilution factor (1000) x number of transformation tubes (30)” 
a total number of 2.1 x 106 transformants were calculated. To perform a successful 
screening 1.47 x 107 (= 7 x 2.1 x 106) transformants were needed to ensure full 
coverage of the cDNA library for the subsequent screening. Due to the fact that each 
of the 1 ml aliquots contained 2.8 x 108 cfu (estimated by plating and colony counting 
one 1 ml aliquot) a 52.5 µl volume (~1.47 x 107 cfu) was used to inoculate ~1.42 ml 
~45 kDa 
52 kDa 
38 kDa 
1 2 3 
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YNB (Gal,Raf) ura-/his-/trp-/leu- liquid media to obtain a 1 x 107 cfu/ml culture. After 
incubation at 30°C and 150 rpm for 4 h, to induce prey production by the presence of 
galactose, 100 µl aliquots were spread onto YNB (Gal,Raf) ura-/his-/trp-/leu- plates 
(~1 x 106 cfu/plate) and left at 30°C for more than 7 days.  
 
5.6.2 Screening of transformants for potential positive interactors 
 
The cDNA library screening was carried out in duplicate to ensure that as many 
potential interacting protein partners for hNEIL3 as possible would be found. 
Although the growth of first colonies started after five instead the expected two days, 
the results were assumed to be genuine as it was still within the timeframe indicated 
in the DupLEX-A application guide (OriGene, Figure 54), especially as negative 
control plates (clones containing either prey or bait and reporter vector only) showed 
no growth over ten days incubation at 30°C. Therefore, 216 colonies were picked on 
day seven and spotted onto YNB (Gal,Raf) ura-/his-/trp-/leu- master plates followed by 
incubation at 30°C for two days. On these plates, 190 colonies grew (see in 
Appendix, Figure 106) and were used for further tests. 
 
 
Figure 54: One out of 28 YNB (Gal,Raf) ura
-
/his
-
/trp
-
/leu
-
 plates as example for showing 
growth of 100 µl of induced transformants (~1 x 10
6
 colony forming units) per plate over a  
72 h period. 
 
 
Day 5 Day 6 Day 7 
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5.6.3 Galactose/Glucose tests with potential positive clones 
 
In the pJG4-5 vector, library fusion protein expression is induced by a Gal1 promoter 
(for more details see Appendix - Figure 100). Therefore, yeast carrying potential 
protein partners for hNEIL3 should only be able to grow on Gal+ but not on Gal-/Glu+ 
plates and the 190 potential positive colonies were spotted onto YNB (Gal,Raf) ura-
/his-/trp-/leu- and YNB (Glu) ura-/his-/trp-/leu- plates and grown over night at 30oC. 
Unfortunately, growth for all 190 colonies occurred on both selective media. It was 
assumed the use of the most sensitive yeast strain, EGY48, that contained six LexA 
operators had resulted in autoactivation of leucine expression by hNEIL3, even 
although autoactivation tests were negative (Section 5.4.1). To double check this 
result, 190 x 2 ml tubes containing 1 ml Glu+ liquid media were prepared and 
inoculated with all 190 colonies from the Gal+ master plates. After overnight 
incubation at 30°C and 200 rpm, 20% of the cultures grew. On the second day 40% 
had grown and on the third day >80% had grown (data not shown). Because the 
DupLEX-A application guide (OriGene) for the Y2H assay suggested that growth on 
plates should be checked after 1-2 days, a final test was performed. All 190 colonies 
were picked again from Gal+ master plates, inoculated into 600 µl YNB (Gal,Raf) ura-
/his-/trp-/leu- liquid medium and grown at 30°C and 200 rpm for 2 days. Then 2 µl of 
each culture was spotted onto both Gal+ and Glu+ plates. This method ensured the 
same concentration of colony forming units on both plates. These plates were then 
incubated at 30°C. After 24 hours the first examination showed equal growth on both, 
Gal+ and Glu+ plates (some spots even grew faster on Glu+ plates, Figure 55). 
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Galactose plates        Glucose plates 
 
Figure 55: Galactose/Glucose test of potential positive interactors on leucine lacking YNB 
medium. 
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5.6.4 X-Gal test of potential positive interactors 
 
Although, results from the Galactose/Glucose test (Section 5.6.3) indicated that non-
specific activation of Leu2 expression had occurred in these clones, the X-Gal 
screening was performed to confirm this. This assay is to check if the potential 
positive clones obtained from the initial Leu2 screen show the same behaviour in an 
alternative reporter gene assay that uses LacZ gene expression instead of Leu2. 
This test was performed on YNB (Gal, Raf, X-Gal) ura-/his-/trp- and YNB (Glu, X-Gal) 
ura-/his-/trp- plates as indicated in the manual (Figure 56) but additionally on YNB 
(Gal, Raf, X-Gal) ura-/his-/trp-/leu- and YNB (Glu, X-Gal) ura-/his-/trp-/leu- plates to 
determine if the lack of leucine affected the ability of the clones to metabolise X-Gal 
(Figure 57). 
 
Following incubation at 30°C overnight, growth was observed on both Glu+ and Gal+ 
plates lacking leucine, which is the same result as obtained for the initial 
Galactose/Glucose test (Section 5.6.3). If growth on glucose plates was due to a 
non-specific interaction, it would be expected that all colonies would turn blue in the 
presence of either glucose or galactose. However contrary to this, and unexpectedly, 
a differential response was observed with 60 colonies turning blue and the remainder 
(30 colonies) remaining colourless on galactose containing medium. Encouragingly, 
very few colonies turned blue on glucose plates (5 out of 65 colonies; red circles in 
Figure 57) and similar results were obtained independent of the presence of leucine 
in the media (Figure 56, Figure 57). Therefore, this result suggested that the protein-
protein interactions might be genuine in this screen and the isolation of the library 
plasmids from colonies that turned blue on Gal+ but remained white on Glu+ plates for 
DNA sequencing was carried out. 
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Figure 56: Potential positve clones spoted onto YNB (Gal,Raf,X-Gal) his
-
/ura
-
/trp
-
 (left) and YNB (Glu,X-Gal) his
-
/ura
-
/trp
-
 (right). Grey doted circles indicate 
clones were chosen for further experiments, yellow circles indicate clones that 
showed to be potential genuine clones after plasmid extraction (Section 5.6.7). 
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Figure 57: Potential positve clones spotted onto YNB (Gal,Raf,X-Gal) his
-
/ura
-
/trp
-
/leu
-
 (left) and YNB (Glu,X-Gal) his
-
/ura
-
/trp
-
/leu
-
 (right). Grey doted circles 
indicate clones were chosen for further experiments, yellow circles indicate 
clones that showed to be potential genuine clones after plasmid extraction 
(Section 5.6.7), red circles indicate clones where X-Gal degradation was higher 
on Glu
+
 plates than on Gal/Raf
+
 plates, an indicator for false positives. 
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5.6.5 Library plasmid DNA identification – “modified” standard method 
 
In this method the library plasmid pJG4-5 (Figure 100) was extracted from yeast as 
described in Section 4.13.4.1. Although, plasmid DNA was obtained from all clones, 
a digestion with EcoRI and XhoI of these vectors revealed that some vectors 
contained a band around 2000 bp (Figure 58). DNA sequencing of these vector 
inserts confirmed, the bands were hNEIL3 inserts and the band around 10,000 bp 
was the pEG202 vector (sequencing data not shown). Only the clones 14, 41, 59, 63 
and 200 were pJG4-5 vectors carrying a random cDNA insert from the library (see 
BLAST results in Appendix 8.6.1). 
 
 
Figure 58: Agarose gel electrophoresis of potential positive clone plasmid extractions. Clones 
15, 21, 28, 33, 50, 57, 64 and 208 were pEG202 plasmids carrying a hNEIL3 cDNA insert. 
Clones 14, 41, 59, 63, 200 show different sizes of inserts and were potential positives. 
 
This result was unexpected, as the bacterial KC8 strain used for electroporation is 
trp- and as pJG4-5 enables tryptophan production only clones carrying this plasmid 
should grow on media lacking tryptophan. This shows that pEG202-N3 was also 
electroporated into the bacterial trp- KC8 strain instead of, or along with, the library 
plasmid pJG4-5 and that tryptophan selection did not work as was intended. 
Therefore, the experiment was repeated with the original method described in the 
DupLexA manual (OriGene) but the efficiency was even lower. Out of 22 clones used 
for extraction and electroporation into KC8 cells only 6 were transformed successfully 
and subsequent restriction enzyme digest with EcoRI and XhoI revealed that only 
three contained the library vector (clones 28, 89 and 99 in Figure 59).  
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Figure 59: Agarose gel electrophoresis of potential positive clones 15, 28, 89, 91, 
99 obtained by the standard plasmid extraction method described in the DupLexA 
application guide (OriGene). 
 
Therefore, a more specific method was designed (Section 4.13.4.2) that allowed 
direct DNA sequencing of PCR products obtained from the cDNA library inserts 
without the need for separation of the extracted plasmid mixture (pEG202-N3, pJG45 
and pRB1840) from yeast. 
 
5.6.6 Library plasmid DNA identification – “PCR Method” 
 
An initial test of the alternative method using direct PCR from yeast plasmid 
extractions on four clones, confirmed that the same insert sequences were obtained 
by PCR by both methods. DNA fragments obtained by the PCR method from clone 
15 (negative control) and clones 14, 28 and 63 showed the same size (Figure 60) as 
previously obtained by using the standard method (Figure 58, Figure 59). 
Furthermore, DNA sequencing of these PCR products revealed that they had the 
same sequence as obtained from the products in Section 5.6.5. In addition, it was 
even possible to sequence the cDNA of clone 28 for the first time. Hence, it was 
confirmed that the alternative method was highly specific and with a higher efficiency 
that made it possible to sequence the cDNA of all potential positive clones quickly. 
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Figure 60: Agarose gel electrophoresis of PCR 
products (cDNA inserts from clones 14, 15, 28, 63) 
amplified from pJG4-5 library plasmids extracted 
from potential positive clones. 
 
As the functionality of the PCR method was successfully validated it was now 
possible to extract library plasmid DNA from the 60 potential positive yeast clones 
and to directly amplify the cDNA sequences with Taq polymerase for subsequent 
DNA sequencing. The quality of all PCR products, after purification was good enough 
to proceed with DNA sequencing without the need of further processing (Appendix 
8.5, Table 25). Figure 60 to Figure 66 show PCR products of all clones chosen 
through evaluation of the X-Gal test (Section 5.6.4) for the DNA sequencing step. 
Figure 61 shows that all PCR reactions worked except for clone 50. 
 
 
 
Figure 61: Agarose gel electrophoresis of PCR products (cDNA inserts from clones 
21, 33, 41, 50, 57, 64, 73, 74, 77, 78) amplified from pJG4-5 library plasmids and 
extracted from yeast strain EGY48. 
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Figure 62 shows that PCR worked for all clones. However, clones 89 and 91 showed 
several bands and subsequent DNA sequencing gave no results (Appendix 8.6.1). 
Furthermore, subsequent DNA sequencing revealed that clone 83, 86, 95 and 96 
were also not genuine PCR products. 
 
 
Figure 62: Agarose gel electrophoresis of PCR products (cDNA inserts from clones 83, 86, 
88, 89, 91, 95, 96, 97, 99) amplified from pJG4-5 library plasmids and extracted from yeast 
strain EGY48. 
 
Figure 63 shows PCR products for all clones tested. However, clone 121 did not give 
any result in subsequent DNA sequencing (Appendix 8.6.1). 
 
 
 
Figure 63: Agarose gel electrophoresis of PCR products (cDNA inserts from clones 111, 113, 
117, 120, 121, 123, 124, 125, 126, 127) amplified from pJG4-5 library plasmids and extracted 
from yeast strain EGY48. 
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Figure 64 shows that PCR products were obtained for all clones used except for 
clone 156. 
 
 
Figure 64: Agarose gel electrophoresis of PCR products (cDNA inserts from clones 131, 136, 
142, 147, 148, 149, 151, 156, 160, 162) amplified from pJG4-5 library plasmids and extracted 
from yeast strain EGY48. 
 
Figure 65 reveals that PCR products from clones 178 and 190 were apparently not 
amplified properly. However, while this was confirmed by DNA sequencing for clone 
190 it was not for 178 which showed to be correctly amplified by PCR with Taq 
polymerase indicating that the band around 500 bp was genuine (Appendix 8.6.1). 
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Figure 65: Agarose gel electrophoresis of PCR products (cDNA inserts from clones 163, 166, 
170, 178, 182, 185, 188, 189, 190, 191) amplified from pJG4-5 library plasmids and extracted 
from yeast strain EGY48. 
 
Figure 66 shows that PCR products were obtained for all clones. However, the band 
for clone 196 was blurred and although subsequent DNA sequencing revealed a 
sequence for that clone, it could not be identified by BLAST (Appendix 8.6.1). 
 
 
Figure 66: Agarose gel electrophoresis of PCR 
products (cDNA inserts from clones 193, 196, 199, 
200, 208) amplified from pJG4-5 library plasmids 
and extracted from yeast strain EGY48. 
 
5.6.7 DNA sequencing of potential clones 
 
DNA sequencing and subsequent BLAST analysis of the 60 PCR products obtained 
from potential positive plasmid extractions revealed several potential genuine 
interactors (i.e. they were considered genuine if the library sequences contained a 
coding sequence in the correct reading frame in the library vector). The growth 
hormones chorionic somatomammotropin hormone 1 (placental lactogen; CSH1), 
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chorionic somatomammotropin hormone 2 (CSH2) and chorionic gonadotropin, beta 
polypeptide 8 (CGB8) were found in more than one clone. In addition, a number of 
unique clones were discovered that coded for, proteoglycan decorin, the 
metallopeptidase inhibitor TIMP2, a homeobox protein domain (HOPX), the RNA-
binding protein ELAV1 (HuR), haemoglobin (gamma G, HBG2 and beta, HBB) and 
the translational-controlled tumour protein TPT1 (Appendix 8.6.1). 
 
5.6.8 Mating Assay 
 
After DNA sequencing of the potential positive clones was completed, a mating 
assay was performed to further confirm their ability to interact with hNEIL3. 
Therefore, all three plasmids present in each of the clones (the library, bait and 
reporter plasmid) were isolated and the mixture used to transform the yeast strain 
EGY48. In order to ensure that EGY48 cells contained only library plasmids, the 
transformants were streaked onto YNB (Glu) trp- plates ensuring that tryptophan 
would be the only selective factor (as required for the library vector pJG4-5). 
However, as the plasmid extractions used for this transformation also contained 
pEG202-N3 (enables histidine production) and pRB1840 (enables uracil production) 
it was necessary to further identify the transformants obtained via tryptophan 
selection and containing pJG4-5. Therefore, colonies were re-streaked onto YNB 
(Glu) his-/ura-/trp-, YNB (Glu) ura-/trp-, YNB (Glu) his-/trp- and YNB (Glu) trp- plates. 
This way it was possible to pick colonies only growing on YNB (Glu) trp- but not on 
one of the others, which confirmed that those clones only carry the cDNA library 
vector (pJG4-5). Transformants obtained this way contained library plasmids carrying 
cDNA inserts of either HOPX, SMC6, Phosphorylase 1, CSH1, CGB8, CSH2, TPT1, 
ELAV1, Decorin or Haemoglobin. These clones were then picked from the trp- plates 
and restreaked onto YPD plates with a vertical orientation (Figure 67). In addition, the 
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vector pEG202-N3 was transformed along with the reporter plasmid pRB1840 into 
the yeast mating strain RFY206. These transformants were streaked in a horizontal 
orientation onto YPD that crossed the vertical streak containing EGY48 
transformants carrying the cDNA library vector pJG4-5 (Figure 67). If mating occurs 
between the RFY206 and EGY48 strains in the middle of the cross, clones at this 
position should contain all three plasmids (pEG202-N3, pRB1840 and pJG4-5) while 
cells on the outside of the cross should remain in their initial state. Therefore, clones 
picked from the middle should be able to produce histidine, uracil and tryptophan. 
Only these clones were able to grow on YNB (Glu) ura-/his-/trp- plates (Figure 68). In 
addition a positive control was generated. The vector pBait expresses a LexA fusion 
protein that is known to interact with the B42 fusion protein that is expressed by 
pTarget. Therefore, this vector combination was used as a positive control in the 
mating assay and was generated the same way as described before. 
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Figure 67: “Mating crosses” of yeast strain RFY206 containing hNEIL3 and 
reporter plasmid (lane from left to right containing bait plasmid pEG202-N3 + 
reporter plasmid pRB1840) and strain EGY48 containing potential positive 
findings (library plasmids containing cDNA of HOPX (1); SMC6 (2); 
Phosphorylase 1 (3); CSH1 (4); CGB8 (5); CSH2 (6); TPT1 (7); ELAV1 (8); 
Decorin (9); Haemoglobin beta (10)) after two days of growth. 
 
In Figure 68 it can be seen that clones transferred from the junction of the “mating 
cross” grew on YNB (Glu,X-Gal) ura-/his-/trp- plates while clones picked from the 
outsides of the cross did not. This was as expected and was found for all mated 
clones. 
 
1 2 3 4 
5 6 7 8 
9 10 
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Figure 68: Confirmation of successful mating between strains RFY206 and EGY48. 
Cells picked from top of “mating cross” were spotted onto down arrow in picture (↓), 
cells picked from left of “mating cross” were spotted onto right arrow location (→), 
cells picked from the centre of the “mating cross” were spotted onto +. 
 
The clones that grew (+ circle in Figure 68) were transferred onto YNB (Glu,X-Gal) 
ura-/his-/trp- and YNB (Gal,Raf,X-Gal) ura-/his-/trp- plates and incubated at 30°C for 5 
days in order to confirm LacZ gene expression that was observed in the initial 
screening (Section 5.6.4). However, only the mated clone containing CGB8 cDNA 
protein turned pale blue, all other clones remained white (Figure 69). This is a 
contradictory result (except for CGB8) to that obtained in Section 5.6.4, indicating 
that the initial results were most likely false positives. The positive control with pBait 
and pTarget show strong expression of the LacZ gene showing that the method itself 
works. 
 
 
Figure 69: Mating assay showed colour change of pBait/pTarget (+) 
and CGB8/pEG202-N3/pRB1840 (5) after 5 days of incubation at 37°C. 
 
1 2 
3 4 
5 6 
7 8 
9 10 
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The next step would have been to repeat the mating assay without pEG202-N3 but 
with a bait vector such as pLexA-Max, pBait or pRHFM1 that should not interact with 
the prey proteins and therefore the clones should remain white. However, as the 
phenotype seen during the initial blue/white screening (Section 5.6.4) could not be 
repeated no further mating tests were performed. 
 
5.7 Y2H screening with a Jurkat T-Cell cDNA library 
 
Following the placental cDNA library screening, a second screening with a cDNA 
library obtained from a Jurkat T-Cell line (OriGene) was performed as this cell line 
was known to have different gene expression patterns for hNEIL3 compared to 
placental tissue. Therefore, EGY48 yeast cells were generated that carry the LacZ 
reporter plasmid pSH18-34 that has 8 LexA operators in front of the LacZ gene 
instead of 1 operator in the pRB1840 plasmid used in the first screening. This was 
expected to increase sensitivity in the X-Gal test. The large scale transformation 
efficiency was 1.38 x 105 cfu per µg library plasmid DNA and 4.14 x 106 total 
transformants were calculated. This was two fold higher total transformants than had 
been obtained for the placental library transformation (Section 5.6.1). The calculation 
and preparation of the plates was carried out as described before (Section 5.6.1). 
 
After three days of incubation at 30°C, the first colonies became visible (data not 
shown). This was two days earlier than for the placental cDNA library screening 
(Section 5.6.2). After the fifth day of incubation a total of 56 colonies were picked 
from YNB (Gal,Raf) ura-/his-/trp-/leu- screening plates and diluted in 50 µl YNB while 
4 µl of this solution was spotted onto YNB (Gal,Raf) ura-/his-/trp-/leu-, YNB (Glu) ura-
/his-/trp-/leu-, YNB (Gal,Raf,X-Gal) ura-/his-/trp- and YNB (Glu,X-Gal) ura-/his-/trp- 
plates for further analysis. 
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5.7.1 Galactose/Glucose test of potential positive interactors 
 
After 24 h, growth occurred on all plates. However, no or less growth was expected 
on the YNB (Glu) ura-/his-/trp-/leu- plate compared to the YNB (Gal,Raf) ura-/his-/trp-
/leu- plate (Figure 70) as there is no prey protein expression induced due to the lack 
of galactose, i.e. no interaction with hNEIL3-LexA should occur that enables the cells 
to express Leu2 and thus they should not grow on plates lacking leucine. This result 
is similar to that obtained from the first screening when using the placental cDNA 
library (Section 5.6.3). 
 
 
Figure 70: Fifty-six potential positive clones picked from 
screening plates and spotted onto YNB (Gal,Raf) ura
-
/his
-
/trp
-
/leu
-
 (left) and YNB (Glu) ura
-
/his
-
/trp
-
/leu
-
 (right) plates. 
 
5.7.2 X-Gal test of potential positive interactors 
 
Although there was strong growth of all 56 clones on the YNB (Glu) ura-/his-/trp-/leu- 
plates (Figure 70, right), the blue/white screening on X-Gal media and identification 
of the cDNA library insert by sequencing was still carried out. After two days of 
incubation on YNB (Glu,X-Gal) ura-/his-/trp- and YNB (Gal,Raf,X-Gal) ura-/his-/trp- a 
YNB(Gal,Raf)-all 
YNB(Gal,Raf)-all 
YNB(Glu)-all 
YNB(Glu)-all 
 Thomas ROEDL – PhD Thesis – Salford 2013 128 
colour change to blue of some colonies became visible. However, only clones 1, 2, 3, 
4, 5, 6, and 43 (green circles in Figure 71 to Figure 73) seemed to be genuine as 
they became blue on YNB (Gal,Raf,X-Gal) ura-/his-/trp- but remained white on YNB 
(Glu,X-Gal) ura-/his-/trp- plates. Colonies 16, 20, 28, 29, 38, 39 and 48 (red circles in 
Figure 71 to Figure 73) seemed to be false positives as the colour change only 
occurred on YNB (Glu,X-Gal) ura-/his-/trp- or on both YNB (Gal,Raf,X-Gal) ura-/his-
/trp- and YNB (Glu,X-Gal) ura-/his-/trp- plates. 
 
It must be mentioned that some colonies seemed not to grow properly in general. 
The reason could be that these colonies were very small compared to others when 
picked from screening plates and after dilution in the 50 µl YNB prior spotting only a 
low concentration of cfu remained in the 5 µl that was finally spotted. However, even 
after longer incubation these colonies did not seem to grow in size and therefore they 
were assumed to be false positive clones. 
 
 
Figure 71: On day 3 the colour change became 
more distinguishable. Green circled clones were 
used in further tests. Red circled clones were not 
used is in further tests. 
 
YNB(Gal,Raf,X-Gal)+leu 
YNB(Gal,Raf,X-Gal)+leu YNB(Glu,X-Gal)+leu 
YNB(Glu,X-Gal)+leu 
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Figure 72: On day 4 more colonies changed 
the colour from white to blue on Gal/Raf 
plates. Green circled clones were used in 
further tests. Red circled clones were not 
used is in further tests. 
 
     
Figure 73: On day 5 the colour change 
became more distinguishable. Green and 
yellow circled clones were used in further 
tests. Red circled clones were not used is in 
further tests. 
 
Since after five days incubation more clones (yellow circles in Figure 73) turned blue 
on YNB (Gal,Raf,X-Gal) ura-/his-/trp- and remained white on YNB (Glu,X-Gal) ura-/his-
/trp-, than was initially observed on day 3, those clones were also considered as 
potential positive. Hence, clones 1 - 10, 12, 13, 15, 17 - 19, 22, 23, 26, 33, 37, 43 - 
45, 51, 52 and 55 were picked to sequence their cDNA library inserts. 
 
YNB(Gal,Raf,X-Gal)+leu 
YNB(Gal,Raf,X-Gal)+leu YNB(Glu,X-Gal)+leu 
YNB(Glu,X-Gal)+leu 
YNB(Gal,Raf,X-Gal)+leu 
YNB(Gal,Raf,X-Gal)+leu YNB(Glu,X-Gal)+leu 
YNB(Glu,X-Gal)+leu 
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To confirm if the potential positive clones that changed colour on YNB medium 
containing X-Gal + galactose but not on medium containing X-Gal + glucose 
expressed NEIL3 interacting polypeptides (Figure 71 to Figure 73), 10 ml YNB liquid 
cultures containing glucose or galactose respectively but lacking leucine were 
inoculated and incubated for 48 h at 260 rpm and 30°C. The liquid cultures 
containing glucose grew even faster than the ones that contained galactose/raffinose 
(Figure 74) and this phenotype was the same for all selected clones and is similar to 
the tests carried out in Section 5.7.1 and 5.6.3. This is the opposite of what was 
expected. However, as for the placental cDNA library screening, sequencing was still 
performed. 
 
1) After 24 h incubation at 30°C and 260 rpm. 
 
2) After 48 h incubation at 30°C and 260 rpm. 
 
Figure 74: Incubation of potential positive clones 
in YNB (Gal,Raf), leu
-
 or YNB (Glu), leu
-
 
respectively after 24 h (1) and 48 h (2) of 
incubation at 260 rpm and 30°C. 
 
5.7.3 DNA sequencing of potential positive clones 
 
DNA sequencing of the potential positive clones obtained after screening the Jurkat  
T-Cell cDNA library revealed that all the clones tested were false positive as their 
YNB(Gal,Raf), leu
-
 YNB(Glu), leu
-
 
YNB(Gal,Raf), leu
-
 YNB(Glu), leu
-
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cDNA library sequences were either not protein coding sequences or the DNA 
sequence was out of frame (Appendix 8.6.2). Therefore, further tests such as the 
mating assay were not carried out. 
 
5.8 Interaction studies of human LigIIIα and Polβ with hNEIL3-LexA 
 
As EGY48 clones containing pEG202-N3 and the LacZ reporter plasmid pSH18-34 
were already available, it was of interest to test proteins that were already known to 
physically interact with NEIL1 and NEIL2 (Section 2.3.6). Therefore, the BER 
downstream proteins LigIIIα and Polβ were chosen for this experiment and their 
cDNAs were transformed into the Y2H library plasmid pJG4-5 that had previously 
been used for the screening experiments. However, as only the restriction sites for 
XhoI and EcoRI were available in the multiple cloning site of the vector (Appendix 
Figure 100) and the fact that both, LigIIIα and Polβ, contain XhoI and EcoRI 
restriction sites in their CDS sequences it was necessary to perform an alternative 
method of cloning (for more details see Section 4.13.6). 
 
5.8.1 Preparation of library vectors containing either LigIIIα or Polβ 
 
The cDNAs of LigIIIα and Polβ were readily cloned into the vector pCMV-XL5 
(OriGene, Appendix Figure 95) and were ready to use in PCR. 
 
5.8.1.1 Designing primers for PCR of LigIIIα and Polβ cDNA 
 
As the multiple cloning site in the Y2H library vector pJG4-5 (Appendix Figure 100) 
only offers one pair of restriction sites for cloning (EcoRI and XhoI) the primers were 
designed accordingly. However, as discussed before, this resulted in a problem as 
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LigIIIα as well as Polβ contain both an EcoRI and a XhoI site in their CDS. Therefore, 
it was not possible to simply clone the PCR products into a pGEM-T vector and cut it 
out again with restriction enzymes to obtain an insert with cohesive ends that can be 
used to clone into pJG4-5. Therefore, a protocol was designed and carried out using 
mung bean nuclease to clone the PCR products directly into pJG4-5 (for more details 
see Section 4.13.6). To make this method work the 5′ base of each restriction site 
used in each primer was left out (Table 21). Furthermore, it was important to use a 
proofreading DNA polymerase that produces blunt end products. 
 
Table 21: Primers used for amplification of LigIIIα and Polβ cDNA. 
hLig3aEcoRI-5′G: Tm: 72.98°C (Finnzyme Tm)-- nt: 34 -- GC ratio: 35.92% 
5`- AA TTC ATG TCT TTG GCT TTC AAG ATC TTC TTT CC-3` 
hLig3aXhoI-5′C: Tm: 71.93 °C (Finnzyme Tm) -- nt: 26 -- GC ratio: 57.69% 
5`- TC GAG CTA GCA GGG AGC TAC CAG TCT -3` 
hPOLB-EcoRI-5′G: Tm: 76.29 °C (Finnzyme Tm)-- nt: 25 -- GC ratio: 52.00% 
5`- AA TTC ATG AGC AAA CGG AAG GCG CC-3` 
hPOLB-XhoI-5′C: Tm: 75.91 °C (Finnzyme Tm) -- nt: 24 -- GC ratio: 58.33% 
5`- TC GAG TCATTCGCTCCGGTCCTTG -3` 
 
Figure 75 shows the results of a PCR with the designed primers and that the 
expected band sizes were achieved (3030 bp for LigIIIα and 1008 bp for Polβ). 
 
                  
Figure 75: Agarose gel electrophoresis of  
PCR of LigIIIα (left) and Polβ (right). 
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5.8.2 Preparation of library vector pJG4-5 for blunt end cloning 
 
The size of the Y2H library vector pJG4-5 was checked by restriction enzyme digest 
using EcoRI and XhoI and separated on an agarose gel along with undigested 
plasmid DNA (Figure 76). 
 
 
 
Figure 76: Agarose gel electrophoresis 
of digested pJG4-5 (1, 2, 3) and 
undigested pJG4-5 (4) 
 
After it was confirmed that the linearized pJG4-5 DNA was the correct size (6449 bp), 
a large scale double-digest with EcoRI and XhoI was performed, separated by 
agarose gel electrophoresis and gel purified. The resulting DNA concentration of the 
linearized plasmid DNA was ~100 ng/µl in a total volume of 50 μl. 
 
5.8.3 Ligation of LigIIIα and Polβ into linearized pJG4-5 
 
As described in Section 4.13.6, prior to ligation it was necessary to blunt-end the 
pJG4-5 vector to allow the inserts to be integrated in frame. Therefore, mung bean 
nuclease was used under the conditions shown in Table 22.  
 
Table 22: Conditions for Mung Bean Nuclease blunting reaction 
Components Amount  
DNA (100 ng/µl) 26.5 µl 
10X mung bean nuclease Buffer 3.0 µl 
5 units of mung bean nuclease 0.5 µl 
Total 30.0 µl 
 
bp 
10000 
8000 
6000 
1 2 3 4 
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The mixture was incubated at 30°C for 30 minutes followed by enzyme deactivation 
with 0.01% SDS. After blunting, the DNA was purified using the Wizard SV Gel and 
PCR clean up kit (Promega). The final concentration of linearised, blunt-ended  
pJG4-5 was 90 ng/µl in a total volume of 30 μl. It was possible to ligate LigIIIα or Polβ 
cDNA into the pJG4-5 vector using the conditions shown in Table 23. 
 
Table 23: Conditions for ligation of LigIIIα or Polβ cDNA, respectively, into pJG4-5. 
LigIIIα  pJG4-5 Polβ  pJG4-5 
Components Amount Components Amount 
10X T4 DNA Ligase Buffer 2.0 µl 10X T4 DNA Ligase Buffer 2.0 µl 
pJG4-5 vector (90 ng/µl) 2.4 µl pJG4-5 vector (90 ng/µl) 2.4 µl 
LigIIIα cDNA 3.8 µl Polβ cDNA 1.3 µl 
Nuclease-free water 10.8 µl Nuclease-free water 13.3 µl 
T4 DNA Ligase 1.0 µl T4 DNA Ligase 1.0 µl 
Total 20.0 µl Total 20.0 µl 
 
After the mixtures were incubated overnight at 16°C, transformation of the ligation 
mixtures into Novablue competent cells was performed as described in Section 4.1. 
After incubation of the transformations on LB-Agar containing 50 µg/ml carbenicillin 
at 30°C overnight >200 colonies per plate were obtained for further investigations. 
 
5.8.4 Confirmation of correct integration of LigIIIα and Polβ into pJG4-5 
 
As the ligation of LigIIIα or Polβ cDNA, into pGJ4-5 was performed with blunt end 
fragments, the integration could have occurred in two ways. Therefore, it was 
necessary to screen for a clone that contains pJG4-5 carrying LigIIIα or Polβ in the 
correct orientation for protein expression in later experiments. As pJG4-5, LigIIIα and 
Polβ each contain a XhoI restriction site, it was possible to perform single restriction 
digestions to obtain two fragments of known size for each plasmid if the insert was in 
the correct orientation. However, if the insert is ligated into pJG4-5 in the wrong 
direction the 5′ XhoI restriction site is destroyed and thus XhoI cuts only once which 
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results in only a single band on the agarose gel. Therefore, if the ligation was correct 
the resulting band sizes for pJG4-5 containing LigIIIα should be 7157 bp and 2310 bp 
and for pJG4-5 containing Polβ 6739 bp and 706 bp. 
 
For constructs, pJG4-5-LigIIIα and pJG4-5-Polβ, 30 clones were picked from each 
transformation plate to inoculate LB liquid cultures in preparation for plasmid DNA 
isolation. After plasmid DNA was recovered from each clone, 60 restriction digests 
with XhoI were performed in order to find a clone carrying the correct insert  
(Figure 77 to Figure 82). Interestingly, for each construct, pJG4-5-LigIIIα and pJG4-5-
Polβ, only one out of 30 picked clones was carrying the correct plasmid (clone L28 in 
Figure 80 and P21 in Figure 82). 
 
  HL1     L1  L2   L3   L4  L5  P1  P2 P3  P4 P5 
 
Figure 77: Agarose gel electrophoresis of restriction digest with XhoI of extracted 
pJG4-5 plasmid DNA from clones L1-L5 containing LigIIIα and P1-P5 containing Polβ 
cDNA. 
 
 HL1      P6     P7      P8    P9    P10     PU     LU     L6      L7      L8     L9     L10 
 
Figure 78: Agarose gel electrophoresis of restriction digest with XhoI of extracted 
pJG4-5 plasmid DNA from clones P6-P10 containing Polβ and L6-L10 containing LigIIIα 
cDNA. PU and LU are undigested P6 and L6 respectively. 
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 HL1        L11      L12      L13    L14     L15       L16     L17      L18      L19     L20 
 
Figure 79: Agarose gel electrophoresis of restriction digest with XhoI of extracted 
pJG4-5 plasmid DNA from clones L11-L20 containing LigIIIα cDNA. 
 
  HL1    L21     L22   L23    L24    L25    L26   L27    L28    L29   L30     LU 
 
Figure 80: Agarose gel electrophoresis of restriction digest with XhoI of extracted 
pJG4-5 plasmid DNA from clones L21-L30 containing LigIIIα cDNA. LU is undigested 
L21. L28 is a positive clone that was picked for further experiments. 
 
  HL1   P11    P12   P13   P14   P15   P16   P17   P18    P19   P20   PU 
 
Figure 81: Agarose gel electrophoresis of restriction digest with XhoI of extracted 
pJG4-5 plasmid DNA from clones P11-P20 containing Polβ cDNA. PU is 
undigested P11. 
 
 HL1   P21     P22    P23   P24   P25   P26   P27    P28   P29   P30    PU  
 
Figure 82: Agarose gel electrophoresis of restriction digest with XhoI of extracted 
pJG4-5 plasmid DNA from clones P21-P30 containing Polβ cDNA. PU is 
undigested P21. 
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In order to confirm the integrity of these two clones, further restriction digests with 
EcoRI and XhoI (either single- or double-digests) were performed. Agarose gel 
electrophoresis revealed the expected band sizes for these clones and therefore 
confirmed that the integration of LigIIIα and Polβ into pJG4-5 had been successful. 
The calculated band sizes for the restriction digest with XhoI for pJG4-5 containing 
LigIIIα were 7169 bp and 2310 bp (LX in Figure 83) and for pJG4-5 containing Polβ 
6751 bp and 706 bp (PX in Figure 83). The result of the restriction digest with EcoRI 
showed the expected band sizes 7117 bp and 2362 bp for pJG4-5 containing LigIIIα 
(LE in Figure 83) and 7011 bp and 446 bp for pJG4-5 containing Polβ (PE in Figure 
83). Finally, the double-digest with EcoRI and XhoI also resulted in the expected 
band sizes 668 bp, 720 bp, 1642 bp and 6449 bp for pJG4-5 containing LigIIIα (LDD 
in Figure 83) and 144 bp, 302 bp, 562 bp and 6449 bp for pJG4-5 containing Polβ 
(PDD in Figure 83) while the 144 bp band was not visible due to the resolution of the 
gel used. 
 
    HL1   LX  LE LDD LU     HL1 PX  PE PDD PU 
     
Figure 83: Agarose electrophoresis of restriction digest of 
L28 (left) and P21 (right) with XhoI (LX and PX), EcoRI (LE 
and PE) and XhoI and EcoRI (LDD and PDD). LU and PU 
was undigested DNA. 
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5.8.5 Small scale transformation of pJG4-5-LigIIIα and pJG4-5-Polβ into 
EGY48 
 
The constructs pJG4-5-LigIIIα and pJG4-5-Polβ generated in Section 5.8.1 to 5.8.4 
were transformed into EGY48 already containing pEG202-N3 and the LacZ reporter 
plasmid pSH18-34 using the small scale transformation protocol described in Section 
4.13.1. However, no transformants were obtained for the Polβ clone and only three 
colonies for pJG4-5-LigIIIα. Due to time limitations the transformation was not 
repeated, instead the interaction studies using X-Gal plates for blue/white selection 
and leucine lacking plates for Leu2 selection were performed. 
 
5.8.6 Testing LacZ and Leu2 gene expression for LigIIIα/hNEIL3 clone 
 
The three colonies obtained through transformation along with a negative control 
(EGY48 containing pEG202-N3, pSH18-34 and empty pJG4-5) were picked, added 
to 50 µl YNB, then 5 µl spotted onto either, YNB (Gal,Raf,X-Gal) ura-/his-/trp-, YNB 
(Glu,X-Gal) ura-/his-/trp-, YNB (Gal,Raf) ura-/his-/trp-/leu-, or YNB (Glu) ura-/his-/trp-
/leu- plates and incubated at 30°C for more than four days. After four days a strong 
colour change became visible for pJG4-5-LigIIIα on YNB plates containing X-Gal and 
galactose but remained white on YNB plates containing X-Gal and glucose. This 
would indicate a positive interaction result as the prey protein expression in this case 
of LigIIIα is only induced on X-Gal plates containing galactose and therefore should 
only interact here with NEIL3 that then can induce LacZ expression. However, the 
negative control carrying empty pJG4-5 showed a similar colour change indicating 
the results could be false positives (Figure 84). On YNB plates lacking the amio acid 
leucine, no growth was detected, which shows that there was no interaction between 
hNEIL3 and LigIIIα as this would have resulted in Leu2 gene expression and 
therefore in growth on the YNB plate containing galactose (bottom right in Figure 84). 
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Figure 84: YNB (Gal,Raf,X-Gal) ura
-
/his
-
/trp
-
 (top right),  
YNB (Glu,X-Gal) ura
-
/his
-
/trp
-
 (top left), YNB (Gal,Raf) ura
-
/his
-
/trp
-
/leu
-
 (bottom right), YNB (Glu) ura
-
/his
-
/trp
-
/leu
-
 (bottom left) plates 
spotted with three different pJG4-5-LigIIIα clones and a negative 
control. 
 
When the experiment was repeated, the LigIIIα/hNEIL3 clone 2 seemed to have a 
potential positive interaction as the colour change occurred earlier then for the 
negative control (Figure 85). 
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Figure 85: Repetition of interaction experiment showed in Figure 84. 
 
However, more evidence that there is an interaction between hNEIL3 and LigIIIα is 
required and a repeat of the small scale transformation with a higher efficiency 
(Section 5.8.5) must be achieved in the first place. 
 
5.9 Overexpression of hNEIL3 and mNEIL1 in Pichia pastoris 
 
It is of great interest to obtain purified and active hNEIL3 protein in order to perform 
assays that allow investigations of its DNA repair capabilities as well as protein-
protein or DNA-protein interactions in vitro. Therefore, it was decided to use a 
eukaryotic expression system based on the yeast P. pastoris and the constitutive 
expression vector pGAPZA in order to express full-length and truncated versions of 
hNEIL3. 
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5.9.1 Confirmation of pGAPZA clones obtained from bacterial stocks 
 
pGAPZA vectors containing either full length mNEIL1 cDNA (CDS) constructed by 
Constantina Stylianou (2010) or full length hNEIL3 cDNA (CDS) and truncated 
versions of hNEIL3 (394 and 502 amino acids) constructed by Mengxin Yin (2010) 
were used for protein overexpression in P. pastoris. 
 
To confirm that the pGAPZA clones carried the correct inserts a single and double-
digest with EcoRI and XhoI was performed (Figure 86). 
 
Figure 86: Agarose gel electrophoresis picture showing single and double-digests of 
pGAPZA containing either hN3-394 (A, B, C, D), hN3-502 (E, F, G, H) or mNEIL1 (I, J, K, L) 
inserts. EcoRI single digest is shown in lanes A, E and I. XhoI digest is shown in lanes B, F, J. 
XhoI and EcoRI double-digest is shown in lanes C, G, K. The lanes D, H and L contained 
undigested plasmid DNA. 
 
There are two XhoI restriction sites in the multiple cloning site of pGAPZαA and an 
EcoRI site in between these two sites. It was expected that EcoRI would not cut any 
of the plasmids as this restriction site was deleted during the cloning process. 
However, this was not the case for hN3-394 but for hN3-502 and mNEIL1 (A, E and I 
in Figure 86). Because EcoRI seemed to cut the used clone of hN3-394 (hN3-394-
Clone-3), four more clones obtained from frozen stocks of hN3-394 and full length 
hNEIL3 were digested with EcoRI and AvrII. As expected for hN3-394-Clone-3 two 
bands appeared after digestion. However, all the other clones (hN3-394-Clone- 1, 2, 
4, 5 and full length hNEIL3) seemed to be genuine as the plasmid was linearized and 
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not cut twice (Figure 87). Therefore, clone 1 of hN3-394 (1 in Figure 87) was used for 
electroporation into P. pastoris. 
 
 
Figure 87: Agarose gel electrophoresis of double-digest with EcoRI 
and AvrII. Full length hNEIL3 (N3), hN3-394-Clone1, (1) hN3-394-
Clone2 (2), hN3-394-Clone3 (3), hN3-394-Clone4 (4), hN3-394-
Clone5 (5). 
 
5.9.2 Linearization of pGAPZαA clones hN3-394, hN3-502 and mNEIL1  
 
After the correct insert integration was confirmed, three separate plasmid DNA 
extractions were performed for each clone and the three eluates combined and 
purified with the Wizard Gel and PCR purification kit (Promega) to increase final DNA 
concentration in a total volume of 150 μl (Table 24). This was necessary to perform 
electroporation at a high efficiency. 
 
Table 24: DNA concentration in 150 μl total volume after purification 
Clone Concentration 
hN3-394 725.9 ng/ul 
hN3-502 943.1 ng/ul 
mNEIL1 738 ng/ul 
 
To allow integration of each pGAPZαA clone into the chromosomal DNA of  
P. pastoris via homologous recombination, the plasmids had to be linearized. 
Therefore, each vector was digested with AvrII and linearization was confirmed on an 
agarose gel (Figure 88). Although shadow bands appeared on the agarose gel the 
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products were considered genuine as later PCR of genomic extracts will confirm 
(Section 5.9.4). 
 
 
Figure 88: Agarose gel electrophoresis of linearized  
pGAPZαA vectors containing hN3-394, hN3-502 or mNEIL1. 
 
5.9.3 Electroporation of pGAPZαA clones into P. pastoris 
 
P. pastoris cells were electroporated with pGAPZαA containing either, hNEIL3, hN3-
394, hN3-502 or mNEIL1 as described in Section 4.14.1. After electroporation the 
clones were spread onto YPD containing 100 mg/ml Zeocin in six different volumes 
(10 µl, 20 µl, 50 µl, 100 µl, 200 µl and 500 µl). In addition P. pastoris only (also 
electroporated but without DNA) was also plated in these volumes as a negative 
control. After three days of incubation at 30°C colonies appeared for hN3-394, hN3-
502 and mNEIL1 on each plate except the 10 µl plates. The electroporation with 
hNEIL3 resulted in one colony only on the plate with 200 µl of sample. However, this 
construct was prepared in a separate electroporation which might have caused 
different conditions which led to a low electroporation efficiency. For the negative 
control, plates that contained 10 µl – 200 µl sample showed no growth but the plate 
that contained 500 µl of electroporated sample of P. pastoris only (negative without 
DNA) showed strong growth. However, this can be explained by the high 
concentration of cfu plated that most likely caused a neutralization of Zeocin over 
time resulting in the survival of some cells. But as the other negative plates showed 
no growth colonies that grew on plates with 200 µl or less were used for subsequent 
manipulations. Two single colonies from two different plates from each 
hN3-394 hN3-502 mNEIL1 
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electroporation were picked re-plated on YPD plates containing 100 mg/ml Zeocin. 
The plates the colonies were picked from are shown in Figure 89.  
 
 
 
 
 
 
 
Figure 89: YPDS plates containing electroporated clones 
after four days of incubation at 30°C. Colonies picked for 
further experiments are marked with a black circle. 
 
After colonies appeared, one from each plate was used to inoculate 10 ml of YPD 
broth and grown overnight at 30C at 250 rpm and frozen stocks (-80°C) were 
prepared as described in Section 4.2.1. 
 
5.9.4 PCR of chromosomal DNA extractions from P. pastoris 
 
To confirm correct integration of pGAPZαA carrying either, hNEIL3, hN3-394, hN3-
502 or mNEIL1, PCR using the primers pGAP-Forward and 3′ AOX1 was carried out 
hN3-394 50 µl 100 µl 
100 µl 
100 µl 
50 µl 
20 µl 
hN3-502 
mNEIL1 
200 µl 
hNEIL3 
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(for more details on primers see Section 4.14.3). In Figure 90 it can be seen that all 
clones picked from electroporation plates contain inserts that correlate to the 
expected sizes (including 540 bp the primers add to the insert, 1722 bp for hN3-394, 
2046 bp for hN3-502, 1710 bp for full length mNEIL1 and 2358 bp for full length 
hNEIL3 band size was expected; Figure 90).  
 
 
 
Figure 90: Agarose gel electrophoresis of PCR products amplified 
from P. pastoris clones carrying full length (1) and truncated 
versions of hNEIL3 (hN3-394 (2) and hN3-502 (3)) and full length 
mNEIL1 (4) cDNA. 
 
5.9.5 SDS-PAGE of cell lysates 
 
After P. pastoris with integrated pGAPZαA carrying full length hNEIL3 CDS cDNA 
and untransformed P. pastoris were incubated in 50 ml YPD for 96 h, a total protein 
extraction was performed using sonication as described in Section 4.10.1. 
Subsequently, protein quantification using the Bradford assay (Section 4.10.3), 15 to 
30 µg of total protein were separated through a 12% SDS-PAGE at 200 V for  
1 h (Figure 91). 
 
No distinguishable band was detected indicating that overexpression of NEIL3 within 
the cell had not occurred. As the pGAPZαA vector carries a protein secretion 
sequence that is fused to the expressed protein, another SDS-PAGE using the 
culture medium/supernatant of the liquid culture. After 48 h incubation there was no 
band for hNEIL3 overexpression visible on the gel. However the control, mNEIL1, 
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showed a band at the predicted size (~63 kDa) after 48 h (Figure 92). Thus, although 
further experiments are required to confirm the identity of the observed band, these 
preliminary results indicate that the P. pastoris overexpression system with 
pGAPZαA vector could be used to express the NEIL proteins. 
 
 
Figure 91: Coomassie blue staining of an SDS-PAGE gel of hNEIL3 (NEIL3) and 
untransformed P. pastoris (Con.) after different incubation times. 
 
 
Figure 92: Coomassie blue staining of an SDS-PAGE gel of secreted proteins from mNEIL1 
(mN1) and full length and truncated versions (394, 502 and full) of hNEIL3 after 24 h and 48 h 
incubation. 
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6 Discussion 
 
6.1 Yeast two-hybrid results 
 
The vectors pEG202 and pEG202-NLS containing the hNEIL3 cDNA sequence were 
successfully generated in preparation for the Y2H assay (Section 5.1). Expression of 
hNEIL3 fused to LexA (hNEIL3-LexA) was confirmed by western blot analysis 
(Section 5.5). Furthermore, autoactivation tests were performed and showed that full 
length hNEIL3 did not autoactivate any of the reporter genes used in this assay. 
hNEIL3 was also able to enter the nucleus after translation as shown by the 
repression assay results (Section 5.4). Therefore, based on these control 
experiments hNEIL3 seemed to be a suitable candidate for use as a bait protein in 
the Y2H assay. 
 
As proteins larger than ~60 kDa (NEIL3 = 68 kDa [Krokeide et al., 2009]) have been 
suggested to be expressed at low levels in yeast cells (Fashena et al., 2000), this 
might explain the delayed growth observed in the screening with the placental cDNA 
library. This is because, only if NEIL3 interacts with another protein leucine will be 
expressed and cells are able to grow on media lacking leucine as is the case in the 
large scale screening. Thus, if NEIL3 expression occurs only at a low level, the 
production of leucine, and therefore growth of yeast colonies during screening will be 
delayed (Section 5.6.1; Fashena et al., 2000). However, complicating the issue, the 
colonies that were obtained from the placental, as well as from the Jurkat T-Cell 
cDNA library screening, showed growth on medium lacking leucine, but containing 
glucose and because prey protein expression is only induced if galactose is present, 
this is suggestive of a false positive result. Contrary to this, however, the Y2H system 
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that was used in this project includes a second selection method, the LacZ selection 
allowing a blue/white screening. This second screening system uses a different 
selection method where positive interactions lead to expression of β-galactosidase 
from a reporter plasmid rather than leucine which is expressed from the genomic 
DNA. Hence, interactions that were negative in the first instance during leucine 
selection might be positive in the blue/white screening assay due to the different DNA 
substrate NEIL3-LexA is binding to (plasmid DNA). Using this assay, all potential 
positive clones from the initial screen also grew on plates lacking leucine but 
containing either glucose or galactose as before (Section 5.6.3). However, using 
blue/white screening on plates containing X-Gal different phenotypes were observed 
(Section 5.6.4), which led to the assumption that interaction between NEIL3 and 
those prey proteins might still be genuine. 
 
The following Sections discuss the results of potential positive protein partners for 
hNEIL3. However, as the Jurkat T-Cell screening revealed only out of frame or non-
coding prey cDNA sequences (Section 5.7.3) this screening will not be included in 
the discussion. 
 
6.1.1 Potential positive interactors 
 
The most promising finding was the homeobox protein (HOPX), because as for 
NEIL3, higher expression levels have been found in MOLT4 cell lines. In addition, 
HOPX is thought to be a tumour suppressor protein, which gives rise to the 
hypothesis that NEIL3 might play a role in its regulation and ability to bind to DNA 
(European Bioinformatics Institute, 2012e). Furthermore, this protein contains a 
conserved homeodomain that is known to be “involved in transcriptional regulation of 
key eukaryotic developmental processes” (NCBI, 2011). Although, the LacZ 
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phenotype could not be confirmed by the mating assay and the fact that it appeared 
only once during screening, this protein could still be worth investigating further, as it 
makes functional sense that it might interact with NEIL3. As explained later for 
CGB8, the recovered mRNA sequence encompassed the whole CDS and also large 
parts of the 5′ and 3′ UTR. Therefore, the CDS on its own could either be cloned into 
the library vector pJG4-5 and retested in Y2H, or it could be used in a pull-down 
assay for immunological interaction studies. Because of its small size (222 bp) it is 
not as expensive as many other protein coding DNA sequences to purchase  
(CDS sequence can be found here http://1.usa.gov/P5obYb). 
 
The chorionic somatomammotropin hormone 1 (placental lactogen, CSH1, European 
Bioinformatics Institute, 2012a), chorionic somatomammotropin hormone 2 (CSH2, 
European Bioinformatics Institute, 2012b) and chorionic gonadotropin, beta 
polypeptide 8 (CGB8, European Bioinformatics Institute, 2012c) were found several 
times, lending support to the idea that they might be genuine interactors. However, 
on performing mating assays (Section 5.6.8) only CGB8 showed the same 
phenotype as during blue/white screening (Section 5.6.4). Evidence of interaction 
could not be confirmed for any of the other clones. One possible reason for this could 
be that the yeast spontaneously mutated during growth and gained a LacZ 
expression phenotype independently of the prey protein. 
 
As a first step to confirm that the interaction between CGB8 and NEIL3 was genuine 
a further mating assay could be performed using bait proteins other than NEIL3 that 
are unlikely to interact with CGB8, such as those expressed by the Y2H bait vectors 
pLexA-Max, pBait or pRHFM1. If the resulting colonies remain white compared to the 
clones expressing NEIL3, a pull-down system using the CDS DNA of CGB8 should 
be performed for further confirmation that the interaction is genuine. It is crucial to 
make further tests as the DNA of the isolated library insert also covers parts of the  
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5′ and 3′ UTR of CGB8 in addition to the CDS, as mentioned previously. 
Furthermore, as the pJG4-5 library vector that CGB8 was expressed from carries an 
ATG start codon upstream relative to the insert, the 5′-UTR sequence will have been 
translated as well. This might have led to a random peptide that interacted with 
NEIL3, or bound to the LexA binding side on the reporter plasmid. 
 
As mentioned before, the protein hormones CSH1, CSH2 and CGB8 appeared more 
often than other proteins in the placental cDNA library screen. Although this could be 
a sign of genuine protein partners it also has to be considered that the number of 
these interactions could be due to the fact that the cDNA library used was not 
normalized and therefore that some cDNAs obtained by reverse transcription were 
present statistically more often than others. Giving credence to this, the protein 
hormones CSH1 and CSH2 are mainly expressed during pregnancy in placental 
tissue and are involved in lactation and foetal growth, while expression patterns for 
CGB8 are unknown. 
 
Other putative interactors found from the placental library Y2H screen included 
decorin, TIMP2, ELAVL1, haemoglobin subunit beta and the tumour protein TPT1. 
However, none of these proteins appears to be linked to NEIL3, given what we know 
about its cellular location and possible molecular function. The negative results in the 
mating assay and the fact that these proteins were found only once during screening 
increase the chance they are false positives. 
 
6.1.2 Reasons for false positive results 
 
Common false positive protein interaction partners found in most Y2H screens are 
ribosomal and proteasome specific proteins and these were also identified via DNA 
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sequencing during this Y2H screening with placental cDNA library. Golemis et al. 
(1999) suggest that if only individual cDNAs were found during sequencing of 
putative positive clones this might be due non-specific binding of the bait protein with 
false positives. On the other hand if several putative clones contained several cDNA 
of the same protein it is very likely that this clone is genuinely positive. 
 
Krokeide et al. (2009) found that when NEIL3 is overexpressed in mammalian cells, it 
results in extreme cytotoxicity. This might also be a problem when full length hNEIL3 
is expressed in yeast during Y2H. It is known that when bait proteins poison yeast, it 
almost always results in a high frequency of false positive clones in screens 
(Duttweiler, 1996; Serebriiskii et al., 2000). One indicator that shows this might have 
happened here is the delay in the start of colony growth during the screening. Instead 
of two days it took five days until growth of colonies was first detected (Section 
5.6.2). Therefore, during this time, the yeast may have evolved mutations in the host 
strain due to selective pressure by the leucine lacking media and the toxicity of 
NEIL3, allowing the cells to grow on selective media without interaction of bait and 
prey. Further evidence that the host yeast strain had mutated can be inferred from 
the fact that potential positive colonies, picked from the screening plates, grew on 
glucose medium lacking leucine (Section 5.6.3; MacDonald et al., 2001). That would 
also explain why the initial autoactivation test (Section 5.4.1) showed no 
autoactivation of Leu2 expression by full-length hNEIL3, because at that stage of the 
project, the yeast strain contained no mutations. 
 
In addition, the fact that for the Jurkat T-Cell library screen the colonies appeared 
after only three days but with the same phenotype as described above leads to the 
conclusion that the expression of the Leu gene caused by mutation happened only 
due to toxicity of overexpressed NEIL3 rather than selective pressure. 
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In contrast to this theory the phenotype of a negative control clone which expressed 
the bait, NEIL3-LexA, and the activation domain B42 on its own (without the prey) did 
not show any growth on plates lacking leucine suggesting that the hypothesis that a 
mutation led to leucine production and therefore growth of random cells was not 
correct. However, interestingly a colour change was observed for the same clones on 
the blue/white screening plates (‘negative’ in Figure 84). This was contradictory to the 
results from both Y2H library screenings. In these screenings some clones remained 
white on both plates which indicated that no interaction had occured. As clones 
expressing NEIL3-LexA on its own do not show this phenotype it leads to the 
conclusion that NEIL3-LexA might interact with B42 itself resulting in the observed 
colour change of the colonies to blue. In addition, if B42 is fused to another protein, 
the final product might fold in a way that hinders NEIL3-LexA binding to the B42 
domain and therefore does not allow LacZ gene expression. This would explain why 
the colonies remained white on X-Gal plates. The extended C-terminus of NEIL3 
might play a crucial role in this interaction as its function remains unknown. 
Therefore, it may be important to use truncated versions of NEIL3 for the negative 
control to confirm this hypothesis. On the other hand, the fact that no growth of 
negative control clones on plates lacking leucine was observed might indicate that 
NEIL3-LexA, or the prey fusion protein, was not able to enter the nucleus in the first 
place, whereas some prey was able to and activated leucine expression on their 
own. However, if the repression assay (used to confirm localization of bait NEIL3-
LexA into the nucleus after expression) performed in Section 5.4.3 is compared with 
the repression assay performed by Dr. Manal Shalaby (2009) the same grade of 
colour change can be observed (Figure 52 and Figure 93). Because of these 
contradictory results, it remains unclear if hNEIL3 was able to enter the nucleus or 
not. 
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Figure 93: Comparison between repression assay results. Top = Result of a repression 
assay performed by Manal Shalaby (2009); positive control (A); pEG202-Tip-1 (B); negative 
control (C). Bottom = result of repression assay from Section 5.4.3; negative (1); pEG202-N3 
(2); pEG202-NLS-N3 (3); and positive (4) control. 
 
As Liu et al. (2013) stated “Full-length mNeil3 is … prone to aggregation.” it might be 
possible that NEIL3 protein accumulated in the yeast and therefore allowed some 
proteins to bind depending on what structure was formed and what motifs were 
presented to the surrounding area. 
 
According to Serebriiskii et al. (2000), transcription of the LacZ gene can be activated 
by the expressed prey protein itself or if co-expressed with the bait protein. This 
would result in a colour change on media where the expression of the prey protein is 
induced by the galactose, while colonies on plates that contain glucose, where the 
prey protein is not expressed, would remain white, as observed in this project. This 
would also explain why not all clones showed this phenotype during screening and 
why autoactivation tests carried out with hNEIL3 did not show any activation of LacZ 
gene expression on its own (Section 5.4.2). 
1 
2 
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Degradation of hNEIL3 after expression cannot be ruled out as the western blot that 
was carried out in Section 5.5 was performed with a 24 h culture. This does not 
represent the conditions during a screening that took more than five days for the 
yeast to grow. Additional faint bands were observed when the western blot was 
performed after 24 h that might indicate degraded hNEIL3-LexA. If hNEIL3-LexA is 
degraded over time, perhaps one or more of the proteolytic products are able to 
interact with proteins expressed from the cDNA library and hence activating leucine 
expression. 
 
Regarding this project, the autoactivation tests appear to be correct, as 
autoactivation of leucine expression by hNEIL3 would have led to early growth (or 
high background growth) during screening on plates lacking leucine rather than a 
delay of growth. Furthermore, a more evenly distributed colour change during the 
blue/white screening would have been expected as NEIL3 should also autoactivate 
LacZ gene expression than was observed for both Y2H screenings performed.  
 
6.2 Overexpression in P. pastoris 
 
Before starting these experiments, a band of the expected size was obtained 
following western blotting with an anti-LexA antibody on lysates obtained from  
S. cerevisae strain EGY48 that expresses a hNEIL3-LexA fusion protein for use in 
Y2H (Figure 53). Therefore, having shown that expression of full length hNEIL3 was 
possible in yeast, it was decided to try to overexpress hNEIL3 using a P. pastoris 
system optimized for recombinant protein expression. 
 
Thus, several clones of P. pastoris each carrying either full length CDS cDNA of 
hNEIL3, full length CDS cDNA of mNEIL1 or truncated versions of hNEIL3 (amino 
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acid length 394 or 502) were successfully generated, correct DNA integration was 
confirmed by PCR and clones were stored at -80°C for further experiments. 
 
Coomassie blue stained SDS-PAGE gels of samples of culture medium that should 
contain secreted protein showed a band for mNEIL1 at the predicted size, whereas 
no band was visible for hNEIL3 (Figure 92). Although different temperatures (28°C 
and 30°C), incubation times (24 h to 120 h) and culture volumes (10 ml and 50 ml) 
were used to increase the likelihood of hNEIL3 protein expression, no recombinant 
protein was detected. However, western blotting with a monoclonal anti-His-Tag 
antibody did not recognize either protein indicating that the observed band was not 
his-tagged NEIL1 and the antibody was not binding as expected or was denatured. 
Unfortunately, no positive control was available to check the latter possibility. 
Similarly, a rabbit polyclonal anti-hNEIL3 antibody used in western blotting with cell 
lysates and liquid culture medium did not reveal the existence of any hNEIL3 protein. 
Further experiments would be needed to clarify the situation, but unfortunately time 
did not permit this. 
 
In addition, it has previously been reported that in E. coli, overexpressed full length 
hNEIL3 protein is very unstable and difficult to recover from cells in detectable 
quantities (Krokeide et al., 2009; Takao et al., 2009; Liu et al., 2010, 2012). Hence, 
hNEIL3 might be rapidly degraded after its expression and/or secretion into the 
medium from P. pastoris. However, since it was possible to isolate a full length 
hNEIL3-LexA fusion protein expressed in S. cerevisiae EGY48 cells, clearly hNEIL3 
was not completely degraded when expressed as a fusion protein. Therefore, either 
hNEIL3 was protected from degradation because it was part of a fusion protein, or 
the  
S. cerevisiae strain EGY48 has different cellular conditions than the P. pastoris 
strain, or the fact that hNEIL3 was not secreted in the S. cerevisae system might 
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explain the successful recovery. To confirm this latter hypothesis, further experiments 
would have to be carried out, e.g. expression of hNEIL3 in P. pastoris without the 
secretion signal to see if it is secreted in the first place and to determine if it stays 
intact if not secreted. 
 
Difficulty in expressing active full length NEIL3 could be related to the extended  
C-terminal domain and its tandem GRF-zinc finger motifs as, interestingly, both 
APE2 and TopoIIIα, which have this domain, have also been reported to be difficult 
to express and purify (Hanai et al., 1996; Hadi & Wilson, 2000). This was confirmed 
by Krokeide et al., (2009) who made truncated versions of mouse NEIL3 without the 
GRF-zinc finger motifs that showed a much more efficient expression of active 
protein, leading to the conclusion that GRF-zinc finger motifs probably hinder the 
correct expression and folding of NEIL3. In addition, recent studies show that 
processing of the N-terminal methionine in NEIL3 is crucial for its activity and 
underscores the importance of posttranslational modifications (Liu et al., 2012). This 
group co-expressed an E. coli methionine aminopeptidase Y168A variant with mouse 
and human NEIL3 to improve the N-terminal methionine processing. This way they 
were able to obtain a higher percentage of active full length and truncated mouse 
and truncated human NEIL3. Interestingly, 85% of the full length mouse NEIL3 
protein remained inactive and no active full length human NEIL3 protein was 
obtained. This indicates the difficulty encountered in expression of full length NEIL3 
and that the problem lies principally in its C-terminal region where amino acid 
residues 400 to 500 are predicted to be structurally disordered. This region of the 
NEIL3 polypeptide contains only a putative NLS domain (amino acid residues  
465-468). Based on this information, truncated versions of NEIL3 generated in prior 
studies (Krokeide et al. 2009; Liu et al., 2012) should also be used in future studies of 
hNEIL3 in comparison with the full length version, should this be achievable. 
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6.3 Future outlook 
 
It must be considered if it is useful to use a Y2H assay to search for NEIL3-
interacting proteins. NEIL3 is only expressed in vertebrate cells, which has led to the 
suggestion, that the biological function of NEIL3 is specific to higher eukaryotes 
(Takao et al., 2009). Therefore, this leads to the conclusion that NEIL3 may require 
mammalian cell - like conditions including specific posttranslational modifications, 
which may not be identical or appropriately controlled in yeast cells, to be fully 
functional. 
 
Mammalian two-hybrid as alternative to Y2H 
 
Although mammalian two-hybrid (M2H) systems have been used less than Y2H 
systems, the fact that yeast do not provide the full range, or correct control of 
posttranslational modifications as mammalian cells, gives the system an advantage. 
The functionality of the M2H system was verified by Luo et al. (1997), who confirmed 
the interaction of the mouse p53 tumour suppressor protein with the simian virus 40 
large T antigen. Furthermore, they showed that assay results can be obtained within 
48 h of transfection and also made the point that studying protein interactions in 
mammalian cells may be closer to the actual in vivo interactions in the cell of origin 
(Luo et al., 1997). The reason why Y2H is more commonly used is that M2H is not 
suitable to screen large numbers of prey proteins due its format and it is more likely 
to give false negative results, which means that potential protein partners for NEIL3 
may stay undiscovered (Dr. A.W. Oliver personal communication; Anon, 2007). 
Therefore, while Y2H is much more sensitive, results obtained should be confirmed 
in a M2H assay. However, as discussed in Section 6.1.2, it is important to consider 
that overexpression of hNEIL3 might be toxic to primary eukaryotic cells in general. 
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Co-immunoprecipitation 
 
Co-immunoprecipitation is commonly used to confirm potential protein-protein 
interactions in vivo. Because the protein of interest is expressed in its natural 
environment, post-translational modifications that may be necessary for interaction 
will occur and the proteins will be available in their native conformation. To this end, it 
would be interesting to use the MOLT4 lymphoblastic leukaemia cell line in these 
investigations, since recent studies have shown high gene expression levels for 
hNEIL3 in this cell line (Figure 104; Genomics Institute of the Novartis Research 
Foundation, 2009). Another system that may hold promise for future studies makes 
use of the HaloTag technology developed by Promega. This could be used to 
investigate the cellular localization of NEIL3 and possible protein interactions in pull-
down studies. The HaloTag system is a mammalian expression vector system that 
uses a tag that codes for a monomeric 33 kDa protein that is fused during expression 
to either the N-terminal or C-terminal end of the protein of interest. As NEIL3 showed 
extreme cytotoxic effects when overexpressed in mammalian cells, it is of special 
interest to express NEIL3 at low levels and with HaloTag it might still be possible to 
visualize or recover it within or from the cell (Krokeide et al., 2008).  
 
FRET/BRET 
 
The problem with co-immunoprecipitation is that the cell-content has to be extracted, 
which may cause an alteration in the conformation of the protein complex of interest. 
This may lead to a loss of interaction with a potential protein partner. To observe 
protein-protein interactions in situ, immunofluorescence methods such as 
fluorescence resonance energy transfer (FRET) and bioluminescence resonance 
energy transfer (BRET) can be used. However, these techniques are only suitable to 
confirm an interaction observed by another method and thus it is not useful for 
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screening large numbers of prey proteins. However, they maybe useful for confirming 
potential protein-protein interactions determined by in vitro assays in a mammalian 
cell environment and to reveal their location within the cell (Anon, 2007). 
 
6.4 Overall discussion 
 
Recent studies investigating DNA glycosylase and AP lyase activities of NEIL3 
suggest that this protein plays a role in BER (Krokeide et al., 2009; Takao et al., 
2009; Liu et al., 2010, 2012, 2013). Therefore, NEIL3 would contribute to the defence 
against ROS in a cell and in the maintenance of genomic stability. However, recent 
research also suggests that overexpressed BER enzymes play a vital role in the 
survival of tumour cells treated with genotoxic agents. For example, a high level of 
APE1 expression was linked to tumour cell resistance to chemo- and radiotherapy by 
several groups (Bobola et al., 2005; Freitas et al., 2003; Robertson et al., 2001). On 
the other hand, if APE1 was downregulated it sensitized these cells to anticancer 
drugs and induced apoptosis (Izumi et al., 2005; Robertson et al., 1997; Wang et al., 
2004). 
 
Although the common DNA oxidation product 8-oxoG has not been identified as a 
preferred substrate for NEIL3, other types of oxidized guanine, such as FapyG and 
the hydantoin lesions Sp and Gh (oxidised forms of 8-oxoG), were found to be 
released by the N-terminal DNA glycosylase domain of NEIL3 (Liu et al., 2012). In 
addition, studies on gene expression patterns in neoplastic cells revealed that 
expression of the NEIL3 gene is dramatically increased in metastatic cancer cells 
compared to that of other BER genes such as hOGG1 (Kauffmann et al., 2008). The 
fact that proteins that are linked to DNA repair and also to DNA replication are 
overexpressed in melanoma cells could partly explain the resistance of these 
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malignant cells to genotoxic chemotherapy agents. Compounds that inhibit specific 
proteins involved in DNA repair such as PARP-1 have already been developed and 
their use in combination with other chemotherapy agents shows some benefit in the 
clinic (O’Shaughnessy et al., 2009; Kummar et al., 2012). The latest clinical trials 
show that PARP-1 inhibitors are especially effective for the treatment of breast 
cancer where the cells have a mutation in the tumour suppressor genes BRCA 1 or 2 
resulting in a decreased rate of DSB repair, so called synthetic lethality 
(O’Shaughnessy et al., 2009; Tutt et al., 2010). 
 
One reason why PARP-1 was used as a target for inhibition in the first place is that it 
plays a role in BER and its inhibition was known to delay strand rejoining (Hooten et 
al., 2012; Mansour et al., 2010). As NEIL3 expression is so much higher in malignant 
cells compared to normal cells it might play a crucial role in combating DNA damage 
and therefore securing cancer cell survival. Therefore, it is of great interest to 
investigate the effects on viability of a NEIL3 knockout (or double knockout with 
PARP) cancer cell line treated with a genotoxic agent. 
 
However, the problem in inhibiting proteins that are involved in DNA repair is that it 
affects the whole organism and results in collateral toxicities (Drew & Plummer, 
2009). Furthermore, each metastasis will be resistant to different drugs, which makes 
treatment of metastatic cancer difficult. However, as NEIL3 is highly expressed in 
malignant cells, inhibiting it might preferentially target the tumour cells and on the 
other hand have less effect on normal cells. In addition, NEIL3 might play a crucial 
role in genomic maintenance to secure cell survival and increased resistance of the 
cell against DNA targeted anticancer drugs (Hildrestrand et al., 2009). Although the 
inhibition of DNA glycosylases may be inefficient due to back up functions of other 
DNA glycosylases, or make cells even more resistant to genotoxic agents, as shown 
for knockout mouse models, respectively (Rinne et al., 2004; Roth & Samson, 2002) 
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NEIL3 could still be an interesting target for protein inhibiting anticancer drugs 
because of its spatially and temporally restricted expression pattern (Hegde et al. 
2008b). Tumour cell targeted NEIL3 knockdown by siRNAs is another treatment 
possibility that is the subject of much recent research (Pecot et al., 2011). 
 
The first evidence that a DNA glycosylase is involved in regulation of the cell cycle 
was given for the DNA glycosylase MPG which inhibits p53-mediated cell cycle arrest 
(Song et al. 2012). Like NEIL3, MPG expression is cell cycle dependent with levels 
highest during G1 phase (Bouziane, 2000). Since it is known that NEIL3 gene 
expression is upregulated in cells leaving the G0 phase and entering G1 phase 
(Neurauter et al., 2012), it might be of interest to investigate possible interactions of 
NEIL3 with p53 or other cell cycle regulatory proteins. 
 
Another indicator that NEIL3 is active during DNA replication is the similarity of its  
C-terminal end with that of TopoIIIα. TopoIIIα is expressed mainly in testes and is 
active during DNA recombination on the double Holliday junction dissolvasome 
complex (Chen et al., 2012). Interestingly, the function of TopoIIIα relies on its  
C-terminal tandem GRF zinc finger domain (Chen et al., 2012), which is also present 
in the C-terminal domain of NEIL3. Further evidence that this domain is involved in 
recombination is that the other type IA topoisomerase, TopoIIIβ which is not able to 
dissolve the double Holliday junction, has a shorter C-terminus that lacks the GRF 
zinc fingers (Chen et al., 2012). This group also showed that these GRF zinc fingers 
are responsible for the interaction with the first 133 N-terminal amino acids and the 
150 C-terminal amino acids of the Bloom Syndrome protein (BLM helicase; Hu et al., 
2001). In addition, BLM helicase is considered to be a major protein interaction 
partner for p53 and therefore indirectly regulates transcription and cell growth but on 
the other hand p53 indirectly regulates the processing of Holliday junctions by its 
inhibitory interaction with BLM (Wang et al., 2001; Yang et al., 2002). Interestingly, 
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overexpression of BLM helicase showed an inhibition of proliferation which might 
also affect the expression of NEIL3 as the expression levels of NEIL3 are high in 
proliferating cells (Garkavtsev et al., 2001). Therefore, the GRF Znf at the C-terminal 
region of NEIL3 might also be able to interact with the BLM helicase. Furthermore, 
FEN1 also was shown to interact with BLM helicase (Sharma et al., 2004). This is 
interesting, because FEN1 shows similar expression patterns to that of NEIL3 
(Neurauter et al., 2012). Therefore, with increased knowledge about these protein 
domains, it might be possible to find other potential binding partners that have 
conserved BLM helicase motifs. 
 
Furthermore, TopoIIIα together with BLM helicase are known to play an important 
role in the alternative pathway of telomere lengthening in the absence of telomerase. 
In fact, an absence of TopoIIIα led to an increase in overall DNA damage on 
telomeres in cells lacking telomerase (Temime-Smaali et al., 2008). This indicates 
that TopoIIIα might be an essential telomere-associated factor and as expression 
levels of NEIL3 are high in testes, where telomeres are maintained at their maximum 
length, it might be worth focusing studies for NEIL3 on telomere maintenance 
pathways. The fact that no change in phenotype of NEIL3-/- mice was observed might 
be due to the short period of time the tests were made and no generational studies 
have been reported (Torisu et al., 2005). As telomeres are known to play an 
important role in aging, a change in telomeres, either by their shortening or mutation, 
might affect an organism only in later stages of life (Cherif et al., 2002). On the other 
hand, first attempts to link high expression levels of NEIL3 in tumour cells to telomere 
shortening were not successful (Frias et al., 2008). However, these studies were 
carried out in non-small cell lung cancer cells which have not been reported to have 
high levels of active NEIL3 (Section 2.3.5.2.3). Hence, it is important to consider that 
NEIL3 has very tissue specific expression patterns which might acutely affect the 
phenotype only of certain tissues, but not the whole organism. 
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The fact that the expression level of NEIL3 is elevated in certain oxidatively stressed 
cells and during G1-S phase and the similarity of its C-terminal structure with that of 
TopoIIIα leads to the conclusion that NEIL3 might play a role in counteracting the 
effects of oxidative stress on telomeres via its DNA glycosylase activity and maybe in 
cooperation with BLM helicase. As it was found that stressed animals have shorter 
telomeres on average, which might be related to increased levels of oxidative stress, 
it might be worth repeating these tests in NEIL3 knockout mice with respect to their 
telomeres (Epel et al., 2004). 
 
There is also evidence that p53 not only interacts with BLM helicase but also with 
WRN to inhibit their activity (Yang et al., 2002). Interestingly WRN is also an 
interaction partner for NEIL1 that enhances its DNA glycosylase activity on oxidized 
purines (Das et al., 2007a). As the expression of NEIL1, like NEIL3, is cell cycle 
dependent and is also mainly active on ssDNA substrates, it would be of great 
interest to determine potential interactions between NEIL3 and WRN. 
 
To date, several groups have reported that an efficient expression and purification of 
active full length NEIL3 in an eukaryotic cell system in amounts high enough to be 
used in downstream assays could not be achieved (Krokeide et al., 2009; Liu et al., 
2010 and 2012) and although it was possible in this project to express full length 
NEIL3 as a fusion protein in an eukaryotic cell system (yeast) it was not possible to 
purify active NEIL3 for further use. 
 
It is known that NEIL1 and NEIL2 interact with other proteins involved in BER such 
as PNK, Polβ and LigIIIα and thus it is possible that NEIL3 also has to interact with 
these proteins to fulfil its function in BER (Wiederhold et al., 2004; Das et al., 2006). 
The first evidence of interaction was found for RPA as it was co-localized with 
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hNEIL3 in the nucleus and alignment of hNEIL3 protein sequence with sequences 
from proteins known to bind to PCNA and RPA revealed a putative PCNA- (residues 
80-96) and RPA-binding (residues 30-45) site (Morland et al. 2002). 
 
BER is known to be a pathway where many different protein complexes are involved 
depending on the sort of DNA damage. Proteins contained in such complexes can 
either act as scaffold proteins or as enhancers that increase the activity or turnover 
rate of other proteins. An example of an enhancer is the YB-1 protein which 
significantly enhances the base excision activity of NEIL2 via a stable interaction 
(Das et al., 2007b). However, as YB-1 also interacts with the downstream proteins 
LigIIIα and Polβ, it is likely that NEIL2 and YB-1 are part of a larger protein complex 
during DNA repair. Furthermore, YB-1 is also an interacting partner of APE1. If APE1 
is posttranslationally acetylated it modulates YB-1-mediated activation of expression 
of the ABC-transporter P-glycoprotein-1 (Chattopadhyay et al., 2008). The 
membrane protein P-glycoprotein-1 is responsible for multidrug resistance by acting 
as an efflux pump to remove xenobiotics such as antitumour agents from cells 
(Kakumoto et al., 2005). If NEIL3, with respect to its high expression levels in cancer 
cells, also indirectly stimulates P-glycoprotein-1 expression through YB-1 modulation, 
it might explain why these cells show a high degree of drug resistance. On the other 
hand, it was recently shown that YB-1 and RPA inhibit the AP lyase activity of NEIL1 
on ssDNA, presumably due to competition, as YB-1 and RPA both have a high 
affinity for ssDNA (Pestryakov et al., 2012). 
 
Not only proteins such as YB-1 might be an important target for further investigations 
on the biological role of NEIL3 but also posttranslational modifications, in particular 
acetylation. For example, for NEIL2 it was found that posttranslational acetylation of 
the Lys49 residue by the acetyltransferase p300 inhibits its DNA glycosylase and AP 
lyase activity (Bhakat et al., 2004). Interestingly, Lys49 is a residue that is conserved 
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within the NEIL family. Acetylation on residues other than Lys49 might affect the 
ability of NEIL3 to interact with certain protein partners and has to be considered 
when carrying out protein-protein interaction studies. For example, it was shown that 
PCNA is also acetylated by p300, however, when it is deacetylated by histone 
deacetylase-1 (HDAC1) it loses its affinity for Polβ and Polδ (Naryzhny & Lee, 2004). 
Other proteins that are acetylated by p300 are FEN1, Polβ, OGG1 and thymine DNA 
glycosylase (TDG) (Bhakat et al., 2006; Hasan et al., 2001, 2002; Tini et al., 2002). 
For example, acetylation of OGG1 at Lys338/Lys341 increases its rate of repair of  
8-oxoG by 2.5-fold (Bhakat et al., 2006) which leads to the suggestion that p300 
might play a crucial role in the regulation of BER proteins. 
  
DNA glycosylases such as OGG1 (Hill et al., 2001), UNG (Parikh et al., 1998), TDG 
(Privezentzev et al., 2001; Waters, Gallinari et al., 1999), single-strand selective 
monofunctional uracil DNA glycosylase (SMUG1) (Kavli et al., 2002) and NTH1 
(Marenstein et al., 2003) are known to have a higher affinity to the AP-site they 
create than they had to the original DNA lesion. However, APE1 seems to have more 
affinity for the AP lesion, replacing the DNA glycosylases and therefore increasing 
their turnover rate (Hill et al., 2001; Parikh et al., 1998; Privezentzev et al., 2001; 
Kavli et al., 2002; Marenstein et al., 2003). It must be considered that these DNA 
glycosylases are either monofunctional (UNG, TDG, SMUG1) or bifunctional with  
β-lyase activity (OGG1 and NTH1) but that both result in a substrate for APE1 (either 
AP-site for monofunctional or unsaturated aldehyde overhangs for bifunctional DNA 
glycosylases). For the NEIL proteins this is not the case as they have a β,δ-lyase 
activity resulting in the release of the deoxyribose sugar leaving 5′-P and 3′-P. 
Therefore, the function of APE1 that increases the turnover rate of other DNA 
glycosylases may not be applicable to the NEIL proteins, as the 3′-phosphatase 
activity of APE1 is very weak (Wiederhold et al., 2004). Therefore, APE1 may be 
unlikely to interact with NEIL3. However, perhaps PNK plays a similar role to APE1 
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for the NEIL proteins by increasing their turnover rate due to its affinity for 3′-P sites. 
Recently, it was shown that in the presence of XRCC1, LigIIIα and Polβ, PNK is part 
of a BER complex with NEIL1 and NEIL2 (Wiederhold et al., 2004; Das et al., 2006). 
Similarly, PCNA is known to enhance the activity of NEIL1 on the oxidized base  
5-OH-U from ssDNA where it acts as a clamp that helps NEIL1 to load the substrate 
(Dou et al., 2008). Although, PCNA does not stimulate NEIL2 it might still play a role 
in the function of NEIL3 as its substrates are more related to those of NEIL1. 
 
While they usually act as DNA glycosylases, NEIL1 and OGG1 also can stimulate the 
poly(ADP-ribosyl)ation activity of PARP-1 by binding to its C-terminal domain 
(Hooten et al., 2011, 2012). This is an example of proteins (in this case NEIL1 and 
OGG1) that can have different functions depending on the kind of interaction. Hence, 
it is not controversial if it is proposed on one hand that NEIL3 plays a part in BER 
during DNA replication and in recombination of chromosomes on the other. Another 
example of a multifunctional protein is XRCC1, a scaffold protein known as a 
fundamental protein interactor during BER and SSB repair. If NEIL3 acts during BER 
as suggested, XRCC1 might be a very important target as a protein partner for 
NEIL3. It might stabilise the DNA binding capability of NEIL3 or it could recruit other 
proteins essential for the DNA interaction or repair process. 
 
As NEIL3 contains a RanBP zinc finger and a NLS sequence it is likely that NEIL3 
also has to interact with specific nucleus transport proteins to be located correctly 
within the cell after its translation (Section 2.3.5.2.3). 
 
A suppression of HIV integration following RNAi knockdown of proteins involved in 
BER was first reported by Kameoka et al. (2004). NEIL3 also seems to play an 
important role in this as recent siRNA studies revealed that genomic HIV integration 
in cells lacking NEIL3 is significantly decreased (Yoder et al., 2011; Espeseth et al., 
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2011a and Zhou et al., 2008). One hypothesis might be that bifunctional DNA 
glycosylases such as NEIL3 help the viral integrase protein to fulfil its function. For 
example, perhaps NEIL3 can interact with the integrase protein transporting it into 
the nucleus via its NLS where it then binds to DNA. Once NEIL3 has excised an 
oxidized base and cut the resulting AP site via its AP-lyase activity, the resulting gap 
could be used by the integrase itself to insert the vDNA in form of a DNA loop. 
Subsequent DNA replication would then fully integrate the vDNA into the genomic 
DNA. However, such a DNA loop would be prone to recognition by p53 which would 
activate repair complexes such as MMR or even induce apoptosis. On the other 
hand, depending on its final conformation the loop could be resistant to repair 
mechanisms as was proposed for MMR and short DNA loops (Lang et al., 2011). The 
fact that HIV cannot replicate within a cell during quiescence (G0-phase in cell cycle) 
because this state blocks the reverse transcription process gives further evidence for 
the involvement of hNEIL3 in vDNA integration as its expression is stimulated by the 
release from quiescence (Amado & Chen, 1999; Neurauter et al., 2012). The patent 
submitted by Espeseth et al. (2011b) regarding drugs inhibiting hNEIL3 underscores 
the importance of studying the biological role of hNEIL3 in relation to HIV integration 
and lentivirus integration in general. This patent also includes MUTYH, LigIIIα, Polβ 
as potential drug targets to hinder HIV integration. However, the inhibition of LigIIIα 
and Polβ would affect the whole organism and its DNA metabolism that includes 
DNA repair, replication and recombination, whereas hNEIL3 might have a significant 
effect on HIV integration but not on the overall fitness of the organism and this could 
reduce harmful side-effects. 
 
The fact that there was no obvious change in the phenotype of NEIL3-/- mice does 
not mean that the organism was not affected at all. As stated before, maybe only 
specific tissues were affected or the observations were too short in time to see 
changes that might have only arisen with age. In addition it has to be considered that 
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perhaps the learning and memory capacity of NEIL3-/- mice is affected which is not 
necessarily an obvious aspect. Therefore, strategies to test this should be devised as 
also suggested by other groups (e.g. Marin-Burgin & Schinder, 2012). Evidence for 
the influence of NEIL3 on the brain was given by Regnell et al. (2012) who 
discovered morphologic alterations in the hippocampal network and reduced 
neurogenesis in vivo for NEIL3-/- cells. Neurogenesis is essential for the restoration of 
brain function after injury and also required for shaping the structural basis for 
learning and memory in the hippocampal structure (Sejersted et al., 2011). Hence, 
NEIL3 might play a crucial role as the main DNA glycosylase for Sp and Gh lesions 
in ssDNA in neuronal cells and therefore may be essential for retaining the cognitive 
behaviour in vertebrates. 
 
Conclusions and future perspectives 
 
The aim of this project was to find potential interacting protein partners for human 
NEIL3 and thus provide a clue to understanding the biological role of NEIL3. While 
recent studies have begun to shed light on the different biological processes that 
NEIL3 is involved in, it is still not clear why mammalian cells require this DNA 
glycosylase in particular, and what role the unique protein motifs play in its biological 
activities. It is known that the N-terminal region of NEIL3 includes a DNA glycosylase 
and H2TH motif conserved among NEIL1, NEIL2 and Fpg/Nei in E. coli. The function 
of these domains in the other proteins leads to the conclusion that NEIL3 plays a role 
in DNA repair. However, the predominantly C-terminal protein domains have yet to 
be ascribed a biological function and unfortunately this question remains as relevant 
now as at the start of this project. 
 
While mouse NEIL3 expression was shown to be upregulated in hematopoietic tissue 
and testes, during embryonic development and in stem/progenitor rich regions in the 
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brain the gene expression patterns of human NEIL3 in these tissues remains largely 
to be determined (Hildrestrand et al., 2009; Kauffmann et al., 2008; Morland et al., 
2002; Rolseth et al., 2008; Takao et al., 2009; Torisu et al., 2005). As all these 
tissues contain highly proliferating cells, and the fact that NEIL3 is upregulated in 
early S phase, makes it most likely that its function is to remove lesions from the 
genome in replicating cells (Neurauter et al., 2012). As it is known that NEIL3 shows 
higher activity in murine neural stem/progenitor cells compared to differentiated cells 
(Rolseth et al., 2008; Hildrestand et al., 2009), and that NEIL3-/- mice show a 
decreased repair capacity in damaged areas of the brain, it leads to the conclusion 
that NEIL3 gene expression is stimulated by transcription factors that are regulated 
by the differentiation and proliferation state of vertebrate neural progenitor cells. 
 
To date, the potential interacting protein partners found in this project remain to be 
confirmed. However, although there seems to be no link between a protein such as 
CGB8 and NEIL3, it does not necessarily mean that it is a false positive result. NEIL3 
was shown and is suggested, as discussed before, to play an important role in 
several independent processes within a cell. Therefore it is still important to 
undertake further efforts to find potential protein partners. Such proteins might be 
responsible for posttranslational modifications of NEIL3 or help NEIL3 to bind to DNA 
or other proteins. Such results would help to develop hypotheses or to confirm 
assumptions already made about the biological role of NEIL3. To confirm its place 
within BER, further investigations have to be carried out which focus on interaction 
with downstream and scaffold proteins involved in BER. The focus herein should be 
on in vivo investigations as only this way can the correct folding and posttranslational 
modification be ensured. 
 
The recently identified DNA substrates that NEIL3 can release from DNA comprise 
oxidized guanines (Liu et al., 2012), which are likely to be formed more frequently by 
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ROS in cells that have an increased metabolic rate (Beckman & Ames, 1998). If the 
latest results regarding gene expression levels and the DNA repair capability of 
NEIL3 are brought together with the fact that ROS generation is especially increased 
in cancer cells (Pelicano et al., 2004), it makes good sense that rapidly dividing cells 
need NEIL3 to secure their genomic integrity during DNA replication and therefore 
stimulate its expression. Thus, further studies should be focused on a restricted 
assortment of cell types where high expression of NEIL3 has been determined, such 
as cancer cell lines. Clarifying the significance of increased expression levels of 
NEIL3 in tumour cells might also explain its potential function within the normal cell 
and maybe NEIL3 can even be used as a new biological marker for diagnostic 
purposes or as a target for next generation cancer drugs. In addition, as evidence 
was found that NEIL3 reduces reverse transcription up to or including integration of 
HIV (Espeseth et al., 2011a; Yoder et al., 2011; Zhou et al., 2008), another benefit of 
NEIL3 inhibiting drugs could be their use in the prevention of HIV pathogenesis. 
 
In summary this work has demonstrated the following: 
 
- Design, construction and validation of new DNA vectors for Y2H  
and LexA fusion protein expression 
- Successful expression of hNEIL3-LexA in yeast 
- Identification of potential interacting clones and DNA sequences 
- Establishment of a Y2H system for DNA glycosylases 
- Possible interaction between LigIII and hNEIL3 
- Use of P. pastoris as an expression system 
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8 Appendix 
 
8.1 Vector maps 
 
 
 
Figure 94: Vector map from the pCMV6-AC vector from OriGene and  
its multiple cloning site (MCS). 
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Figure 95: Vector map from the pCMV6-AC vector from OriGene  
and its multiple cloning site (MCS). 
 
 
Figure 96: Vector map of the pGEM-T vector from Promega. 
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Figure 97: Vector map of the blunt end cloning vector pJET1.2/blunt  
from the CloneJet PCR Cloning Kit. 
 
 
 
Figure 98: Vector map of the bait vector pEG202 used in Y2H 
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Figure 99: Vector map of the bait vector pEG202-NLS used in Y2H. 
 
 
Figure 100: Vector map of the library plasmid pJG4-5 used in Y2H. Expression of 
fusion protein is induced by a GAL1 promoter. 
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Figure 101: Vector map of the reporter plasmid pJK101 used in 
the repression assay in Y2H. 
 
 
Figure 102: Vector map of the LacZ reporter plasmids pSH18-34 (high 
sensitivity), pJK103 (medium sensitivity) and pRB1840 (low sensitivity). 
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Figure 103: Vector map of P. pastoris overexpression vector pGAPZαA(B,C).  
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8.2 NEIL3 origin sequence included in the pCMV6-AC vector from 
OriGene 
 
grey = coding sequence 
 
GCGCAGCGTTGAGTTGCACAGCGGTATTCTCACCAGGCCCTGCAATCGGTGGGCCACAGTGCCGGCCAC
AGAG 
ATGGTGGAAGGACCAGGCTGTACTCTGAATGGAGAGAAGATTCGAGCGCGGGTGCTCCCGGGCCAGGCG
GTGACCGGCGTGCGGGGAAGCGCTCTGCGGAGTCTGCAGGGCCGCGCCTTGCGGCTCGCAGCCTCCACG
GTTGTGGTCTCCCCGCAGGCTGCTGCACTGAATAATGATTCCAGCCAGAATGTCTTGAGCCTGTTTAAT
GGATATGTTTACAGTGGCGTGGAAACTTTGGGGAAGGAGCTCTTTATGTACTTTGGACCAAAAGCTTTA
CGGATTCATTTCGGAATGAAAGGCTTCATCATGATTAATCCACTTGAGTATAAATATAAAAATGGAGCT
TCTCGTGTTTTGGAAGTGCAGCTCACCAAAGATTTGATTTGTTTCTTTGACTCATCAGTAGAACTCAGA
AACTCAATGGAAAGCCAACAGAGAATAAGAATGATGAAAGAATTAGATGTATGTTCACCTGAATTTAGT
TTCTTGAGAGCAGAAAGTGAAGTTAAAAAACAGAAAGGCCGGATGCTAGGTGATGTGCTAATGGATCAG
AACGTATTGCCTGGAGTAGGGAACATCATCAAAAATGAAGCTCTCTTTGACAGTGGTCTCCACCCAGCT
GTTAAAGTTTGTCAATTAACAGATGAACAGATCCATCACCTCATGAAAATGATACGTGATTTCAGCATT
CTCTTTTACAGGTGCCGTAAAGCAGGACTTGCTCTCTCTAAACACTATAAGGTTTACAAGCGTCCCAAT
TGTGGTCAGTGCCACTGCAGAATAACTGTGTGCCGCTTTGGGGACAATAACAGAATGACATATTTCTGT
CCTCACTGTCAAAAAGAAAATCCTCAACATGTTGACATATGCAAGCTACCGACTAGAAATACTATAATC
AGTTGGACATCTAGCAGGGTGGATCATGTTATGGACTCCGTGGCTCGGAAGTCGGAAGAGCACTGGACC
TGTGTGGTGTGTACTTTAATCAATAAGCCCTCTTCTAAGGCATGTGATGCTTGCTTGACCTCAAGGCCT
ATTGATTCAGTGCTCAAGAGTGAAGAAAATTCTACTGTCTTTAGCCACTTAATGAAGTACCCGTGTAAT
ACTTTTGGAAAACCTCATACAGAAGTCAAGATCAACAGGAAAACTGCATTTGGAACTACAACTCTTGTC
TTGACTGATTTTAGCAATAAATCCAGTACTTTGGAAAGAAAAACAAAGCAAAACCAGATACTAGATGAG
GAGTTTCAAAACTCTCCTCCTGCTAGTGTGTGTTTGAATGATATACAGCACCCCTCCAAGAAGACAACA
AACGATATAACTCAACTATCCAGCAAAGTAAACATATCACCTACAATCAGTTCAGAATCTAAATTATTT
AGTCCAGCACATAAAAAACCGAAAACAGCCCACTACTCATCACCAGAGCTTAAAAGCTGCAACCCTGGA
TATTCTAACAGTGAACTTCAAATTAATATGACAGATGGCCCTCGTACCTTAAATCCTGACAGCCCTCGC
TGCAGTAAACACAACCGCCTCTGCATTCTCCGAGTTGTGAGGAAGGATGGGGAAAACAAGGGCAGGCAG
TTTTATGCCTGTCCTCTACCTAGAGAAGCACAATGTGGATTTTTTGAATGGGCAGATTTGTCCTTCCCA
TTCTGCAACCATGGCAAGCGTTCCACCATGAAAACAGTATTGAAGATTGGACCTAACAATGGAAAGAAT
TTTTTTGTGTGTCCTCTTGGGAAGGAAAAACAATGCAATTTTTTCCAGTGGGCAGAAAATGGGCCAGGA
ATAAAAATTATTCCTGGATGCTAA 
TATCTGTAGATTCTCTGGCATTTAGTCTCTTCAAACTGTGTATAATGTTTGGTCCTCCTCTGTTTCATA
GAAAAGTCATAGAATATGATACATTGAAAAGTTACTGCAAAAAAAAAAAAAAAAAAA 
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8.3 Motif sequences in hNEIL3 (OriGene) 
 
GCGCAGCGTTGAGTTGCACAGCGGTATTCTCACCAGGCCCTGCAATCGGTGGGCCACAGTGC
CGGCCACAGAG 
 
One line is 1-19 aa or 1-57 bp. Sequences in bold are motifs. 
 
N-terminal domain of NEIL 3 (1-151 aa) 
ATGGTGGAAGGACCAGGCTGTACTCTGAATGGAGAGAAGATTCGAGCGCGGGTGCTCCCGGG
CCAGGCGGTGACCGGCGTGCGGGGAAGCGCTCTGCGGAGTCTGCAGGGCCGCGCCTTGCGGC
TCGCAGCCTCCACGGTTGTGGTCTCCCCGCAGGCTGCTGCACTGAATAATGATTCCAGCCAG
AATGTCTTGAGCCTGTTTAATGGATATGTTTACAGTGGCGTGGAAACTTTGGGGAAGGAGCT
CTTTATGTACTTTGGACCAAAAGCTTTACGGATTCATTTCGGAATGAAAGGCTTCATCATGA
TTAATCCACTTGAGTATAAATATAAAAATGGAGCTTCTCGTGTTTTGGAAGTGCAGCTCACC
AAAGATTTGATTTGTTTCTTTGACTCATCAGTAGAACTCAGAAACTCAATGGAAAGCCAACA
GAGAATAAGAATGATG 
 
H2TH motif (151-244 aa) 
AAAGAATTAGATGTATGTTCACCTGAATTTAGTTTCTTGAGAGCAGAAAGTGAAGTTAAAAA
ACAGAAAGGCCGGATGCTAGGTGATGTGCTAATGGATCAGAACGTATTGCCTGGAGTAGGGA
ACATCATCAAAAATGAAGCTCTCTTTGACAGTGGTCTCCACCCAGCTGTTAAAGTTTGTCAA
TTAACAGATGAACAGATCCATCACCTCATGAAAATGATACGTGATTTCAGCATTCTCTTTTA
CAGGTGCCGTAAAGCAGGACTTGCTCTCTCTAAA 
 
CACTATAAGGTTTACAAGCGTCCCAATTGTGGTCAGTGCCACTGCAGAATAACTGTGTGCCG
CTTTGGGGACAATAACAGAATGACATATTTCTGTCCTCACTGTCAAAAAGAAAATCCTCAAC
ATGTTGACATATGCAAGCTACCGACTAGAAATACTATAATCAGTTGGACATCTAGCAGGGTG
GATCATGTTATGGACTCCGTGGCTCGGAAGTCGGAA 
 
Zf-RanBP (319-343 aa) 
GAGCACTGGACCTGTGTGGTGTGTACTTTAATCAATAAGCCCTCTTCTAAGGCATGTGATGC
TTGCTTGACCTCA 
 
AGGCCTATTGATTCAGTGCTCAAGAGTGAAGAAAATTCTACTGTCTTTAGCCAC 
 
NEIL3 unique motif (362-402 aa) 
TTAATGAAGTACCCGTGTAATACTTTTGGAAAACCTCATACAGAAGTCAAGATCAACAGGAA
AACTGCATTTGGAACTACAACTCTTGTCTTGACTGATTTTAGCAATAAATCCAGTACTTTG 
 
GAAAGAAAAACAAAGCAAAACCAGATACTAGATGAGGAGTTTCAAAACTCTCCTCCTGCTAG
TGTGTGTTTGAATGATATACAGCACCCCTCCAAGAAGACAACAAACGATATAACTCAACTAT
CCAGCAAAGTAAACATATCACCTACAATCAGTTCAGAATCTAAATTATTTAGTCCAGCACAT
AAAAAACCGAAAACAGCCCACTACTCATCACCAGAGCTTAAAAGCTGCAACCCTGGATATTC
TAACAGTGAACTTCAAATTAATATGACAGATGGCCCTCGTACCTTAAATCCTGACAGC 
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Zf-GRF 1 (505-550 aa) 
CCTCGCTGCAGTAAACACAACCGCCTCTGCATTCTCCGAGTTGTGAGGAAGGATGGGGAAAA
CAAGGGCAGGCAGTTTTATGCCTGTCCTCTACCTAGAGAAGCACAATGTGGATTTTTTGAAT
GGGCAGATTTGTCC 
 
TTC 
 
Zf-GRF 2 (552-596 aa) 
CCATTCTGCAACCATGGCAAGCGTTCCACCATGAAAACAGTATTGAAGATTGGACCTAACAA
TGGAAAGAATTTTTTTGTGTGTCCTCTTGGGAAGGAAAAACAATGCAATTTTTTCCAGTGGG
CAGAAAATGGG 
 
CCAGGAATAAAAATTATTCCTGGATGCTAA 
 
 
TATCTGTAGATTCTCTGGCATTTAGTCTCTTCAAACTGTGTATAATGTTTGGTCCTCCTCTG
TTTCATAGAAAAGTCATAGAATATGATACATTGAAAAGTTACTGCAAAAAAAAAAAAAAAAA
AA 
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8.4 SNPs in hNEIL3 DNA 
 
SNPs in hNEIL3 cDNA (from OriGene) compared to hNEIL3 cDNA (from NCBI). 
 
hNEIL3 cDNA insert in pCMV6-AC vector from OriGene: 
 
GCGCAGCGTTGAGTTGCACAGCGGTATTCTCACCAGGCCCTGCAATCGGTGGGCCAC
AGTGCCGGCCACAGAG 
 
ATGGTGGAAGGACCAGGCTGTACTCTGAATGGAGAGAAGATT 
CGA (AA pos.: 15 ; Codon NCBI: CGC ; Syn.: Arg) 
GCGCGGGTGCTCCCGGGCCAGGCGGTGACCGGCGTGCGGGGAAGCGCTCTGCGGAGT
CTGCAGGGCCGCGCCTTGCGGCTCGCAGCCTCCACGGTTGTGGTCTCCCCGCAGGCT
GCTGCACTGAATAATGATTCCAGCCAGAATGTCTTGAGCCTGTTTAATGGATATGTT
TACAGTGGCGTGGAAACTTTGGGGAAGGAGCTCTTTATGTACTTTGGACCAAAAGCT
TTACGGATTCATTTCGGAATGAAAGGCTTCATCATGATTAATCCACTTGAGTATAAA
TATAAAAATGGAGCTTCT 
 
CGT (AA pos.: 117 ; Codon NCBI: CCT ; Missense: G=Arg, C=Pro) 
GTTTTGGAAGTGCAGCTCACCAAAGATTTGATTTGTTTCTTTGACTCATCAGTAGAA
CTCAGAAACTCAATGGAAAGCCAACAGAGAATAAGAATGATGAAAGAATTAGATGTA
TGTTCACCTGAATTTAGTTTCTTGAGAGCAGAAAGTGAAGTTAAAAAACAGAAAGGC
CGGATGCTAGGTGATGTGCTAATGGATCAGAACGTATTGCCTGGAGTAGGGAACATC
ATCAAAAATGAAGCTCTCTTTGACAGTGGTCTCCACCCAGCTGTTAAAGTTTGTCAA
TTAACAGATGAACAGATCCATCACCTCATGAAAATGATACGTGATTTCAGCATTCTC
TTTTACAGGTGCCGTAAAGCAGGACTTGCTCTCTCTAAACACTATAAGGTTTACAAG
CGT 
 
CCC (AA pos.: 252 ; Codon NCBI: CCT ; Syn.: Pro) 
AATTGTGGTCAGTGCCACTGCAGAATAACTGTGTGCCGCTTTGGGGACAATAACAGA
ATGACATATTTCTGTCCTCACTGTCAAAAAGAAAATCCTCAACATGTTGACATATGC
AAGCTACCGACTAGAAATACTATAATCAGTTGGACATCTAGCAGGGTGGATCATGTT
ATGGACTCCGTGGCTCGGAAGTCGGAAGAGCACTGGACCTGTGTGGTGTGTACTTTA
ATCAATAAGCCCTCTTCTAAGGCATGTGATGCTTGCTTGACCTCAAGGCCTATTGAT
TCAGTGCTCAAGAGTGAAGAAAATTCTACTGTCTTTAGCCACTTAATGAAGTACCCG
TGTAATACTTTTGGAAAACCTCATACAGAAGTCAAGATCAAC 
 
AGG (AA pos.: 381 ; Codon NCBI: AGA ; Syn.: Arg) 
AAAACTGCATTTGGAACTACAACTCTTGTCTTGACTGATTTTAGCAATAAATCCAGT
ACTTTGGAAAGAAAAACAAAGCAAAACCAGATACTAGATGAGGAGTTTCAAAACTCT
CCTCCTGCTAGT 
 
GTG (AA pos.: 424 ; Codon NCBI: GTT ; Syn.: Val) 
TGTTTGAATGATATACAGCACCCCTCCAAGAAGACAACAAACGATATAACTCAA 
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CTA (AA pos.: 443 ; Codon NCBI: CCA ; Missense: T=Leu, C=Pro ) 
TCCAGCAAAGTAAACATATCACCTACAATCAGTTCAGAATCTAAATTATTTAGTCCA
GCACATAAAAAACCGAAAACAGCC 
 
CAC (AA pos.: 471 ; Codon NCBI: CAA ; Missense: C=His, A=Gln) 
TACTCATCACCAGAGCTTAAAAGCTGCAACCCTGGATATTCTAACAGTGAACTTCAA
ATTAATATGACAGATGGCCCTCGTACCTTAAATCCTGACAGCCCTCGCTGCAGTAAA
CACAACCGCCTCTGCATTCTCCGAGTTGTGAGGAAGGATGGGGAAAACAAGGGCAGG
CAGTTTTATGCCTGTCCTCTACCTAGAGAAGCACAATGTGGATTTTTTGAATGGGCA
GATTTGTCCTTCCCATTCTGCAACCATGGCAAGCGTTCCACCATGAAAACAGTATTG
AAGATTGGACCTAACAATGGAAAGAATTTTTTTGTGTGTCCTCTTGGGAAGGAAAAA
CAATGCAATTTTTTCCAGTGGGCAGAAAATGGGCCAGGAATAAAAATTATTCCTGGA
TGCTAA 
 
TATCTGTAGATTCTCTGGCATTTAGTCTCTTCAAACTGTGTATAATGTTTGGTCCTC
CTCTGTTTCATAGAAAAGTCATAGAATATGATACATTGAAAAGTTACTGCAAAAAAA
AAAAAAAAAAAA 
 
Explanations: 
 
CDS [Coding Sequence (e.g. ATGGTGGAA…)] 
 
Origin Sequence [Addition to CDS (e.g. GCGCAGCGTT…)] 
 
(e.g.) CGA...: SNPs (Single Nucleotide Polymorphisms) 
 
AA pos.:  Amino Acid Position (Codon Position) of SNP 
 
Codon NCBI:  Codon at same AA pos. but found altered in cDNA sequence on 
NCBI. 
 
Syn.: Synonymous – different codon but same resulting amino acid 
 
Missense: Different codon as well as different resulting amino acid 
 
ATG:  Start codon 
 
TAA:  Stop codon 
 
 
Source for SNP findings: 
 
http://www.ncbi.nlm.nih.gov/projects/SNP/  Gene ID for NEIL3 = 55247 
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8.5 PCR product quality from EGY48 yeast extractions 
 
Table 25: PCR product quality, obtained from potential positive EGY48 yeast clones from 
placental cDNA library screening, after purification using sonication method 
Yeast Clone Number Concentration (ng/µl) 260nm/280nm 260nm/230nm 
21 74.4 1.80 1.71 
33 65.2 1.83 1.52 
41 59.4 1.78 1.58 
50 54.4 1.81 0.90 
57 36.1 1.81 1.75 
64 47.2 1.81 1.33 
73 45.3 1.81 1.80 
74 53.9 1.82 1.70 
77 48.2 1.80 0.88 
78 59.2 1.84 1.34 
83 40.3 1.90 2.41 
86 43.2 1.90 2.46 
88 51.3 1.86 2.34 
89 36.3 1.92 2.34 
91 32.5 1.90 0.39 
95 39.5 1.89 2.38 
96 36.2 1.86 2.13 
97 50.9 1.90 2.07 
99 45.5 1.87 2.47 
103 13.1 1.81 2.05 
111 72.3 1.63 0.94 
113 37.6 1.83 1.91 
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Yeast Clone Number Concentration (ng/µl) 260nm/280nm 260nm/230nm 
117 37.2 1.76 1.60 
120 46.8 1.84 1.62 
121 37.3 1.84 1.65 
123 42.4 1.82 1.70 
124 42.9 1.82 1.57 
125 44.0 1.80 1.50 
126 39.1 1.87 1.75 
127 34.3 1.79 1.35 
131 34.0 1.89 1.27 
136 35.0 1.85 0.27 
142 32.6 1.84 1.44 
147 43.8 1.86 1.67 
148 24.5 1.84 1.41 
149 26.6 1.82 1.68 
151 27.6 1.80 1.74 
156 28.0 1.76 1.28 
160 35.5 1.82 0.23 
162 40.4 1.83 1.42 
163 44.9 1.87 2.05 
166 36.7 1.82 1.70 
170 42.3 1.78 1.67 
178 32.1 1.85 1.77 
182 37.7 1.80 1.68 
185 37.0 1.83 0.52 
188 39.8 1.85 1.72 
189 40.1 1.78 1.15 
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Yeast Clone Number Concentration (ng/µl) 260nm/280nm 260nm/230nm 
190 on 23 Nov 28.5 1.80 1.40 
190 on 24 Nov 120.4 1.37 0.33 
191 36.7 1.82 1.43 
193 38.0 1.80 1.06 
196 23.3 1.88 1.38 
199 39.0 1.90 1.82 
200 40.4 1.85 1.77 
208 34.6 1.86 1.36 
 
8.6 Complete sequencing (BLAST) results of Y2H screenings 
8.6.1 Complete sequencing (BLAST) results of placental cDNA library screen 
 
Clone 
No. 
BLAST Result 
Conserved  
Domains 
In 
frame? 
CDS? 
14 
  
Protein phosphatase 1, regulatory (inhibitor) 
subunit 7  
LRR_SD22 Leucine 
Rich repeats 
? YES 
15 No PCR product       
21 
Decorin (DCN), transcript variant C, mRNA 
(also Variants B, A2, A1, E, D) 
LRR_TYP Leucine 
Rich repeats 
(Superfamily) 
YES YES 
28 
Interleukin 1 receptor accessory protein 
(IL1RAP), RefSeqGene on chromosome 3 
-------------No 
domain found--------
------- 
-   
33 RPL10 ribosomal protein L10  
Ribosomal_L16_L1
0e domain 
NO YES 
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Clone 
No. 
BLAST Result 
Conserved  
Domains 
In 
frame? 
CDS? 
41 
Homo sapiens shisa homolog 5 (Xenopus 
laevis) (SHISA5), mRNA 
-------------No 
domain found--------
----- 
- YES 
50 No PCR product   -   
57 No DNA Sequence found by sequencing   -   
59 
Homo sapiens chromosome 6 genomic 
contig, GRCh37.p5 Primary Assembly -- 
Features of the part of sequence: AN1-type 
zinc finger protein 3 [Homo sapiens] 
  - NO 
63 
Homo sapiens gamma-aminobutyric acid 
(GABA) A receptor, epsilon (GABRE), mRNA 
  - NO 
64 
TIMP metallopeptidase inhibitor 2 (TIMP2), 
mRNA 
NTR_like 
(Superfamily) 
YES YES 
73 Ribosomal protein L30 (RPL30), mRNA 
Ribosomal_L7Ae 
(Superfamily) 
YES YES 
74 
RNA binding motif protein 8A (RBM8A), 
mRNA 
--------------No 
domain found--------
-------- 
YES YES 
77 
Chorionic gonadotropin, beta polypeptide 8 
(CGB8), mRNA (also polypeptide 5, 7, 2, 1 
and luteinizing hormone beta polypeptide 
(LHB) with decreasing E values and Max 
ident) 
GHB_like YES YES 
78 
Chorionic gonadotropin, beta polypeptide 8 
(CGB8), mRNA (also polypeptide 5, 7, 2, 1 
and luteinizing hormone beta polypeptide 
(LHB) with decreasing E values and Max 
ident) 
GHB_like NO? YES 
83 No DNA sequence found by sequencing       
86 No DNA Sequence found by sequencing       
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Clone 
No. 
BLAST Result 
Conserved  
Domains 
In 
frame? 
CDS? 
88 Hemoglobin, alpha 1 (HBA1), mRNA Globin NO YES 
89 No DNA sequence found by sequencing       
91 No DNA sequence found by sequencing       
95 No DNA Sequence found by sequencing       
96 No significant similarity found whith BLAST.       
97 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like NO YES 
99 
Homo sapiens shisa homolog 5 (Xenopus 
laevis) (SHISA5), mRNA 
  -   
103 No PCR product       
111 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like YES YES 
113 
Proteasome (prosome, macropain) subunit, 
alpha type, 5 (PSMA5), transcript variant 1, 
mRNA 
Proteasome_alpha
_type_5 
NO YES 
117 
Osteoclast stimulating factor 1 (OSTF1), 
mRNA 
--------No domain 
found---------- 
- NO 
120 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like YES YES 
121 No DNA Sequence found by sequencing       
123 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like YES YES 
124 
Pregnancy specific beta-1-glycoprotein 5 
(PSG5), transcript variant 1, mRNA 
--------No domain 
found---------- 
- NO 
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Clone 
No. 
BLAST Result 
Conserved  
Domains 
In 
frame? 
CDS? 
125 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like YES YES 
126 
Chorionic somatomammotropin hormone 2 
(CSH2), transcript variant 1, mRNA 
Somatotropin_like YES YES 
127 
Chorionic gonadotropin, beta polypeptide 8 
(CGB8), mRNA 
GHB_like NO? YES 
131 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like YES YES 
136 
Chorionic somatomammotropin hormone 2 
(CSH2), transcript variant 1, mRNA 
Somatotropin_like YES? YES 
142 
Chorionic somatomammotropin hormone 2 
(CSH2), transcript variant 1, mRNA 
--------No domain 
found---------- 
- NO 
147 
Ornithine decarboxylase antizyme 1 (OAZ1), 
mRNA 
ODC_AZ 
(Superfamily) 
? YES 
148 No DNA Sequence found by sequencing   -   
149 
Structural maintenance of chromosomes 6 
(SMC6), transcript variant 1, mRNA 
ABC_SMC6_euk, 
P-loop_NTPase 
(Superfamily) 
YES 
mRNA/
NO 
CDS 
YES 
151 
HOP homeobox (HOPX), transcript variant 3, 
mRNA 
Homeodomain YES YES 
156 No PCR product   -   
160 
ELAV (embryonic lethal, abnormal vision, 
Drosophila)-like 1 (Hu antigen R) (ELAVL1), 
mRNA 
RRM (found two 
times in same 
sequence) 
YES YES 
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Clone 
No. 
BLAST Result 
Conserved  
Domains 
In 
frame? 
CDS? 
162 
Proteasome (prosome, macropain) subunit, 
alpha type, 5 (PSMA5), transcript variant 1, 
mRNA 
Proteasome_alpha
_type_5 
NO YES 
163 Hemoglobin, beta (HBB), mRNA Globin YES YES 
166 
Transglutaminase 2 (C polypeptide, protein-
glutamine-gamma-glutamyltransferase) 
(TGM2), transcript variant 1, mRNA 
--------No domain 
found---------- 
- NO 
170 
Ribosomal protein L9 (RPL9), transcript 
variant 2, mRNA 
Ribosomal_L6 
(Superfamily) 
? YES 
178 
CD59 molecule, complement regulatory 
protein (CD59), transcript variant 5, mRNA 
--------No domain 
found---------- 
- NO 
182 
Gamma-aminobutyric acid (GABA) A 
receptor, epsilon (GABRE), mRNA 
--------No domain 
found---------- 
- NO 
185 
Homo sapiens hemoglobin, gamma G 
(HBG2), mRNA 
Globin YES YES 
188 
Tumour protein, translationally-controlled 1 
(TPT1), mRNA 
TCTP superfamily 
(No more 
information on 
NCBI) 
YES YES 
189 
Secreted protein, acidic, cysteine-rich 
(osteonectin) (SPARC), mRNA 
--------No domain 
found---------- 
- NO 
190 No DNA Sequence found by sequencing   -   
191 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like YES YES 
193 
Gamma-aminobutyric acid (GABA) A 
receptor, epsilon (GABRE), mRNA 
--------No domain 
found---------- 
- NO 
 Thomas ROEDL – PhD Thesis – Salford 2013 227 
Clone 
No. 
BLAST Result 
Conserved  
Domains 
In 
frame? 
CDS? 
196 No Transcript found by BLAST   -   
199 
Chorionic somatomammotropin hormone 1 
(placental lactogen) (CSH1), mRNA 
Somatotropin_like YES YES 
200 
Proteasome (prosome, macropain) subunit, 
alpha type, 5 (PSMA5), transcript variant 1, 
mRNA 
Proteasome_alpha
_type_5 
NO? YES 
208 
(worked 
only with 
PCR 
method) 
Ribosomal RNA processing 9, small subunit 
(SSU) processome component, homolog 
(yeast) (RRP9), mRNA 
WD40 
(Superfamily), TP2 
Nuclear transition 
protein 2 
(Superfamily), DNA 
polymerase III 
subunits gamma 
and tau (Multi 
Domain) 
YES? YES 
 
8.6.2 Complete sequencing (BLAST) results of Jurkat T-cell cDNA library 
screen 
Clone 
No. 
BLAST Result 
Conserved 
Domains 
In 
frame? 
CDS? 
1 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none -- NO 
2 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
3 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
4 No similarity found none   NO 
5 
Homo sapiens nudix (nucleoside diphosphate 
linked moiety X)-type motif 4 (NUDT4), 
transcript variant 2, mRNA  
none   NO 
6 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
7 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
8 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
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9 No similarity found none   NO 
10 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
12 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
13 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
15 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
17 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
18 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
19 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
22 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
23 Cytochrome c oxidase none   NO 
26 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
33 
Homo sapiens solute carrier family 25 
(mitochondrial carrier; phosphate carrier), 
member 3 (SLC25A3), nuclear gene encoding 
mitochondrial protein, transcript variant 2, 
mRNA 
none NO YES 
37 
Homo sapiens ribosomal protein L4 (RPL4), 
mRNA 
none NO YES 
43 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
45 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
51 
Homo sapiens coiled-coil domain containing 
88A (CCDC88A), transcript variant 2, mRNA 
none   NO 
44 
Homo sapiens pyruvate kinase, muscle 
(PKM2), transcript variant 3, mRNA 
Pyruvate kinase 
(PK) 
NO YES 
52 No similarity found none  NO 
55 No similarity found none  NO 
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8.7 Additional pictures 
 
Figure 104: GeneExpression of NEIL3 in different human cell lines. (Image 
taken from http://biogps.gnf.org/#goto=genereport&id=55247(2010)). 
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Figure 105: Structures of mouse/human NEIL3, human NEIL1, NEIL2, E. coli Nei, 
Thermus thermophilus MutM (Fpg) and human APE2 proteins. Black boxes, the 
conserved N-terminal domain; horizontally-striped box, H2TH motif; cross-hatched 
box, zinc finger motifs; hatched box, putative nuclear localization signals; vertically-
striped box, topoisomerase IIIα homologous domain; checkered box, PCNA 
binding motif. (Image taken from Torisu et al., 2005). 
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Figure 106: 216 potential genuine clones on YNB (gal) ura
-
/his
-
/trp
-
/leu
-
 
master plates, picked from screening plates after incubation at 30°C for 
two days. 
